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Abstract
Nucleotide excision repair (NER) is responsible for the removal of helix
distorting lesions from DNA. These include cyclobutane pyrimidine dimers
and 6-4 photoproducts, caused primarily by ultraviolet (UV) radiation. The
persistence of these lesions in the genome can lead to the development of
skin cancer, and furthermore, exposure to UV radiation has been linked with
systemic immunosuppression, which can also increase the risk of tumour
development. Patients with xeroderma pigmentosum have defective NER,
with around a 1000 fold increased risk of developing skin cancer compared
with the rest of the population. In NER, ERCC1 acts in complex with XPF to
make an incision 5' of the lesion and as such is essential for this damage
repair process. ERCC1 is also involved in other types of repair including the
repair of interstrand crosslinks and double strand breaks. Erccl null mice die
at 3 weeks with severe liver abnormalities, so in the laboratory we have
created two longer lived Erccl deficient models: firstly a liver corrected
Erccl null, and secondly an epidermis specific Erccl knockout. In this study
we considered the short and long term effects of UV irradiation on the skin
using the epidermis specific Erccl knockout, in particular the consequences
of unrepaired DNA damage in keratinocytes on UV induced erythema,
immunosuppression, tanning and carcinogenesis. We found the epidermis
specific Erccl knockout mice to be extremely sensitive in all these respects.
As these mice have NER deficient keratinocytes but NER proficient
fibroblasts, immunological cells and melanocytes, we were able to show that
DNA damage in keratinocytes is responsible for initiating a cascade of events
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that leads to systemic immunosuppression, and we also report that DNA
damage in keratinocytes alone leads to UV induced tanning. We went on to
use these mice to investigate proposed anti-cancer therapy, the topical
application of thymidine dinucleotides. We have also further characterised
the liver corrected Erccl null mouse, specifically the neurological features
and an unusual hair phenotype that was observed. We report that
progressive ataxia in animals with an Erccl deficient nervous system is due
to chronic uraemia caused by kidney pathology. Furthermore, we
characterised a brittle hair phenotype in these mice, and concluded that it
was due to an unidentified background effect rather than a specific trait
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1.1 Fundamentals of DNA repair
Maintenance of the genetic code is fundamental for species survival, and
although Darwinian evolutionary theory requires some degree of genetic
variation, cells and organisms must be able to pass on their DNA through
generations and generations. DNA must withstand replicative cycles and
recombinational processes, as well as insult from environmental factors.
Mutations in germ line cells can result in hereditary syndromes and disease
susceptibility being passed through generations. Mutations in somatic cells
can also result in disease, with cancer possibly the most severe
consequence.
In order to protect the integrity of the genome and maintain the information
stored within, several repair mechanisms are in place. Each repair
mechanism deals with a particular type of DNA damage, although there is
evidence for some overlap occurring between some of the mechanisms.
These include direct repair, mismatch repair, base excision repair, nucleotide
excision repair, recombinational repair, non-homologous end joining and
repair of inter strand cross-links.
Direct repair is a simple repair method where an enzyme catalyses the
straightforward removal of a DNA adduct (reviewed by Sancar, 1995 and
1996). Such enzymes include DNA photolyase (found in some prokaryotes
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as well as marsupials), 6-4 photoproduct photolyase (found in Drosophila
and some other species), spore photoproduct lyase (found in the spores of
Bacillus subtllis) and 06-methylguanine DNA methyl transferase (found in all
species investigated), which removes alkyl groups from the DNA.
Mismatch repair (MMR) is important for maintaining the replicative fidelity of
the genome (reviewed by Jun et al, 2006 and Jiricny, 2006). Mismatches are
identified, the DNA is unwound, then an incision is made in the affected
single strand and the mismatched base removed by exonuclease activity.
The gap is then filled and ligated. The consequences of defective MMR are
demonstrated in hereditary non polyposis colorectal cancer (HNPCC), a
syndrome where germline mutations in MMR genes predispose the patient to
colorectal carcinoma (reviewed by de la Chapelle, 2004).
Base excision repair (BER) is the removal of non-bulky adducts from the
DNA (reviewed by Sancar, 1996), often the result of metabolic by-products.
Such damage can be caused by reactive oxygen species, methylation and
hydroxylation. A glycosylase cleaves the damaged base from the attached
deoxyribose, then the abasic sugar is released by apurinic/apyrimidinic lyase
and endonucleases, before a nucleotide fills the gap.
Nucleotide excision repair (NER) is a mechanism for removing bulky adducts
from the DNA, generally caused by UV light or polycyclic aromatic
hydrocarbons (found for example in cigarette smoke). Incisions are made in
20
the damaged strand of DNA by endonucleases, upstream and downstream
of the lesion, before this section is replaced and ligated. In prokaryotes this
is a relatively simple process, involving just three proteins. In eukaryotes
however the mechanism is more complex, involving many more proteins, and
will be considered in more detail in the following section. In mammals,
nucleotide excision repair mainly deals with lesions caused by exposure to
ultraviolet light.
Homologous recombinational repair (HRR) (reviewed by Thompson and
Schild, 2002) is a pathway involved in the repair of DNA double strand
breaks (DSBs). DSBs are caused primarily by x rays or by other types of
ionising radiation, as well as certain chemicals. In this pathway, the 5' strand
of DNA is degraded, resulting in a single strand that can be used to identify
homologous sequence on the paired chromosome and therefore repair the
damage.
Non homologous end joining (NHEJ) is a second pathway for the repair of
DNA DSBs (reviewed by Hefferin and Tomkinson, 2005). This process
requires the broken ends to be physically closely aligned, before NHEJ
proteins bind the broken ends of the DNA. The Ku complex is crucial for this
process and protects the exposed DNA. Bridging then occurs, involving
processing followed by ligation by DNA ligase IV.
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Inter-strand cross-link (ICL) repair is a complex process involving proteins
characteristically part of other repair pathways as well as its own set of
enzymes (reviewed by Mirchandani and D'Andrea, 2006). Cross-linking
agents include cisplatin, mitomycin c and other alkylating agents, many of
which form an important class of chemotherapeutic, anti-cancer drugs. Their
effectiveness is derived from the severe cytotoxic effect of these drugs on
proliferating cells. The exact details of the pathways involved in ICL repair
have yet to be elucidated, although a possible mechanism has been
proposed (Niedernhofer et al, 2005). In short, it appears that the FANC
(Fanconi anaemia) gene products are involved in the initial processing of the
lesion, creating a structure that is then repaired either by NER or by HRR.
The ERCC1/XPF complex appears to be crucial for the repair of ICLs (de
Laat et al, 1998, Chipchase and Melton, 2002, Niedernhofer et al, 2004), and
this will be discussed in more detail later in this chapter.
At this point it is also important to note a cellular process known as
translesion synthesis (TLS). In this process, the cell uses low fidelity
polymerases to bypass a lesion and thus continue replication (reviewed by
Lehmann, 2006). One of these polymerases is DNA Polr], which is defective
in variant XP syndrome (Masutani et al, 1999). When proliferating cell
nuclear antigen (PCNA), a sliding DNA clamp, is stalled by the presence of a
lesion, it is ubiquitinated and able to form interactions with TLS polymerases.
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1.2 Nucleotide excision repair
This thesis will focus on mammalian nucleotide excision repair, and in
particular on the endonuclease ERCC1. NER has been reviewed extensively
(de Laat et al, 1999 and Hoeijmakers, 2001, amongst others), and the
majority of the proteins involved in the pathway are well characterised.
Nucleotide excision repair (NER) deals with helix distorting lesions, primarily
caused by UV radiation. DNA acts as a chromophore for UV, absorbing
energy and forming bulky adducts. The majority of these are cis-syn-
cyclobutane pyrimidine dimers (CPDs), whilst pyrimidine 6-4 pyrimidone
photoproducts (6-4PPs) are also produced (de Boer and Hoeijmakers, 2000).
Briefly, helix distorting lesions are identified. The helix is then held open,
whilst incisions are made on either side of the lesion. The damaged section
is removed, and the gap filled by a DNA polymerase, using the intact strand
as a template. The ends are then joined by DNA ligase.
Two variations on the NER pathway exist. The first of these is global
genome repair (GGR), where damage throughout the genome is repaired at
a constant rate. The alternative is transcription coupled repair (TCR), where
damage in transcribed genes is repaired. TCR employs a different
recognition system in order to allow lesions in transcribed genes, and
specifically those in the transcribed strand, to be repaired at a greater rate
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than damage found in other areas of the genome. The availability of this
pathway allows a cell to repair damage in genes required for transcription,
with priority over damage in parts of the genome not required until the cell
undergoes replication. In this way, a lesion that stalls the transcription
machinery is repaired prefentially over any other lesion.
Figure 1.1 gives an overview of the NER mechanism, showing how GGR and
TCR pathways differ in the first step and subsequently converge.
As mentioned, GGR is a constant process involving inspection of the entire
genome. Lesions are recognised by the XPC-hHR23B complex, which has
been reported as being dispensable for TCR (Venema et al, 1990a).
hHR23B has been identified as a stimulator for XPC activity (Masutani et al,
1997), and together these proteins sense and bind DNA lesions (Volker et al,
2001), recruiting the NER machinery (de Laat et al, 1999). GGR is very
efficient at repairing 6-4PPs and less efficient at removing CPDs (de Boer
and Hoeijmakers, 2000). This is likely to be due to the differing affinity of
XPC for these types of lesions.
The Xpe gene product has also been implicated in damage recognition,
although its exact function remains unclear. XPE seems to be unnecessary
for NER in vitro, as determined by complementation analysis, (de Laat et al,
1999), and XPE patients suffer from mild XP symptoms compared with those
from other complementation groups. The damaged DNA binding complex
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Fig 1.1
















TFIIH (inc. XPB and XPD),
XPG, XPA and RPA ^ — XPG
Recruitment of:
CSA, TFIIH (inc. XPB and










gap is filled using remaining strand as
a template, and the ends are ligated
excised strand with lesion is
removed and degraded
Figure 1.1 Overview of NER mechanism
The recognition steps of GGR and TCR differ but thereafter the NER
mechanism is the same. TFIIH opens the dsDNA, RPA binds the template
strand, and XPA identifies the lesion. XPG makes the 3' incision, then
ERCC1/XPF makes the 5' incision. The damaged strand is removed, and the
gap filled by DNA polymerase and ligated by DNA ligase.
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(DDB) has high affinity for UV induced DNA lesions, and consists of a
p48/p127 heterodimer (Nichols et al, 2000). The p48 subunit (also known as
DDB2) has been identified as the XPE gene product (Rapic-Otrin et al, 2003)
and this appears to be a protein with several roles in cell cycle checkpoints
as well as NER (Kulaksiz et al, 2005). Recently, DDB2 has been reported to
have a role in the modification of histone H2A by ubiquitination, and it is
suggested that this causes a conformational change which may enable the
NER machinery to bind the lesion (Kapetanaki et al, 2006).
Recognition in TCR occurs when RNA polymerase II is stalled by a lesion,
whilst in the process of transcription (Donahue et al, 1994). Cells from
Cockayne Syndrome (CS) patients are defective in TCR (Venema et al,
1990b), and it appears that CS proteins interact with RNA pol II once it has
come across a lesion in the DNA (van Gool et al, 1997). However the
precise functions of CSA and CSB remain unclear.
After a lesion has been identified by either GGR or TCR proteins, the rest of
the NER machinery is recruited to the damaged site. This includes
transcription factor TFIIH, RPA, XPA and endonucleases XPG, XPF and
ERCC1. These roles of these proteins will subsequently be considered in
more detail.
The function of the TFIIH protein complex is to unwind the DNA helix, and it
is involved in transcription as well as NER. TFIIH is composed of ten
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different proteins, with individual functions. XPB unwinds DNA in a 3' to 5'
direction (Ma et al, 1994) and XPD unwinds DNA in a 5' to 3' direction (Sung
et al, 1993). The CAK subcomplex is composed of Cdk7, cyclin H and Mat 1,
and is essential for transcription but not for NER (Mu et al, 1996). The
remaining proteins appear to have structurally important roles. p44 anchors
XPD (Seroz et al, 2000 and Tremeau-Bravard et al, 2001) and p52 anchors
XPB within the TFIIH complex (Jawhari et al, 2003). p62 has been shown to
bind XPG (Gervais et al, 2004), and p34 has DNA binding capacity, although
its exact role is unclear. Finally, TTDA is the most recently identified TFIIH
subunit (Giglia-Mari et al, 2004). This has been shown to be essential for
NER, and associates closely with TFIIH during the repair process (Giglia-
Mari et al, 2006).
Replication protein A (RPA) specifically binds to single stranded DNA, and
was initially described as a requisite protein for DNA replication (Wold and
Kelly, 1988). A role for RPA in excision repair was confirmed by the finding
that RPA specific antibodies inhibited DNA repair in vitro (Coverly et al,
1991). This role has been identified as the stabilisation of the unwound DNA,
as the protein binds the undamaged strand during the NER process (de Laat
et al, 1999).
XPA was identified to be responsible for group A XP disease when cloned
XPA cDNA alleviated UV sensitivity in XP group A derived cells (Tanaka et
al, 1990). XPA binds other proteins involved in NER, and as such is
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considered a crucial factor for the positioning of repair machinery around the
lesion (de Laat et al, 1999).
XPG is an endonuclease which cuts one strand of double stranded DNA at
the 3' side of a double strand/single strand junction. In NER, XPG makes the
3' incision (O'Donovan et al, 1994). Previously it was reported that it does
this before the 5' incision is made (Mu et al, 1996), however it is now debated
whether in fact the incisions are made concurrently (Thorel et al, 2004).
Some patients with XPG deficiency show features of Cockayne syndrome,
and it is postulated therefore that XPG may have a role in transcription. This
is corroborated by evidence showing XPG has a region which interacts with
TFIIH (Thorel et al, 2004). XPG has also been shown to have a role in base
excision repair, as it has been reported to act in the repair of thymine glycol
by stimulating endonuclease III activity (Bessho, 1999).
In NER, ERCC1 and XPF act in complex as an endonuclease
complementary to XPG, identified by purification of the proteins causing XP
group F (Sijbers et al, 1996). It has been reported that ERCC1 interacts with
DNA and with XPA, enabling XPF to perform the incision in the correct
location (Tripsianes et al, 2005). In addition to its role in NER, ERCC1/XPF
is essential for the repair of interstrand cross-links, although its precise
function remains unclear (Bessho et al, 1997, Chipchase and Melton, 2002
and Niedernhofer et al, 2004). ERCC1/XPF has also been shown to be
necessary for homologous recombination repair (Sargent et al, 2000),
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recombination in mouse embryonic stem cells (Niedernhofer et al, 2001) and
for normal haematopoiesis (Prasher et al, 2005).
In summary, the NER pathway is fairly well characterised, as are most of the
proteins involved - however many of these have roles in other cell functions,
that are not always well understood. In future, research in this area will not
only further our understanding of the roles of these gene products in NER,
but also enable us to piece together the overlapping pathways involved in the
maintenance, replication and transcription of the genetic code.
1.3 Human nucleotide excision repair syndromes
Hereditary human NER deficiency results in three syndromes, each with
distinct and overlapping features: xeroderma pigmentosum, Cockayne
syndrome and trichothiodystrophy.
Xeroderma pigmentosum (XP) is characterised by extreme photosensitivity,
excessive pigmentation in response to UV and a heightened susceptibility to
UV induced skin cancer. Several complementation groups have been
identified, XPA-G as well as variant XP, or XPV. XPV is caused by mutation
in Polri (Masutani et al, 1999), however the other XP syndromes are caused
by mutations in the NER genes. XP patients have around one thousand fold
increased risk of skin cancer, and the mean age for initial development of
29
skin cancer is 8 years of age, compared with around 50 in the general
population (reviewed by Kraemer, 1997). A small number of XP patients
have neurological symptoms, and these appear to be those patients with a
more severe NER defect (Bootsma et al, 1998). This phenotype is likely to
be due to the accumulation of oxidative lesions in neurons, leading to
neurodegeneration.
Cockayne's syndrome (CS) is characterised by neurological and
developmental abnormalities, such as microcephaly, kyphosis, gait defects
and mental retardation, as well as incomplete sexual development and
cachectic dwarfism (reviewed by de Boer and Hoeijmakers, 2000).
Genetically, the syndrome is attributed to mutation in either CSA or CSB. CS
patients are photosensitive, however they do not have increased
susceptibility to developing skin cancers compared with the rest of the
population. This conveniently underlines the key differences between
transcription coupled NER and global genome NER, illustrating the
consequences for the organism of the loss of TCR and not GGR. From
these patients we are able to conclude that it is GGR that is essential for
preventing the skin cancers to which XP patients are so susceptible.
However, it is important to note that there are features of CS that cannot be
explained by NER deficiency alone, as XPA patients do not show them, and
these are caused by defects in transcription resulting from lack of TCR. Cells
from CS patients have been reported to be hypersensitive to oxidative
damage (Leadon and Cooper, 1993), although it seems unclear that these
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results were produced reliably (Cozzarelli, 2003). However, an increased
sensitivity to oxidative damage may explain the neurological phenotype of
CS patients, as the neurological system is particularly sensitive to oxidative
damage (reviewed by Halliwell, 2006).
Trichothiodystrophy (TTD) is a syndrome characterised by brittle hair. In
these patients, there is an insufficiency of cysteine rich matrix proteins in the
hair, which leads to hair shafts that are extremely fragile and break easily
(Gillespie and Marshall, 1983, reviewed by Itin and Pittelkow, 1990). This
feature is accompanied by ichthyosis, reduced growth, impaired fertility and
mental retardation. Interestingly, some, but not all, TTD patients show sun
sensitivity, and there are no reports of skin cancer susceptibility. Genetically,
TTD is caused by mutations in one of XPB, XPD or TTDA, all of which are
TFIIH subunits. Physiologically, trichothiodystrophic hair lacks sulphur rich
matrix proteins (reviewed by Nakamura et al, 2001), and this has been linked
with a failure in late stage transcription in the highly differentiated
keratinocytes. In this model, a marker of a late differentiation stage has been
shown to be reduced, implying that transcription has effectively been
exhausted in these cells (de Boer et al, 1998b). Aside from the characteristic
brittle hair and ichthyosis, the symptoms of TTD are comparable with those
of CS. Although XPB, XPD and TTDA are not linked specifically with TCR,
as the CS proteins are, they are linked with transcription itself, which also
has implications for the neurological system. As neurons do not divide, as
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well as being susceptible to oxidative damage, they have unusually high
levels of transcription.
DeSanctis-Cacchione syndrome is an extremely rare disease with features of
XP as well as a severe neurological phenotype. This disease has been
reported to be due to mutation in XPA, as well as CSB in one case (Colella et
al, 2000). Another extremely rare disease is combined XP/CS, showing
symptoms of both disorders - patients have been identified with mutations in
XPB, XPG and XPD (reviewed by Lehmann, 2001).
Mutations in particular NER genes do not necessarily lead to specific
syndromes. For example, mutations in XPD can lead to XP, TTD or XP/CS,
and mutations in CSB can lead to CS or deSanctis-Cacchione syndrome.
This illustrates the complexity of the NER pathway and the roles of the
various proteins involved, as well as the relationship between NER and
transcription.
1.4 Nucleotide excision repair deficiency and cancer predisposition
Cancer development is the result of genetic and epigenetic changes causing
dysregulation of the cell cycle, which leads to uncontrolled proliferation. NER
as well as other types of repair already mentioned in this thesis are required
to deal with lesions throughout the genome, but it is lesions specifically in
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genes involved with cell cycle control, proliferation and apoptosis that are of
extreme importance in cancer development. The link between repair
deficiency and cancer susceptibility could not be more clear. There are a
variety of human syndromes caused by defective repair of one kind or
another, the majority of which have increased cancer risk as their main
feature.
The balance between proliferation, replicative senescence and apoptosis is
tightly regulated by a vast array of proteins (reviewed in Vogelstein and
Kinzler, 1998). A schematic of the cell cycle is shown in figure 1.2.
Dysregulation of the cell cycle can be caused by the inactivation of tumour
suppressor genes or by the activation of oncogenes. Tumour suppressor
genes normally regulate cell cycle checkpoints, and ensure that replication
does not go ahead if the cell is not ready, thereby preventing the
accumulation of mutations. Oncogenes are mutated forms of normal genes
which promote cell growth and proliferation.
The p53 gene product acts as a tumour suppressor and plays a crucial role
in cell cycle regulation. Normal p53 protein accumulates in cells after
exposure to damaging agents, including UV radiation, and causes cycle
arrest in G1 (Kuerbitz et al, 1992). This prevents replication of damaged
DNA, and allows time for repair of the damage to take place. p53 is mutated
in a wide variety of human cancers, including skin cancers, and the







Figure 1.2 Overview of cell cycle
M = mitosis, S = synthesis, G1 and G2 = gap stages, G0 = replicative senescence
The cell cycle is regulated by cyclins, which form complexes with cyclin
dependent kinases (CDKs) in specific patterns. The progression of the cell cycle
is controlled by CDK inhibitors, including p21 (activated by p53), pl6 and pl9.
Adapted from Cotran et al, Robbins Pathologic Basis of Disease
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checkpoint regulatory activity (Lane, 1992). The p53 gene product is a
powerful transcription factor and upregulates the expression of the p21 gene
product, which acts in a complex with other factors to inhibit the
phosphorylation of the Rb gene product, and thereby inhibit cell cycle
progression (Harper et al, 1993). p21 also modulates PCNA, inhibiting its
role in replication but not repair (Li et al, 1994).
An example of an oncogene is mutated c-myc. Proto-oncogenic c-myc is
involved in the early entrance of a cell to the cycle, and its expression is
tightly controlled (reviewed by Chung and Levens, 2005). However in
several human tumours c-myc is either expressed constitutively or
overexpressed, including Burkitt lymphoma (where dysregulation is due
specifically to a translocation) as well as some breast, lung and colon
cancers (Cotran et al, 1999).
Another important aspect of tumourigenesis is regulation of telomerase. The
ends of our chromosomes are protected from exonuclease activity and
subsequent degradation by a non-coding repeat sequence, called the
telomere. Telomeres vary in length and homogeneity, depending on tissue
(de Lange et al, 1990). The telomere repeat sequence is bound by
stabilising factors including TRF1 and TRF2, and forms a characteristic loop
structure known as a T loop (Griffith et al, 1999). In this structure, the 3' end
of the DNA strand loops back on itself and invades the dsDNA. Disruption of
the loop lets the cell know that its replicative capacity is exhausted, and
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triggers signals which induce replicative senescence or apoptosis, dependent
on cell type (reviewed by de Lange, 2002). Telomere length therefore also
has implications for organism aging, as telomeres shorten with successive
rounds of replication. In germline cells, telomere length has to be maintained
to allow infinite reproduction of a species, and therefore these cells express
an enzyme called telomerase, which is not normally expressed in other cells.
The telomerase complex consists of a reverse transcriptase enzyme, as well
as an RNA template and an associated protein (Linger et al, 1997). In the
vast majority of cancer cells, the telomerase enzyme has been reactivated
(reviewed by Shay and Wright, 2006), leading to the conclusion that the main
function of telomeres that are programmed to degrade further with each
reproductive cycle is to guard against tumourigenesis. Aberrant telomerase
activity is currently an exciting target for many forms of putative cancer
therapies.
A further link between telomeres and aging has recently been made by
reports that WRN (a protein mutated in the segmental progeroid disorder
Werner's syndrome) has a role in the processing of the telomeres and
activation of DNA damage responses (Eller et al, 2006).
It should however be noted that differences in telomere damage response
pathways between mice and humans have been reported, and this should be
considered when interpreting data on telomere damage and maintenance in
the mouse model (Smogorzewska and de Lange, 2002).
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It is important to consider that cancer does not arise through defects in DNA
repair proteins in themselves. The reason that patients and animal models
with DNA repair defects are cancer prone is that they experience DNA
damage at a normal rate, but are unable to repair it, and crucially, are unable
to repair mutations in tumour suppressor genes and protooncogenes. The
accumulation of damage and the inevitable disruption of the highly regulated
cell cycle process is what leads to tumourigenesis in DNA repair deficient
patients.
1.5 Mouse models of nucleotide excision repair defects
A variety of mouse models that are deficient in DNA repair have been
generated, and these are listed in a frequently updated database (Friedberg
and Meira, 2006). Many mouse models for NER have also been created,
and have been reviewed recently (Wijnhoven et al, 2006). For each of the
NER proteins, null mice have been created, and these display a range of
lifespans and phenotypes. NER null mice are summarised in Table 1.1. For
some of the NER proteins, as well as the null mouse models, mice with point
mutations, truncations and conditional knockouts have also been made.
These have generally alleviated a severe phenotype and allowed
researchers to study some of the consequences of NER deficiency that are
impossible to consider in mice with an extremely short lifespan. This section
37
will review the existing NER deficient mouse models, however the Erccl
models that have been created in our lab will be considered in more detail in
the next section.
Independent strains of Xpa null mice were created simultaneously (de Vries
et al, 1995 and Nakane et al, 1995). These were created by deletion of
exons 3 and 4, and by insertion of a neo cassette into exon 4, respectively.
Around 50% foetal death of Xpa nulls was reported by de Vries et al,
however normal Mendelian ratios were reported by Nakane et al. However,
both groups reported an absence of Xpa mRNA and protein product. Both
groups also showed a high susceptibility to UV and chemical carcinogen
























































Polh"'" Lin et al,
2006
Normal Not at one
year
Yes
Csa"'" van der Horst
et al, 2002
Normal No Yes
Csb_/" van der Horst
et al, 1997
Normal No Yes
* reported in more recently developed mouse models with a less severe
mutation and therefore longer lifespan
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An Xpb model has been listed in the DNA repair model database (Friedberg
and Meira, 2006), however the paper remains unpublished at this date. It is
reported that a mouse has been created with a mutation mimicking that
found in a human XPB patient, and that the mice are viable although there
are disrupted Mendelian inheritance patterns, suggesting impaired prenatal
development (Weeda et al, currently unpublished).
Xpc mice were generated using an Hprt minigene to disrupt the Xpc
sequence (Sands et al, 1995). These mice are highly susceptible to UV
induced skin cancer, and also show UV induced skin changes reminiscent of
XP, such as hyperkeratosis. More recently, these mice have also been
shown to suffer from spontaneous lung tumours (Hollander et al, 2005)
Xpd null mice are embryonic lethals (de Boer et al, 1998a). A viable mouse
model was created by mimicking a point mutation from a patient, XPDR772W,
with a photosensitive form of TTD, and this mouse appeared to show all the
features of the TTD patient (de Boer et al, 1998b). This mutation confers a
partial NER defect. However on further examination, this mouse model also
showed increased susceptibility to UV and chemical carcinogen induced
carcinogenesis, (albeit not as much as Xpa mice), (de Boer et al, 1999),
which has not been reported in TTD patients. This in itself is interesting, as it
seems a fair assumption that a defect in NER (as opposed to TCR) should
predispose to UV induced carcinogenesis in human patients. However, the
rate of GGR is lower in mice than in humans, perhaps due to the difference
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in life expectancy between these species, which may account for the
increased cancer susceptibility in mice. Furthermore, XPE expression is low
in mice, contributing to low GGR (Alan Lehmann, personal communication).
It is proposed by the authors that TTD patients are in fact somewhat cancer
prone, although not as much as other XP patients, and that the characteristic
scaling of TTD skin itself provides protection from UV damage in the basal
epithelium (de Boer et al, 1999). Furthermore, the TTD mouse has been
shown to display features of premature aging, a phenotype which is
exaggerated further when these mice are crossed with Xpa null mice (de
Boer et al, 2002). This is postulated to be a result of endogenous, oxidative
lesions building up and leading to increased levels of cell death, as well as
defects in transcription (de Boer et al, 2002). Recently, the TTD mouse
model has been determined to have a segmental progeroid, or premature
ageing, phenotype, which is also evident in human TTD patients (Wijnhoven
et al, 2005). These mice display aging features such as osteoporosis,
kyphosis and aortic sarcopaenia. Interestingly, the TTD mouse shows a
reduced level of certain aging-related features, including demyelination of
peripheral nerves, cataract development and pituitary adenoma formation.
This phenotype is similar to that reported for mice on a restricted calorie diet,
shown to prolong lifespan. It is hypothesised that the TTD model in some
way protects itself from potentially harmful metabolic by-products by energy
efficient uptake, explaining the low body weight of these animals (Wijnhoven
et al, 2005). If this is the case, this is a finding that raises many questions
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about the regulation of metabolic efficiency and the regulation of production
of metabolic by-products.
DDB2 mice, postulated to represent Xpe deficiency, have been generated by
deletion of exons 4 and 5 (Yoon et al, 2005). These appear to be highly
susceptible to internal tumours, particularly of the lymphoid tissue, as well as
UV induced skin cancers (Yoon et al, 2005).
An Xpf model mouse has been created recently, modelling a point mutation
from an XPF patient (Tian et al, 2004). This introduced a stop codon into
exon 8 of the Xpf gene. Despite the fact that the patient did not suffer
extremely severe symptoms, all XpfA mice generated died at three weeks,
similar to Ercc1'A mice (McWhir et al, 1993). This implies that the mutation
introduced has in fact created a null Xpf allele, which is backed up by the
lack of evidence forXpfmRNA in cells created (Tian et al, 2004).
Xpg has been knocked out in the mouse using a neo insertion into exon 3 of
the gene (Harada et al, 1999). The mice created produce no Xpg mRNA and
have features reminiscent of Xpf or Erccl deficiency, with impaired growth
followed by a dramatically reduced lifespan (Harada et al, 1999) and
cerebellar abnormalities (Sun et al, 2001).
Since the first Erccl knockout mouse was created (McWhir et al, 1993), a
number of different Erccl models have been created in our laboratory.
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These will be addressed in more detail in section 1.6 of this introduction.
There are also a number of Erccl mouse models that have been created
elsewhere. A knockout model has been reported, using a neo insertion to
disrupt exon 7 of the gene (Weeda et al, 1997). This mouse showed a very
similar phenotype to that reported previously, however there was also an
indication that sex affected survival of the mice to some extent. Female mice
appeared to live somewhat longer and were slightly less runted than male
littermates (Weeda et al, 1997). In this publication a second Erccl model
was also reported. These mice carry an engineered stop codon at position
292, which results in the production of a truncated Erccl protein. These
mice are referred to as Ercc1A?/' and have a life expectancy of around four to
six months. Erccl a7/' mice are runted, have liver abnormalities and signs of
liver dysfunction (Weeda et al, 1997), indicating that this is a useful model
with characteristics of Erccl absence, but with a longer lifespan.
It should be noted that the consequences of loss of Xpf, Xpg and Erccl have
very similar, severe, consequences for the animals. This reflects the
important roles of these endonucleases in other pathways, as well as NER.
Recently a mouse was generated modelling DNA Polrj deficiency, with exon
4 of the Polq gene deleted (Lin et al, 2006). These mice have normal life
expectancy and do not appear to develop spontaneous tumours, although
currently data is not available on these mice after one year of age. Polr]
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mice do show increased susceptibility to UV induced skin cancer (Lin et al,
2006).
Mouse models have also been created that mimic Cockayne syndrome. The
Csb model mouse was generated by mimicking a gene truncation found in a
CSB patient (van der Horst et al, 1997) and the Csa model was created by
interrupting exon 2 of the Csa gene with a hygromycin insert (van der Horst
et al, 2002). These mice are photosensitive, show slightly retarded growth,
but have normal sexual function and life expectancy, although the older mice
do show some signs of neurodegeneration. Despite these mild CS-like
features, these mice are prone to UV induced skin tumours. This highlights a
difference between mice and humans: whereas in human CS patients, GGR
alone is capable of removing UV induced lesions and preventing tumour
formation, in mice TCR must play a greater role (van der Horst et al, 1997
and 2002).
Finally, a mouse model of hHR23B deficiency has been generated, known as
mHR23B~/~. The phenotype reported is much more severe than that of Xpc"A
mice, with the majority of mice suffering perinatal death, and although
survivors display severely abnormal development, many survive 6 months to
one year (Ng et al, 2002). This phenotype confirms that this protein has
roles outwith NER, possibly involving protein stability and degradation (Ng et
al, 2003).
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1.6 Melton group Erccl mouse models
Our laboratory was the first to produce an Erccl null mouse model (McWhir
et al, 1993), using a previously reported targeted Erccl allele where exon 5
is disrupted by insertion of a neo cassette (Selfridge et al, 1992). These
animals were severely runted, weighing around 20% that of control
littermates, and had an extremely compromised life expectancy of around
twenty days. They were found to have a severe liver phenotype which
almost certainly was the cause of the premature mortality. Liver polyploidy is
a characterised feature of aging, and is likely to be a mechanism by which
the liver maintains its complex structure and high function whilst still
replicating nuclei (Biesterfeld et al, 1994, reviewed by Gupta, 2000).
However, Erccl null mice showed ploidy levels at three weeks of age that
were reminiscent of two year old mice. p53 levels were also found to be
elevated in the Erccl null mice. Whilst the liver phenotype was extremely
interesting, this model of nucleotide repair deficiency did not provide a model
comparable with any human diseases and did not allow the study of the
consequences of loss of NER on other tissues, simply due to the lifespan of
these mice being so short.
As the liver had been identified as the prime focus of pathology in the
complete Erccl knockout mice, the next aim was to create a model that was
Erccl deficient but had an Erccl proficient liver. This was achieved using an
Erccl transgene under the control of the transthyretin promoter (reported in
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Selfridge et al, 2001). The use of the transthyretin regulatory sequence
provided liver specific expression of the Erccl transgene.
Erccl null animals expressing the liver transgene had an alleviated
phenotype. Runting was reduced, with animals weighing around 60% of their
wild type littermates, and lifespan was extended to 9-12 weeks. Liver
pathology was absent in these mice, and hepatic function was normal.
However, these animals displayed some kidney abnormalities. These
included slightly increased plasma creatinine levels, a four fold increase in
kidney 8-oxo-guanine DNA adducts as well as some histopathology and an
increase in ploidy levels.
It appeared that having corrected the liver phenotype, these animals were
dying with kidney abnormalities. Although these mice have a somewhat
extended lifespan, this was still insufficient to carry out any long term studies
into the effects of Erccl loss on sensitivity to UV radiation. Some preliminary
short term studies were carried out and did show an high sensitivity to UV
irradiation in these mice (Selfridge, 1999).
Consequently, work in the laboratory was focused on creating a conditional
Erccl knockout with which to study the long term effects of Erccl deficiency
in the skin. This was achieved using the Cre-lox system of targeted
recombination (reviewed by Nagy, 2000). In this system, bacterial
recombinase Cre is controlled by a tissue specific or development specific
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promoter sequence. When or where expressed, Cre recombinase
recognises two loxP sites that have been inserted into the gene of interest,
and catalyses a recombination event between these two sites. This
effectively excises a portion of the gene, and in our case, renders it inactive.
As we wished to create an epidermal specific knockout, we used a
transgenic mouse line expressing Cre recombinase under the control of the
keratin K5 promoter (Ramirez et al, 2004).
K5:: Cre has been shown to be expressed in the basal epithelial layer and in
hair follicles, but in no other tissue (Ramirez et al, 2004). However, when
females carrying the transgene are used for mating, the progeny show
recombination activity in all tissue, regardless of whether these mice have
themselves inherited the transgene. This is indicative of K5v.Cre expression
in the oocyte (Ramirez et al, 2004). For this reason, our breeding scheme
used the K5::Cre transgene derived solely through the paternal line.
To create a floxed Erccl allele, exons 3, 4 and 5 of Erccl were replaced with
an Hprt minigene (Doig et al, 2006, supplementary information figure 1),
which in itself created a second Erccl null allele. Subsequently the Hprt
minigene was replaced by Erccl exons 3 through 5, flanked by loxP sites
(Doig et al, 2006). A schematic diagram of epidermal specific Erccl
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Figure 1.3 Epidermal specific inactivation of Erccl
Cre recombinase expression is controlled by epidermal specific K5
promoter. Cre recognises loxP sites inserted into the Erccl floxed
allele and catalyses a recombination event. This produces the
recombined Erccl locus, from which no functional protein is
generated.
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Using this system we are able to generate mice that have an inactivated
Erccl gene in the epidermis. By Southern blot analysis we found 100%
recombination levels in the epidermis, whereas recombination levels of less
than 5% were found in other internal tissues (Doig et al, 2006).
For all experiments carried out using these animals, Ercc1flox/nu" with K5::Cre
were used as Erccl epidermal specific knockout (ESKO) mice, and
f=rcclflox/wlldtype wjth K5v.Cre mice were used as controls. As the main reason
for developing these mice was to investigate the effects of Erccl deficiency
on UV sensitivity, we used these mice on an albino and hairless (hr)
background.
Using these mice, we were able to study a range of responses to UV
radiation. We planned to investigate UV induced carcinogenesis, the
importance of which has already been considered, as well as several short
term responses to UV irradiation including erythema,
photoimmunosuppression and tanning. These aspects will be introduced in
some detail below.
1.7 UV induced erythema
Erythema is defined as reddening of the skin and can be caused by a range
of factors including infection and inflammation. UV induced erythema is the
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result of dilation and congestion of cutaneous blood vessels, and the degree
of erythema is proportional to dose until at least 15 MED (Farr and Diffey,
1984). In humans, erythema has been shown to follow a biphasic pattern,
with an immediate erythemic peak, followed by a second phase starting
around an hour after UV exposure and peaking after 24-48 hours. This
pattern is similar in other species apart from the hairless mouse, where only
the delayed response is seen (reviewed by Clydesdale et al, 2001).
It is not yet fully clear which substances are responsible for triggering the
inflammatory response to UV, as there are contradictory data available.
Experiments on rats showed that the addition of BOL-148 inhibited early
erythema, implicating 5-hydroxytryptamine (5-HT or serotonin) as having a
major role, as BOL-148 is a 5-HT antagonist. In guinea pigs, antagonists of
Hi and H2 histamine receptors have also been shown to block early
erythema. However, unexpectedly, the addition of antihistamines did not
block erythema (reviewed by Clydesdale et al, 2001).
Greaves and Sondergaard showed in 1970 that ultraviolet induced erythema
in humans is linked with a smooth muscle contracting agent. It is now known
that an increase in prostaglandins, in particular PGE2 and PGF2a, and the
prostaglandin precursor arachidonic acid, can be seen at around twenty-four
hours after exposure to UVB. PGE2 is known to be an inflammatory
mediator. Tests where inhibitors of prostaglandin synthesis were given, such
as indomethacin and aspirin, have shown that these substances decrease
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UV-induced erythema but do not prevent it entirely (Clydesdale et al, 2001),
suggesting that prostaglandins have a role in the erythemal response but that
other substances are also involved.
As well as direct biological damage, UV radiation causes indirect damage by
the production of free radicals. Whilst it is mainly UVA that produces reactive
oxygen species, UVB does induce the synthesis of nitric oxide from l-
arginine. Nitric oxide acts as a vasodilatory agent by increasing levels of
cGMP in vascular smooth muscle, causing the blood vessels to relax. Nitric
oxide is released by keratinocytes after UVB irradiation, and nitric oxide
synthase inhibitor, NG-monomethyl-l-arginine (l-NMMA) has been shown to
have a protective effect against UVB in vivo in guinea pigs (Deliconstantinos
et al, 1995), as well as hairless mice (Russo and Halliday, 2006). This
implies a role for nitric oxide in the erythemal response.
The role of DNA damage as an early modulator in the cascade of events
leading to UV induced erythema is confirmed by other NER deficient mouse
models, which have been shown to be hypersensitive to UV induced
erythema. In particular, TCR deficient models are hypersensitive. Xpa and
Csb knockouts have MEDs of 135-270 Jm"2 compared with Xpc knockouts
and controls which have MEDs of 1080-2160 Jm"2 (Berg et al, 2000). Xpa
knockouts have also been reported to have an MED of 62.5 Jm"2, although
the controls for this group have MEDs of 500 Jm"2 (van Schanke et al, 2005).
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1.8 Photoimmunosuppression
Photoimmunosuppression has multiple consequences, including the
increased susceptibility of the organism to infections (reviewed by Norval,
2001, 2002 and 2006). However, the importance of
photoimmunosuppression in cancer relates primarily to the inability of the
organism to recognise antigenic transformed cells which may become
malignant tumours.
Langerhans cells (LCs) are a subset of antigen presenting cells found in the
epidermis. Their role is to scavenge for antigen, which they trap and
internalise using dendritic processes. The LCs then migrate to the draining
lymph node and process the antigen using the MHC class II pathway. An LC
then presents the antigen to the appropriate naive T cell in the lymph node
using MHC class II. In order to activate the T cell fully, the LC must also
express other, co-stimulatory molecules on its surface.
Stimulated CD4+ T cells differentiate into either T helper 1 (Th1) or T helper
2 (Th2) cells. Th1 cells release cytokines that promote the cellular immune
response (also termed pro-inflammatory). Th2 cells release cytokines that
promote the humoral immune response and suppress the cellular immune
response (also termed anti-inflammatory). Th2 cytokines are involved in the
control of extracellular pathogens, while Th1 cytokines are important in the
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control of intracellular pathogens, and, critically, the control of tumour cells.
LCs and other DCs can also present antigen to CD8+ T cells, T regulatory
(Treg) cells and natural killer T (NK-T) cells.
UV radiation induces the migration of LCs to the lymph nodes in the absence
of antigen (Moodycliffe et al, 1992). The function of these LCs is also
compromised. LCs visible in the skin after UV irradiation have a drastically
altered morphology when viewed using electron microscopy (Dandie et al,
1998). The extensive dendritic processes normally visible are almost
completely withdrawn into the cell body. LCs with damaged DNA are found
at their highest level in the lymph nodes twenty four hours after exposure to
UV (Vink et al, 1996). Enriched populations of dendritic cells from the lymph
nodes of UV irradiated sheep have been shown to have impaired antigen
presenting capabilities for up to two weeks after a UV dose of a single MED
(Dandie et al, 1998). The slow recovery rate of LCs is likely to be due to the
repopulation originating in bone marrow (Obata and Tagami, 1985).
LCs from UV exposed skin stimulate the activation of Th2 cells rather than
Th1 cells (Simon et al, 1990). Treg cells and NK-T cells are also stimulated
by UV exposed LCs and release anti-inflammatory cytokines (Schwarz et al,
2004 and Moodycliffe et al, 2000). This is shown schematically in figure 1.4.
In addition to the loss of normal antigen presenting capacity, there is























Figure 1.4 Overview of photoimmunosuppression
Photoimmunosuppression is triggered by the release of inflammatory
mediators by keratinocytes which induce aberrant Langerhans cell migration.
These accumulate in the draining lymph node where they stimulate T cells in
the absence of co-stimulatory molecules. This causes a Th2 bias in the
immune response, and crucially, activates regulatory T cells (T-regs) which
results in the induction of immune tolerance to the antigen in question.
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antigen in the absence of the required co-stimulatory molecules. UV
exposure has been shown to inhibit the expression of co-stimulatory
molecules on the surface of LCs, including intercellular adhesion molecule-1
(ICAM-1) and CD80/CD86 (Komura et al, 2003). Human monocyte derived
LC-like dendritic cells have been shown to have reduced endocytic activity
and lowered CD32 expression after exposure to UV (Mizuno et al, 2004).
Several factors are implicated in the induction of LC migration. Nitric oxide
synthase inhibitor, NG-monomethyl-l-arginine (l-NMMA) has been shown to
prevent suppression of the allergic response to nickel as well as preventing
the migration of LCs after UV (Yuen et al, 2002 and Kuchel et al, 2003). l-
NMMA has also been shown to improve the protective effect of sunscreen on
the contact hypersensitivity response (Russo and Halliday, 2006), suggesting
a role for nitric oxide. However the main factor is likely to be the bias of the
immune system towards a Th2 environment after UV exposure.
DNA is accepted to be an important chromophore for UV radiation. Studies
on human XP patients have shown UVB induced depletion of LCs (Jimbo et
al, 1992).
In other NER mouse models, epidermal LCs have been shown to be
depleted after UV exposure. Previous studies have shown that Xpa mice
exhibit 59% depletion compared with 33% depletion in controls after a single
250 Jm"2 UVB dose (Miyauchi-Hashimoto et al, 1996). In another study, LC
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depletion after UV exposure was shown to be greater than control mice in
Xpa and Csb mice but not Xpc mice (Kolgen et al, 2003). These findings
underline the importance of TCR rather than GGR in the process of
photoimmunosuppression.
None of these models studied previously were conditional knockouts, and
therefore the cells in the skin and throughout the immune system were repair
deficient. Our Erccl knockouts have repair deficient epidermis, but the LCs
and other immune system cells are repair proficient. If UV induced migration
of LCs is caused solely by DNA damage in the LCs themselves, then our
mice might not show increased LC migration after UV exposure compared
with repair proficient controls. However if UV induced migration of LCs is
caused by factors secreted by DNA damaged keratinocytes, our mice would
show increased LC migration after UV.
The contact hypersensitivity (CHS) response is another means with which to
assay immune system function, and suppression of the CHS response by
UVB radiation is well documented. Previous studies have shown Xpa and
Csb mice to be more susceptible to UV induced suppression of the CHS
response than controls, and Xpc mice to have a similar sensitivity to controls
(Kolgen et al, 2003). This again confirms this importance of TCR over GGR
in the immediate response to UV.
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Erythema and photoimmunosuppression are provoked at a cellular level by
the release of a wide range of cytokines and chemokines. In chapter 3 of
this thesis, we will consider the induction of six such factors from repair
proficient and deficient keratinocytes after UV irradiation, and consequently a
brief introduction to each of these is found below.
Tumour necrosis factor-alpha (TNF-a) promotes local inflammation and
endothelial activation, as well as the formation of sunburn cells. Studies
have shown that TNF-a is released by keratinocytes after UV exposure
(Kock et al, 1990, reviewed by Schade et al, 2005). Levels of TNF-a protein
have also been shown to be upregulated in the ears of Xpa deficient mice
following treatment with systemic immunosuppressive agent
dimethylbenz(a)anthracene (DMBA) compared with wild type mice (Miyauchi-
Hashimoto et al, 2001).
lnterleukin-6 (IL-6) is involved in acute phase immune system reaction and
fever. Human normal and transformed keratinocytes have been reported to
show increased IL-6 mRNA and protein in response to UVB radiation
(Kirnbauer et al, 1991). The release of IL-6 by keratinocytes has been linked
with DNA damage by the assertion that the UV wavelength spectrum that
causes peak IL-6 release coincides with the wavelength spectrum that
causes CPD formation (Petit-Frere et al, 1998).
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lnterleukin-12 (IL-12) is primarily a pro-inflammatory cytokine, its main
function being to promote Th1 type differentiation of CD4+ T cells. IL-12 has
been shown to prevent photoimmunosuppression as well as restore normal
immune function after UV exposure (Schwarz et al, 1996). Furthermore,
intra-cutaneous injection of IL-12 has been shown to reduce UV induced
apoptosis in wild type mice but not in Xpa knockout mice (Schwarz et al,
2002). This may imply a role for IL-12 in the induction of NER. The effects
of IL-12 on keratinocytes are well documented (Schwarz et al, 2002 and
Molenda et al, 2006). However there is only one published paper
documenting UVB induced IL-12 transcription in human keratinocytes (Enk et
al, 1996).
Interferon-gamma (IFN-y) is closely linked to IL-12. IFN-y activates
macrophages and suppresses the Th2 response, and its expression is
thought to be induced by IL-12. IL-12 production by spleen cells has been
shown to be inhibited by UVB exposure (Garssen et al, 1999). There is no
evidence for IFN-y being released by keratinocytes in response to UV.
lnterleukin-10 (IL-10) is a Th2 cytokine and an active suppressor of cellular
immune responses. It is released by a range of cells and suppresses
macrophage function as well as IFN-y production (Fiorentino et al, 1991). IL-
10 undoubtedly plays an important role in the development of
photoimmunosuppression, although its exact role appears to differ between
mice and humans. In humans, macrophages and neutrophils appear to be
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the main source of IL-10 (Piskin et al, 2005); whilst in mice, keratinocytes
produce the majority. In mice, the addition of anti- IL-10 antibodies to
supernatants from UVB irradiated keratinocytes has been reported to reverse
the immunosuppressive effects of the supernatants on the delayed type
hypersensitivity response (Rivas and Ullrich, 1992). Since then, DNA
damage has been linked to the production of IL-10 by UVB irradiated
keratinocytes, in a paper which showed that liposomes containing a DNA
repair enzyme were able to reduce IL-10 secretion by keratinocytes in vitro
as well as in vivo (Nishigori et al, 1996). IL-10 has also been shown to be
increased in cells of the draining lymph nodes of UV irradiated NER deficient
mice (Boonstra et al, 2001).
Macrophage chemoattractant protein-1 (MCP-1) is a chemokine which
targets monocytes, T cells and basophils; its main functions being to induce
monocytes into a tissue to become active macrophages, to promote
histamine release from basophils, and crucially for photoimmunosuppression,
to encourage a Th2 type immune response (Janeway et al, 2001). Members
of the MCP family have been shown to inhibit the production of IL-12 in
tissues rather than in the lymphatic system, and are able to do this
specifically without inhibiting IL-10 or TNF-a (Braun et al, 2000). However
the effects of UVB radiation on keratinocyte MCP-1 expression have not
been studied. With the knowledge that this chemokine suppressed the
cellular immune response, we expect MCP-1 levels might be raised in
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response to UV, however it is unclear whether studying the effects on
keratinocytes alone will provide this result.
1.9 The tanning response
Tanning is an adaptive response that the skin uses to protect itself from UV
radiation. Melanin is produced by melanocytes in vesicles called
melanosomes and passed to keratinocytes. This is accomplished by a
process involving melanocyte exocytosis and keratinocyte phagocytosis
(Virador et al, 2002). UV radiation causes melanocytes to increase pigment
synthesis (Friedmann and Gilchrest, 1987), although it is clear that
keratinocytes play a major role in the regulation of melanin synthesis by
paracrine control. Melanocyte stimulating hormone was first defined by
Fitzpatrick in the 1950s. There is now known to be a family of hormones
which are synthesised by differential processing of pro-opiomelanocortin
(POMC) in the pituitary. This family includes a-MSH and
adrenocorticotrophic hormone (ACTFI). Upon UV exposure, POMC is
4
expressed in the skin, enabling the synthesis of these hormones (Inoue et al,
2003). a-MSH binds melanocortin-1 receptor (MC1-R), a G-protein coupled
membrane spanning receptor. When a-MSH binds MC1-R a cascade of
events results in expression of tyrosinase and related proteins, which are
involved in melanin biosynthesis (reviewed by Yaar and Gilchrest, 2004).
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DNA damage was first suggested as a trigger for melanogenesis when T4
endonuclease V, a DNA repair enzyme, was shown to stimulate melanin
production by melanocytes in culture (Eller et al, 1994). This hypothesis was
strengthened when various DNA damaging agents were shown to increase
melanin production by melanocytes in culture (Eller et al, 1996).
Recently, this issue was addressed using Xpa knockout mice. These mice
showed increased melanogenesis compared with wild type controls after
UVB exposure (van Schanke et al, 2005). However the mice used in this
study were not conditional knockouts, so all the tissues in the mice were Xpa
deficient. Consequently, the authors were unable to conclude whether the
increased melanocyte proliferation was due to DNA damage in melanocytes
themselves or in keratinocytes or fibroblasts.
We plan to approach this issue using our Erccl skin specific knockout mice,
although for these experiments we will use mice crossed on to a hairless
pigmented background, rather than a hairless albino background. These
mice have repair deficient keratinocytes, with wild type melanocytes and
fibroblasts. We expect our mice to tan more readily than controls, implicating
keratinocytes as major effectors in the tanning response.
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1.10 Topically applied thymidine dinucleotides - a possible role in
cancer prevention?
The use of topical thymidine dinucleotides was first reported in the mid
nineties by Barbara Gilchrest's group in Boston (Eller et al, 1994). Initial
reports concerned the application of thymidine dinucleotides (pTpT) to
guinea pig and human skin and the subsequent pigment response. These
showed that skin 'tanned' in a manner similar to UV-induced increased
pigmentation. S91 cells, a murine melanoma line, also responded to pTpT
by producing more melanin (Eller et al, 1994; Eller et al, 1996). It was
postulated that this response was due to the thymidine dinucleotides
mimicking the sequence of DNA excised during the repair of cyclobutane
pyrimidine dimers. A year later the same group concluded that pTpT was
activating p53 and increasing the rate of DNA repair, using reporter systems
as well as measuring damage directly (Eller et al, 1997). This was
corroborated when pTpT was shown to upregulate p53, p21 and PCNA in
human fibroblasts in a similar manner to UV, and furthermore, pTpT
enhanced the UV induced expression of these same factors (Goukassian et
al, 1999). pTpT treatment also seems to enhance DNA repair capacity in
fibroblasts from older donors, bringing levels of repair proteins in line with
those seen in cells derived from newborns (Goukassian et al, 2002).
pTpT appears to mimic the effects of UV radiation in yet another way: levels
of tumour necrosis factor-a and interleukin-10 are increased, and in mice, the
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contact hypersensitivity response is suppressed (Cruz Jnr et al, 2000 and
Curiel-Lewandrowski et al, 2003).
The first paper reporting the long term effect of pTpT application on mouse
skin showed that topical treatment alongside a chronic UV irradiation protocol
protected against skin cancer development (Goukassian et al, 2004).
Interestingly, the published data showed this effect on wild type and Xpc
heterozygous mice, but did not report the effect on Xpc homozygous null
mice. As the authors attributed the protective effect of pTpT to an
upregulation of DNA repair mechanisms, we would expect to see no
protective effect in Xpcv' mice.
As well as being similar to the by-product of NER, pTpT also shares
homology with part of the telomere repeat sequence. As mentioned
previously, the ends of our chromosomes are protected from exonuclease
activity by a non-coding repeat sequence, TTAGGG (reviewed by de Lange,
2002). The telomere repeat sequence is bound by stabilising factors
including TRF1 and TRF2, and forms a characteristic loop structure known
as a T loop (Griffith et al, 1999). In this structure, the 3' end of the DNA
strand loops back on itself and invades the dsDNA. It is likely that disruption
of the loop triggers DNA damage responses within the cell. Oligonucleotides
with telomere sequence homology have been shown to induce apoptosis in
human lymphocyte cells (Eller et al, 2002) and S phase arrest in human
fibroblasts (Eller et al, 2003).
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Despite the amount of data published on the activity of topical pTpT
treatment and its promising anti-cancer properties, there seems to be a lack
of understanding of the mechanisms involved. We believe that our NER
deficient model will help further the understanding of how this potentially
exciting anti-cancer agent exerts its effects.
1.11 Aims of this thesis
This thesis will further consider the implications of Erccl deficiency by
continuing the characterisation of the Erccl mouse models in the lab.
The Erccl epidermal specific knockout (ESKO) mouse will be used to
consider the effects of Erccl deficiency on the short and the long term
responses to UV, in chapters 3 and 4 respectively, and our hypothesis is
that, due to the additional repair functions of Erccl outside the NER pathway,
the Erccl ESKO model will prove more sensitive to UV than simple NER
knockouts. The short term response refers to UV induced erythema,
photoimmunosuppression and tanning. Within this the role of the
keratinocyte will be considered, specifically the effect of DNA damage in the
keratinocyte on the rest of the skin and indeed the rest of the organism,
something we are able to consider thanks to the epidermis specificity of our
knockout model. The long term response refers to UV induced
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carcinogenicity, which will also be addressed with the Erccl ESKO mouse.
The effects of Erccl defiency on UV induced cancer susceptibility is
something which has been unable to be considered in the past, due to the
absence of a sufficiently long lived mouse model.
The work in chapter 5 follows on from chapter 4, where using the Erccl
ESKO mice, we will consider the protective effect of topical thymidine
dinucleotide application. This is a treatment that has been shown to protect
against UV induced skin cancer in mice, however its mechanism of action
remains unclear and is something we are well placed to investigate with our
model that is especially susceptible to UV induced cancer.
Chapters 6 and 7 of this thesis characterise further novel aspects of the
phenotype seen in the liver corrected Erccl null model, considering





2.1 Reagents and suppliers
Abeam: (3-tubulin rabbit polyclonal
Aldrich Chemical Company Inc.: sodium maleate hydrate
Amersham: ECL fluorescence kit, Hyperfilm™ MP high performance
autoradiography film, Storm 860 Phospholmager
BD Biosciences: CBA Assay - mouse inflammation kit, FACSArray flow
cytometry machine
BDH Ltd.: acetic acid, DePex, hydrochloric acid, 1% aqueous eosin
Becton Dickinson: FACScan flow cytometry machine
Bioline: DNA Hyperladder I
Biometra: thermocycler
BioRad: Gel Doc 2000 System with Quantity One 4.6 software
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Calbiochem: anti-neurofilament proteins
Chance Propper Ltd.: micro slides
Dako: monoclonal mouse anti-human Melan-A/Mart 1, goat serum, sheep
anti-mouse::FITC
Developmental Studies Hybridoma Bank: anti-SV2
Dia-Stron Ltd.: erythema meter 220
Fisher Scientific: boric acid, chloroform, EDTA, haematoxylin, isoamyl
alcohol, isopropanol (propan-2-ol), magnesium sulphate, methanol, 10%
SDS, sodium citrate, sodium hydroxide, tri-sodium citrate, xylene
Fluka: glycerol gelatine
Greiner: petri dishes, 96-well plates
Hayman: absolute alcohol
Hettich: Mikro 20 microfuge
Hybaid: gel electrophoresis tank system
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Invitrogen: agarose, Benchmark™ prestained protein ladder, NuPAGE™ 4-
12% Bis-Tris gel
Menzel-Glaser: Superfrost® plus slides
Midland Oligos: thymidine dinucleotides (pTpT)




Philips: 20WT12 UVB lamp
Pierce Biotechnology: Bicinchoninic acid (BCA) protein assay kit
Premier International Foods UK Ltd.: Original Marvel dried skimmed milk
Promega: FITC-VAD-FMK (FITC-conjugated active caspase-3 marker),
25mM magnesium chloride, 10x PCR buffer, Taq DNA polymerase
Roche: Protease Inhibitor cocktail tablets
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Roche Diagnostics: anti-fluorescein-AP Fab fragments, Combur3 test strips
Sakura: Tissue-Tek O.C.T ™ compound
Santa Cruz Biotechnology: bovine anti-goat::HRP, ERCC1 (D-16) goat
polyclonal IgG, goat anti-rabbit::HRP
Scientific Laboratory Supplies Ltd.: 45mm filters, coverslips
Serotec: goat anti-mouse IgG (Fc)::FITC
Sigma: ADP, ammonia, ammonium polysulphide, D-glucose, DMSO, EDTA,
fast blue BB diazonium salt, 40% formalin, gold chloride, Hoechst 33258,
Igepal CA-630 (previously Nonidet P40), lead(ll) nitrate, levamidasole,
magnesium sulphate, naphthol-AS-BI-phosphate, neutral red, oxazolone
(ethoxymethylene-2-phenyloxazol-5-one), PBS tablets, propidium iodide,
ribonuclease inhibitor, silver nitrate, sodium cacodylate, sodium chloride,
sodium deoxycholate, sodium hydroxide, sodium maleate dibasic, sodium
thiosulphate, spermine tetrahydrochloride, sucrose, trypsin, trypsin inhibitor,
Triton X-100, Trizma® hydrochloride, Tween20
Sigma-Genosys: PCR primers
Starstedt: 48- and 96-well PCR plates
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Vector: mouse on mouse kit
VWR International: microscope slides
2.2 Cell culture reagents
Beckman-Coulter: lsoton®ll diluent
BioRad: Chelex® 100 resin
Cellstar®: tissue culture flasks
Coulter: coulter counter, FACScan machine
Gibco™: DMEM
Greiner Bio-one: cell culture dishes, pipettes
Sigma: DMSO, epidermal growth factor, L-glutaminic acid, penicillin G,
streptomycin
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2.3 Cell culture media
Keratinocytes were maintained in media with a low calcium concentration to
prevent the cells from becoming differentiated.







This medium was supplemented as follows:
8% chelex treated FCS (to minimise [Ca2+])




For long term storage, cells were frozen in liquid nitrogen using the culture
medium above supplemented with 10% DMSO and 20% chelex treated FCS.
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2.4 Solutions and buffers
Ammoniacal silver solution: concentrated ammonia was added drop by drop
to 40ml 5% aqueous silver nitrate until a faint opalescence remained after
shaking
CA: 24 parts chloroform, 1 part isoamyl alcohol
Cacodylate formaldehyde fixative: 0.8M sodium cacodylate, 0.2M sucrose,
4% formaldehyde
Davidson's solution: 115ml glacial acetic acid, 330ml 95% ethanol, 220ml
neutral buffered formaldehyde and 335ml ultrapure water
FACS citrate buffer: 8.55% sucrose, 5% DMSO, 40mM tri-sodium citrate,
pH7.6
FACS stock solution: 3.4M tri-sodium citrate, 0.5M Tris-HCI, 1% NP40,
0.52mg/ml spermine tetrahydrochloride, pH7.6
FACS solution A: 30mg/ml trypsin in stock solution
FACS solution B: 0.5mg/ml trypsin inhibitor, 0.1mg/ml ribonuclease inhibitor
in stock solution
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FACS solution C: 0.42mg/ml propidium iodide, 1mg/ml spermine
tetrahydrochloride in stock solution
Fast blue BB solution: 1mM levamisole, 0.88mM naphthol-AS-BI-phosphate,
0.24mM fast blue BB diazonium salt in 100mM Tris HCI, pH9.2; passed
through a 45mm filter
Formalin fixative: 4% formaldehyde in phosphate buffered saline
IHC citrate buffer: 10mM sodium citrate dihydrate
Loading dye: 20% glycerol, 100mM EDTA, 0.1% bromophenol blue
Mixed buffer: 16.6mM MgS04, 66.7mM D-glucose
Modified RIPA buffer: 50mM Tris-HCI, 1% Triton X-100 v/v, 0.2% sodium
deoxycholate w/v, 0.2% sodium dodecyl sulphate v/v, 1x protease inhibitor
mix
PCA: 25 parts redistilled phenol, 24 parts chloroform, 1 part isoamyl alcohol
Proteinase K: 2% proteinase K v/v in sterile distilled water
TBE: 90mM Tris-HCI, 90mM boric acid, 2mM EDTA, pH 8.3
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TBS: 0.005M Tris-HCI, 0.075M NaCI
TBS-T: 0.005M Tris-HCI, 0.075M NaCI, 0.05% Tween-20 v/v; pH 7.4
Tissue lysis buffer: 400mM NaCI, 10mM Tris-HCI, 3mM EDTA, 1% SDS v/v
Tris/mal buffer: 0.19M Tris-HCI, 0.18M sodium maleate, 0.25M sodium
hydroxide
Tris/mal rinsing buffer: Tris/mal buffer diluted 2:3 in water
2.5 Cell culture lines
The cell lines used are described in table 2.1.
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All oligonucleotides were synthesised by Sigma-Genosys.
Table 2.2 PCR primers
Code Sequence (5'—»3') Location PCR reaction
432E TGCAGAGCCTGGGGAAGAACTTCGC Erccl exon 5 Floxed/WT Erccl
F25732 TCAAAGTATGGTAGCCAAGGCAGC Erccl exon 5-3' Floxed/WT Erccl
262W AGCCTACCCTCTGGTAGATTGTCG HPRT cassette KanTai KO
G22234 GCTGTCTCCCTGGCTCTGGATCTG Erccl exon 1-3' KanTai KO
SkCre> ACCTGCCATGAAGACAGCGTTTGCAC K5 v.Cre CK5 transgene
SkCre< TGCACGTTCACCGGCATCAACG K5 v.Cre CK5 transgene
F25731 TGTCTCCCTGGCTCTGGATCTGAC Erccl exon 2-3' Recombined Erccl
F25732 TCAAAGTATGGTAGCCAAGGCAGC Erccl exon 5-3' Recombined Erccl
033M CCCGTGTTGAAGTTTGTGCG Erccl exon 4 Original KO/WT
M4956 GGTTCGAAATGACCGACCAAG Neo cassette Original KO/WT
lntron5.1 CATTCTGCACTGAGGTCCTGA Erccl exon 5-3' Original KO/WT
033M CCCGTGTTGAAGTTTGTGCG Erccl exon 4 TTR transgene
035M CGAAGGGCGAAGTTCTTCCC Erccl exon 5 TTR transgene
Gen9-3' GCTCAGTGATGATCAAAGGAGGTGG Erccl exon 1-5' Origin ofWT Erccl
Gen6 CCCTTCCCGACCCTGCCCGCTCTGG Erccl exon 1-5' Origin ofWT Erccl
D6Mit357a TACAATGGCTCTCCTCCCTG Chromosome 6 a-synuclein
D6Mit357b CCTCAGGATTTAAATAAATTCAAGC Chromosome 6 a-synuclein
D6Mit122a GACACCCAGCATCCATCTTT Chromosome 6 a-synuclein
D6Mit122b TTGTAATTTTTAAAAGATAGGTGTGTG Chromosome 6 a-synuclein
V0727 GTCAGATTCAGAACCAACAAAG Ligase exon 27 Lig1 WT




Mice were maintained in a specialised facility and all procedures were
covered by a Home Office project licence. I am holder of a current Home
Office personal licence which also covers all procedures carried out.
Mice were kept under a twelve hour light/dark cycle, with standard mouse
feed and tap water. All mice had cages lined with wood shavings apart from
the hairless mice, which had a softer paper based bedding, to avoid
problems occurring with their sensitive skin.
Pups were weaned into single sex cages, with a maximum of six animals per
cage, at twenty one days. Identification of individual animals was by ear
marking. The notches removed from the ears for marking was used for DNA
preparation and genotyping assays.
Culling was carried out by schedule one method whenever possible. If
necessary animals were culled by CO2 asphyxiation.
Whenever possible, breeding pairs were set up using animals from the fourth
litter of the previous cross.
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2.8 Breeding schemes
The breeding schemes for animals in the Erccl skin specific knockout stock
are shown in figures 2.1, 2.2 and 2.3. All the animals involved in creating this
stock were albino and hairless. In order to generate the pigmented hairless
animals used for the tanning experiments, the stock was crossed onto a
C57BL/6J background. The scheme for the Erccl liver corrected knockout
stock is shown in figure 2.4.
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Fig. 2.1
XErccl +/- X Erccl flox/flox
CK5 TG +ive CK5 TG -ive
F1 generation:
Erccl flox/+ Erccl flox/- Erccl flox/+ Erccl flox/-
CK5 TG +ive CK5 TG +ive CK5 TG -ive CK5 TG -ive
Figure 2.1 Breeding scheme for CK5 transgene stock
This stock is maintained on a hairless, albino background.
Erccl heterozygous males with the CK5 transgene are crossed
with females from a separately maintained floxed Erccl
homozygous stock. This is because whilst in the adult mouse
the CK5 transgene is expressed specifically in the basal layer of
the epidermis, it is also expressed transiently in the ova. This
causes pups from CK5 TG -Five females to express CK5
throughout their system.
Erccl flox/- CK5 TG -Five animals are used in experiments as
skin specific knockouts, and Erccl flox/+ CK5 TG +ive animals











If 4f 4f *f
Erccl flox/flox Erccl flox/- Erccl flox/+ Erccl +/-
Of these pups, half will be CK5 TG +ive and half will be TG -ive
Figure 2.2 Breeding scheme for CK5 transgene stock
This alternative cross produces a lower ratio of useful
animals, but allows more of the animals from the main
cross to be used as breeding animals. The CK5 transgene
has to come from the male parent and the ratios given for





XErccl flox/+ X Erccl flox/-
CK5 TG +ive CK5 TG -ive
F1 generation:
%r tf
Erccl flox/flox Erccl flox/+ Erccl flox/- Erccl +/-
Of these pups, half will be CK5 TG +ive and half will be TG -ive
Figure 2.3 Breeding scheme for CK5 transgene stock
This alternative cross is effectively the same as the one
shown in figure 2.2. It is another variation which includes
all the necessary alleles, allowing more of the stock animals
to be used for breeding. Again, the CK5 transgene has to
come from the male parent and the ratios given for the




XErccl +/- V Erccl +/-
TTRTG+ive TTR TG +ive
F1 generation:
Erccl +/+ Erccl +/- Erccl +/- Erccl -/-
TTRTG+ive TTRTG+ive TTRTG+ive TTRTG+ive
Figure 2.4 Breeding scheme for TTR transgene stock
This stock is maintained by crossing two Erccl
heterozygotes with the TTR transgene, as Erccl nulls (with
transgene) are infertile. If both parents are homozygous
for the transgene, or even if one is homozygous and one is
hemizygous, all the pups will be transgene positive. This is
what we have tried to achieve. If both parents are
hemizygous then some transgene negative pups will be
produced, and will be culled upon identification.
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2.9 Preparation of genomic DNA from mouse tissue biopsies
An ear section was taken from the mice using a standard ear punch. The
section was then placed in 500|llI tissue lysis buffer with 15fxl 2% proteinase
K solution overnight, on a shaker at 37°C.
Phenol-chloroform extraction: 500p,l PCA was added to the suspension and
mixed thoroughly. This was then micro-centrifuged at 13000g for five
minutes. The aqueous phase was removed and transferred to a new
eppendorf. The phenol phase was discarded. 500p,l CA was added to the
new eppendorf and mixed thoroughly, before being micro-centrifuged again
at 13000g for five minutes. The aqueous phase was removed and
transferred to a new eppendorf, and the lower phase was discarded. 500pil
propan-2-ol (isopropanol) was added to the new eppendorf and inverted
several times. The DNA was allowed to precipitate for ten minutes before
micro-centrifugation at 13000g for three minutes. The supernatant was the
discarded and the pellet washed using 70% ethanol. The pellet was then left
to dry for an hour before resuspending in sterile, deionised water. The DNA
was then stored at -20°C.
2.10 Genotyping of mouse stocks by Polymerase Chain Reaction (PCR)
PCR was used to determine the genotypes of newly weaned mice in the
transgenic stocks. Each reaction tube contained 5ptl PCR buffer (Promega),
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2pJ PCR Mg2+ ions (Promega), 1|il Taq polymerase (Promega), 5mM
mixed dNTPs, 1fxl of each primer and was made up to 50pJ using sterile,
double distilled water.
Table 2.3 shows the primers used for each of the genotyping PCR reactions
and the conditions that were used.
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Table 2.3 PCR asay conditions










KO: 500bp 94°C 5 mins,
(94°C 1min, 65°C 1min, 72°C
1.5mins)x30, 72°C 5 mins
CK5 transgene Skin Cre>
Skin Cre<
TG: 1400bp 94°C 5 mins,
(94°C 1min, 65°C 1min, 72°C
1.5mins)x30, 72°C 5 mins
Recombined Erccl F25731
F25732
R: 200bp 94°C 5 mins,












TG: 170bp 94°C 5 mins,
(94°C 1min, 68°C 1min, 72°C 1min)x30,
72°C 5 mins
Figure 2.5 shows the locations of the primers on the alleles in the CK5 TG




Wild type Erccl locus
12 3
Floxed Erccl locus
1 2 loxP 3
432E F25732
4 5 loxP 6
!M1 H]
Recombined Erccl locus















Figure 2.5 Erccl loci and primer positions in Erccl skin
specific knockout animals
One PCR reaction distinguishes between the wild type and
floxed allele as these result in slightly different sized products.
The recombination PCR will only yield a product when the
recombination event has taken place, otherwise the primers are
too far apart. A third PCR identifies the KT KO allele, with one















































Figure 2.5b Genotyping PCRs used to identify animals in the Erccl ESKO
stock
PCRs were run according to conditions shown in table 2.3
Fig. 2.6
Wild type Erccl locus




Original Erccl knockout locus
M4956 Intron5.1




Figure 2.6 Erccl loci and primer positions in Erccl liver
corrected null animals
A single, three primer PCR identifies the wild type and null
alleles. Primer M4956 in the NEO insert identifies the original
knockout allele. Primers 033M and Intron5.1 identify the wild
type allele, and are too far apart to yield a product in the
knockout locus. 033M and 035M identify the liver replacement









Primers: 033M & 035M
<«— Erccl WT allele
■4— Erccl liver transgene
Figure 2.6b Genotyping PCRs used to identify animals in the Erccl liver
corrected null stock
PCRs were run according to conditions shown in table 2.3
Erccl KO allele
Erccl WT allele
2.11 Separation of DNA fragments by electrophoresis
DNA fragments were separated by gel electrophoresis using 1-2% (w/v)
agarose in TBE with 0.5mg/ml ethidium bromide for visualisation. Loading
dye was added to the DNA samples to a final concentration of 20%. DNA
Hyperladder I was used to provide size markers with which to compare the
band sizes. Electrophoresis was carried out in a horizontal tank, with a TBE
buffered system, with a voltage of 75-150V run through the system. UV light
was used to visualise the DNA fragments and the gel image captured using
Gel Doc EQ software.
2.12 Cell culture
The keratinocytes used in experiments were maintained in low calcium
medium as stated previously, in an incubator at 37°C with 5% C02. Flasks
were split twice a week and medium changed at least every second day,
using aseptic technique inside a category II biological safety hood. When
required, medium was aspirated (along with dead, floating cells), cells were
passaged using trypsin solution and counted using a Coulter cell counter.
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2.13 Cell culture irradiation
Keratinocytes were plated out at a density of 106 in 35mm Petri dishes in 2ml
of medium, the day before UV irradiation. For irradiation, the medium was
aspirated from the dishes and replaced with 0.2ml phosphate buffered saline
(PBS). Cells were irradiated for a length of time determined exactly by the
removal and subsequent replacement of the lids on the Petri dishes. After
irradiation, the PBS was aspirated and replaced with 1ml medium. Medium
was removed from the cultures and stored at -20°C for future use.
2.14 Ultraviolet light irradiation
Ultraviolet B irradiation was carried out using a Philips TL20W/12RS tube,
emitting 2.4Jm"2s"1 from a fixed position. The lamp was held in position in the
lid of a glass sided aquarium tank, the outer dimensions of which were 76cm
x 30.5cm x 38cm. The glass walls of the tank were 5mm thick. The lamp
was calibrated to national standards in this position. This lamp emits
predominantly UVB, with some UVA as well as small amounts of UVC
(Snellman et al, 2003).
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2.15 Measurement of erythema and melanin
Erythema and melanin in the mice was measured using an erythema meter
(Dia-Stron Ltd, model 220). The erythema meter contains a tungsten-
halogen lamp which shines white light into a fibre optic probe. The probe is
held in contact with the skin, and collects any light scattered back from the




Haemoglobin absorbs light at around 546nm, so the strength of the signal at
this wavelength is inversely proportional to the amount of haemoglobin
present. The signal at 632nm acts as a reference as it corrects for skin tone.
Erythema index is calculated as follows and is based on work published in
the British Journal of Dermatology in 1984 (Diffey and Farr):
Erythema index = log 10 (632nm/546nm) x 1000
Melanin absorbs light at around 632nm, and the 905nm signal is used as a
reference for this index:
Melanin index = Iog10 (905nm/632nm) x 1000
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2.16 Topical application of thymidine dinucleotides
Thymidine dinucleotides were obtained from Midland, TX and maintained as
a 2mM stock solution in dH20 at -20°C. For use, stock solution was diluted
1:20 in 3 parts PG and 1 part DMSO to give a 100pM solution. 60pJ of this
solution was applied to each animal.
Control animals were treated with PG/DMSO diluent alone.
2.17 Contact hypersensitivity assay
Protocol adapted from El-Ghorr and Norval, 1999: Mice were sensitised
using 1% oxazolone (ethoxymethylene-2-phenyloxazol-5-one) dissolved in
4:1 acetone:olive oil. Using a pipette, 50pil of the sensitiser (for negative
controls, acetone/olive oil mix alone) was dropped on to the dorsal or ventral
skin of the animal and left to absorb. 5 days later, ear thickness was
measured using a micrometer (Mitutoyo, Japan). 20pil 0.25% oxazolone was
then pipetted on to each ear of the animals. After a further 24 hours, the ear
thickness was re-measured using the micrometer. The increase in ear
thickness was then calculated, and the values obtained for each ear were
averaged to provide a reading for each group.
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2.18 ATPase staining of Langerhans cells
Protocol adapted from Chaker et al, 1984: Mouse ears were collected and
split, before floating in 20mM EDTA, pH7.2 at 37°C for two hours. Epidermal
sheets were peeled off and fixed in cacodylate formaldehyde fixative for one
hour, then rinsed three times in PBS. The sheets were then stained in a 3:2
solution of mixed buffer and tris/mal buffer containing 1.4mM ADP and
3.6mM lead (II) nitrate for seventy minutes. The sheets were then rinsed
three times in tris/mal rinsing buffer and incubated in 2% ammonium
polysulphide for five minutes at room temperature. The epidermal sheets
were then transferred to dH20 and placed on slides, mounted with 90%
glycerol in PBS and covered with a coverslip. Sections were stored at 4°C
and ATPase positive cells were counted under the microscope. Cells were
counted per field view, multiplied up to a value per mm2. Ten field views
were counted per ear and the twenty values averaged to give an average per
mouse.
2.19 Cytometric bead array (CBA) test
Cytokine concentrations were assayed using the CBA mouse inflammation
kit from BD Biosciences, on supernatants collected from cell culture dishes
and stored at -20°C for later use. Briefly, assay standards were prepared
using the lyophilised standard provided in the kit. The six bead reagents
95
were pooled in the appropriate quantities - using 5ptl of each capture bead
for each assay rather than 10pl as described - and vortexed. 25ptl mixed
capture beads (rather than 50pl as recommended) was placed in wells of a
96-well plate, followed by 50fd standard or sample. 25pil PE detection
reagent from the kit was then added to each well and the plate incubated for
two hours at room temperature, protected from the light. 100pl wash buffer
from the kit was added to each well, and the plate centrifuged at 200gfor five
minutes. The supernatant was discarded, and 120pl wash buffer added to
each well, to resuspend the bead. The plate was then analysed using the
FACSArray machine (BD Biosciences) and FACSArray/CBA software.
2.20 Preparation of epidermal samples for FACScanning
A section of dorsal skin was dissected from the mouse. The skin was then
floated, inner side down, on 20mM EDTA in PBS for two hours at 37°C. The
epidermis was peeled off the rest of the skin section, which was discarded,
and placed in 10Opil citrate buffer in an eppendorf tube. 450[il FACS solution
A (trypsin solution) was added and the tube incubated for 30 minutes on a
rotating wheel at room temperature, and vortexed at intervals. 325jxl FACS
solution B (trypsin inhibitor) was added, before a further 10 minutes on the
rotating wheel at room temperature. 250pJ FACS solution C (propidium
iodide) was added, mixed by inversion, and the mixture incubated on ice for
10 minutes. The sample was then filtered through sterile gauze, before
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running through the Becton Dickinson FACScan machine. Data was
analysed using Lysis II software to assess the proportions of cells in G1/G0,
S-phase or G2. Sub-G1/G0 cells were considered apoptotic.
2.21 Protein extraction
Tissue was collected into eppendorf tubes and snap frozen in liquid nitrogen.
Samples were shattered before homogenisation in modified RIPA buffer.
Lysates were then kept on ice for 20 minutes before centrifugation at 2000g
for 15 minutes, then aliquoted and stored at -80°C.
2.22 Protein concentration assay
Protein concentration was determined using the BCA assay kit. 5pJ sample
was incubated with 200|al mixed A and B solution as per kit instructions for 30
minutes. Absorbance at 562nm was measured and protein concentration
calculated using a standard curve.
2.23 Western blotting
Western blotting was used to determine ERCC1 levels in skin samples.
Equivalent amounts of total protein lysate were loaded onto a pre-cast SDS-
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PAGE gel and run at 100V, then transferred onto a membrane at 4°C for one
hour. The membrane was then washed in TBS-T and blocked using 5%
powdered skimmed milk in TBS w/v, for one hour, before incubating with
primary antibody in 5% powdered skimmed milk in TBS w/v overnight, at 4°C.
The membrane was washed three times in TBS-T for 5 minutes each time
before incubating with secondary antibody in 5% dried skimmed milk in TBS
w/v for one hour. The membrane was washed three times in TBS-T for 5
minutes each time and finally for 5 minutes in TBS. Fluorescence was
visualised using enhanced chemiluminescence (ECL) and signals were
detected by conventional photographic film, or by the Storm Phospholmager
system. (3-TUBULIN was used as a loading control for ERCC1.
2.24 Fixation of tissue
Excised tissue was fixed in 4% formaldehyde in PBS overnight before being
transferred into 70% ethanol. Skin sections were laid out onto blotting paper
before immersion in fixative to keep them flat and prevent folding of the
samples.
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2.25 Fixation of eye orbits
Eye orbits were enucleated from the mice using fine forceps. The eye orbits
were then fixed in Davidson's solution at room temperature for 24 hours.
The orbits were then gently dehydrated at room temperature. Firstly they
were immersed in 30% ethanol for 2 hours, then 50% ethanol for a further 2
hours. They were then stored in 70% ethanol at 4°C.
2.26 Haematoxylin and eosin stain
It should be noted that all H&E stains apart from the retinal sections were
carried out by the Department of Pathology, University of Edinburgh using
their own version of the protocol.
Slides were de-paraffinised using three washes in xylene for five minutes
followed by two washes in 100% ethanol for five minutes.
Slides were then hydrated by immersion in 90% ethanol for three minutes,
then 70% ethanol for three minutes, then 50% ethanol for three minutes, then
30% ethanol for three minutes and lastly by immersion in running water for
three minutes.
Slides were then stained for three minutes in haematoxylin, then rinsed well
in running water. They were then immersed in acid/alcohol (1%HCI in 70%
ethanol) for ten seconds and rinsed in water, before being immersed in
saturated lithium chloride solution for ten seconds and rinsed in water again.
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Slides were stained in eosin (three parts 1% aqueous eosin: one part 1%
ethanol: two parts glacial acetic acid) for two minutes, rinsed briefly in water
then in absolute ethanol. They were then immersed in absolute ethanol for
one minute.
Slides were dehydrated by immersing in 100% ethanol for five minutes, three
times, then xylene for five minutes, twice.
The slides were left to drip dry before coverslips were mounted using DePex
and left to set overnight.
2.27 Masson-Fontana stain
The Masson-Fontana staining was carried out by Frances Rae in the NFIS
Royal Infirmary of Edinburgh Pathology department. Skin sections were
fixed and embedded as for H&E staining. Sections were deparaffinised by
two, five minute washes in xylene and then hydrated by three, five minute
washes in decreasing concentrations of ethanol before washing in running
water. Sections were then stained with ammoniacal silver solution at 56°C
for 20 minutes, and checked periodically in this time. They were then
washed in copious distilled water, toned in 5% gold chloride w/v for 5 minutes
and washed again in distilled water before fixing in 5% sodium thiosulphate
w/v. Sections were then washed in distilled water and counterstained with
0.1% neutral red for 1 minute before dehydration by immersing in 100%
ethanol for five minutes, three times, then xylene for five minutes, twice. The
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slides were left to drip dry before coverslips were mounted using DePex and
left to set overnight.
2.28 Melan-A/Mart 1 immunohistochemical stain
Skin samples were fixed in 4% formalin, embedded in paraffin, sectioned and
mounted on Superfrost® slides. Sections were deparaffinised by two, five
minute washes in xylene and then hydrated by three, five minute washes in
decreasing concentrations of ethanol before washing in running water. The
slides were then boiled in citrate buffer for five minutes to retrieve antigen,
cooled in tap water, then blocked in 0.3% hydrogen peroxide in methanol for
five minutes. Sections were then blocked using the mouse on mouse (MOM)
kit mouse IgG blocking reagent, diluted 1:25 in PBS, for one hour. Sections
were washed in PBS then incubated in MOM kit antibody diluent 1:50 in PBS
for five minutes, before blotting and incubating for one hour with the primary
antibody, mouse anti-human Mart 1, diluted 1:500 in the MOM kit antibody
diluent as used above. The slides were washed in PBS and incubated for
one hour with the secondary antibody, goat anti-mouse IgG (Fc)::FITC,
diluted 1:200 in PBS. The slides were washed again in PBS and incubated
for one hour with the tertiary antibody, anti-fluorescein-AP Fab fragments,
diluted 1:2000 in 100mM Tris HCI, 150mM NaCI, pH7.5. The slides were
washed in the Tris HCI/NaCI solution before staining with fast blue BB
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solution for 3 minutes. Slides were washed in tap water, fixed in 4% formalin
overnight and mounted using warmed glycerol gelatine.
2.29 Immunocytochemistry of neuromuscular junctions (NMJs)
For analysis of neuromuscular junctions (NMJs) we used two muscles from
each animal, the transverses abdominis and the deep lumbrical muscle
(found in the hind paw). Muscles were dissected and fixed in 4%
paraformaldehyde in PBS for 1 to 2 hours before labelling with 5jag/ml a-
bungarotoxin conjugated to tetramethylrhodamine isothiocyanate (TRITC-a-
bungarotoxin). Muscles were then incubated overnight in primary antibodies
against 165 kDa neurofilament proteins and synaptic vesicle protein SV2,
both at a 1:200 dilution. These were visualised using sheep anti-mouse
FITC-conjugated secondary antibodies, also used at 1:200. (Protocol
described by Newbery et al, 2005). The NMJs were the imaged using a laser
scanning confocal microscope. Axon bundles were checked for
fragmentation and NMJs checked for innervation. In each animal around 100
synapses were counted and innervation status recorded.
2.30 Gross classification of skin tumours
Animals in carcinogenesis protocols were monitored weekly for skin tumours.
Any tumours were measured using callipers and recorded so that their size
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and appearance could be tracked weekly. Skin tumours were classified
according to their gross size and appearance as described in table 2.5.
Average epidermal thickness was calculated by measuring a length of skin,
measuring epidermal area over that length and dividing area by length to
give an average thickness. Where possible, ten readings were taken per
animal, however sometimes the extent of dysplasia prevented this.
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Table 2.5 Gross classification of skin tumours
Tumour Size Appearance
Papule < 2mm Raised epidermal mass
Exophytic mass a 2mm 'Stalk-like' appearance; projecting from skin
Endophytic mass s 2mm Inward growing mass
104
2.31 Histological classification of tumours
UV induced skin tumours were classified histologically by Dr David
Brownstein according to the parameters described in table 2.6.
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Table 2.6 Histological classification of skin tumours
Classification Appearance
Acanthosis Epidermal hyperplasia without dysplasia
Actinic keratosis Epidermal hyperplasia with dysplasia of basal
cell layer, but retention of external granular cell
layer
Carcinoma in situ Full thickness dysplasia, absent stratum
granulosum, intact basement membrane
see Penetration of basement membrane and
dermal invasion
- Grade 1 Prominent keratin pearls with obvious granular
cell layer
- Grade 2 Fewer keratin pearls, few or absent granular
cells often associated with parakeratosis
- Grade 3 No keratin pearls, keratinised cells or groups
of cells
- Grade not specified (GNS) Cells or nests of cells judged to have
penetrated the basement membrane
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2.32 Opto-Kinetic Response (OKR) test
The OKR test was performed to assess the visual ability of the mice. This
test was first described by Thuang et al, 2002. A variation on this protocol
was used - briefly, mice were placed on a pedestal inside a large, vertical
cylinder, approximately 30cm in diameter and 60cm in height. The cylinder
could be lined with vertically, black and white striped paper. These stripes
were either 2°, 4 °, or 8 0 wide, and the cylinder could be rotated slowly in
either direction. Each mouse was recorded using a fixed video-camera for
one minute in each direction, with each stripe width - a total of six minutes
per mouse.
2.33 Assessment of motor function using Roto-Rod
Accelerating Roto-Rod was used to assess motor function and coordination
in the mice. The Roto-Rod is a horizontal, rotating cylinder of around 4cm in
diameter, covered with ridged rubber to facilitate grip. The mouse is required
to walk forward to remain on top of the cylinder. The mouse was placed on
the Roto-Rod, which would rotate at a slow speed for thirty seconds. This
was to allow to mouse to become accustomed to the movement required.
After thirty seconds, the speed of rotation was slowly increased at a constant
rate until the mouse was unable to remain on top of the cylinder. The
amount of time the mouse was able to remain on the Roto-Rod before falling
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off was recorded. For each mouse, readings were taken on three
consecutive days and averaged.
2.34 Proteinurea test
The amount of protein in the urine of the mice was quantified using Combur3
test strips. The strips are dipped in a drop of urine and the colour of the strip
compared with a range of colours provided in the kit. These colours then
translate to a concentration of protein in the urine.
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Chapter 3




This chapter addresses the consequences of loss of nucleotide excision
repair on the short term effects of ultraviolet irradiation in the skin.
Nucleotide excision repair (NER) is of prime importance in the skin due to its
role in the removal of UV induced DNA lesions, particularly cyclobutane
pyrimidine dimers and 6-4 photoproducts. This is demonstrated by the
severe skin related symptoms in the majority of NER deficiency syndromes
(reviewed by de Boer and Hoeijmakers, 2000). The issue of carcinogenicity
is addressed in chapter 4 of this thesis, while this chapter focuses on the
immediate effects of UV on the skin.
Exposure of the skin to UV radiation results in local inflammatory events as
well as systemic immunological events. Erythema is triggered by local
inflammation as a result of excessive UV exposure.
Photoimmunosuppression was first observed in 1977 when modulation of the
immune response was described after UV exposure. As well as the
immediate consequences of photoimmunosuppression, in the long term this
phenomenon contributes to UV induced carcinogenicity by reducing the
host's ability to recognise and destroy tumour cells. When UV induced skin
tumours were transplanted into non-irradiated syngenic mice, the tumours
were destroyed by the immune response. However when UV induced
tumours were transplanted into irradiated syngenic mice, the tumours were
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not destroyed and continued to grow (Fisher and Kripke, 1977). Kidney
transplant patients receiving immunosuppressive drugs have been shown to
be especially susceptible to skin cancer (Moloney et al, 2006), as well as
other malignancies.
Melanogenesis and melanocyte proliferation are also caused by UV
exposure, and result in tanning. Xpa null mice have shown increased
melanocyte proliferation in response to UV (van Schanke et al, 2005),
implying a role for DNA damage in stimulation of melanocyte proliferation.
Transcription coupled repair, rather than global genome repair, is implicated
as a factor in the short term effects of UV. Erythema has been linked with
deficient TCR, whereas development of squamous cell carcinoma has been
linked with deficient GGR (Berg et al, 2000). Mice with deficiencies in GGR
alone, for example those lacking Xpc, have been shown to have similar
immune and erythemic responses to UV as wild type mice (Berg et al, 2000,
Garssen et al, 2000). Deficient TCR has also been linked with enhanced
photoimmunosuppression (Boonstra et al, 2001). This is likely to be due to
the fact that cyclobutane pyrimidine dimers (CPDs) are repaired rapidly by
TCR in actively transcribed genes, but CPDs in the rest of the genome are
repaired at a much slower rate by GGR. Xpa null mice lack TCR and GGR,
and are sensitive to both the short and long term effects of UV (de Vries et al,
1995).
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Erccl is involved in TCR and GGR and as such we expect our Erccl
knockout animals to show heightened sensitivity to the short term effects of
UV. As Erccl is also involved in the repair of inter-strand crosslinks and
homologous recombination (Niedernhofer et al, 2004 and Chipchase and
Melton, 2002), we predict that Erccl knockout animals could be even more
sensitive than Xpa knockout mice.
We investigated the consequences of Erccl deficiency using our conditional
Erccl knockout mouse, in which Erccl deficiency is restricted to the basal
layer of the epidermis. This allowed us to work with mice that have a normal
life expectancy. We also used mice on a hairless, albino background, which
allowed us to investigate the skin phenotype without the complication of fur
or pigment.
3.2 Erccl epidermis specific knockout mice are more sensitive to UV
induced erythema than wild type controls
For reasons already discussed, we hypothesised that Erccl epidermal
specific knockout (ESKO) knockout mice would show increased sensitivity to
UV induced erythema compared with controls, and potentially compared with
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Figure 3.1 Epidermis specific knockout animals are much more
sensitive to UVB irradiation induced erythema than controls.
In this experiment, the erythema index in ESKO animals was compared with
controls after exposure to a single dose of UV. Erythema was measured
once before exposure, to set a baseline level, and regularly thereafter, until
erythema index had returned to pre-UV levels. Each group contained five
animals. Values shown represent the mean erythema index ± SEM.
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An erythema profile was established for Erccl ESKO animals and control
littermates and is shown in figure 3.1. A single dose of 500 Jm"2 UVB
resulted in significant erythema in Erccl ESKO animals, with a peak at
around 48-60 hours after UV exposure. Erythema subsided in around a
week. The same dose did not produce erythema in control littermates. A
dose of 6000 Jm"2 UVB was required to elicit a response in controls that was
comparable with the effect of 500 Jm"2 UVB on Erccl ESKO animals. This
translates to a twelve fold difference in UV sensitivity between the two
groups.
Minimal erythemal doses (MEDs) were measured for Erccl ESKO animals
and for controls. Results are shown in figure 3.2. This was done by
exposing mice to a variety of UV doses and comparing erythema index
before UV, with the value measured 48 hours after exposure. This timepoint
was chosen because erythema had been shown to peak at around this time
after UV exposure, and therefore the smallest increase in erythema should
be detectable. Any increase in erythema index was recorded, with an
increase of greater than ten being considered significant. This was because
measured erythema indices did vary by up to ten units from day to day in
animals regardless of UV exposure.
Our control mice had an MED of 900 Jm"2, while the Erccl ESKO mice had
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Figure 3.2 The minimal erythemal dose of UVB for the ESKO
animals was much lower than control animals.
Erythema was measured before, and then 48 hours after UV exposure.
Any change in the erythema index of more than ten units was
considered significant. Each group consisted of one animal, apart from
those with error bars which consisted of three animals.
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3.3 Epidermal antigen presenting cells in Erccl ESKO animals migrate
more readily after UV exposure compared with controls
We hypothesised that UV induced LC migration is in fact due to DNA
damage in both keratinocytes and LCs themselves. Therefore we expected
to see some depletion of LCs in Erccl ESKO animals, but not as much as
would be seen in complete NER knockouts.
The number of LCs present in epidermal sheets was counted in Erccl ESKO
animals and controls one week after a single dose of UV, and the results are
shown in figure 3.3. A single UV dose of 500 Jm~2, which caused no
erythema in controls but significant reddening in Erccl ESKOs, resulted in a
slight depletion in LCs in controls and 50% depletion in Erccl ESKO animals.
In order to induce 50% depletion in control animals, a dose of 6000 Jm"2 was
required. This translates to a twelve fold increased sensitivity to the LC
depleting effect of UV in Erccl ESKO animals.
3.4 UV exposure causes suppression of the contact hypersensitivity
response in control and Erccl ESKO mice
A recognised test of the immune status of an animal is the contact
hypersensitivity (CHS) assay (reviewed by Grabbe and Schwarz, 1998 and






























Epidermis specific knockout animals
Figure 3.3 Epidermal Langerhans cells in epidermis specific knockout
animals are more susceptible to the effects of cutaneous UVB exposure
than control animals.
Epidermal Langerhans cells were counted one week after animals were exposed
to a single UV dose. Each group consisted of five animals.
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of the organism to mount an inflammatory response to a cutaneously applied
sensitiser. Exposure of the skin to UV causes a suppression of this
inflammatory response.
We have confirmed the local and systemic immunosuppressive effects of UV
radiation in our control mice. When the mice were exposed to UV and
sensitiser is applied dorsally, we were able to show that UV radiation caused
local immunosuppression, as seen in figure 3.4a. When the mice were
exposed to UV and sensitiser was applied ventrally, we confirmed that UV
also caused systemic immunosuppression, shown in figure 3.4b. It should
be noted that although the extent of suppression was similar in both
experiments, in the absence of UV the contact hypersensitivity response was
greater in dorsally sensitised animals than ventrally sensitised animals. This
is possibly due to a larger number of antigen presenting cells present in
dorsal skin compared with ventral skin.
We went on to assay the CHS response of our Erccl ESKO animals, shown
in figure 3.5. Although our Erccl ESKO animals showed a suppression of
the inflammatory response after UV exposure, we were unable to show a
difference between controls and Erccl ESKO animals. This may be due to
the fact that with our UV lamp we were unable to give a low enough dose of
UV. Figure 3.6 shows results obtained after a single UV dose of 500 Jm"2,
however this extent of immunosuppression was seen at doses as low as a













































Figure 3.4 The contact hypersensitivity response is suppressed by
UVB radiation in control animals after dorsal and ventral
sensitisation with the irritant.
The contact hypersensitivity assay measures the ability of the organism to
mount a secondary immune response to an irritant to which the organism
has previously been exposed.
For A, the irritant was applied dorsally, two days after a single UV dose or
a sham irradiation. After UV the response is suppressed, implying that UV
exposure has acted locally to inhibit the primary immune response to the
irritant.
For B, the irritant was applied ventrally, two days after a single UV dose or
a sham irradiation. As after UV the response is suppresssed, we can
conclude that UV exposure has acted systemically to inhibit the organism's


























Figure 3.5 UVB irradiation causes suppression of the contact
hypersensitivity response in control and epidermis specific
knockout animals.
In this experiment the irritant was applied ventrally. Each group
consisted of three animals.
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response was almost completely abrogated in control animals as well as
repair deficient animals.
3.5 UV irradiation causes altered cytokine profiles in Erccl null
keratinocytes compared with Erccl wild type keratinocytes
Photoimmunosuppression is largely due to an altered cytokine environment
caused by UV exposure. As mentioned previously, this relates to a Th2 bias
in the immune response.
Data regarding cutaneous cytokine response to UV radiation in the literature
are mixed. Whilst it is universally accepted that UV radiation causes
immunosuppression, the exact mechanisms remain unclear. There is much
evidence that cells present in the epidermis release anti-inflammatory
mediators, with key cytokines including tumour necrosis factor-a and
interleukin-10. However, there is also data suggesting that keratinocytes
release pro-inflammatory mediators, causing inflammation and the influx of
macrophages and neutrophils; which in turn release anti-inflammatory
mediators and cause systemic immunosuppression (Kang et al, 1994 and
Teunissen et al, 2002).
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Keratinocytes themselves absorb the majority of the UV radiation insult and
as such we wanted to determine whether the NER status of keratinocytes in
culture affects the balance of cytokine release.
For these experiments we used spontaneously transformed keratinocytes
isolated from our Erccl wild type and null mice. We also used PAM 212 cells
- a well characterised murine keratinocyte line to compare with our wild type
cells.
In the series of figures illustrating cytokine levels, the in-house wild type cells
and PAM 212 are shown on graphs together, where the Erccl null cells are
shown on separate graphs. This is because Erccl null keratinocytes have a
much lower survival rate after UV exposure, as they are considerably more
sensitive to low doses than wild type keratinocytes (personal communication,
Ann-Marie Ritchie). Due to this, a different range of UV doses had to be
used for the repair proficient and deficient cells, although some of the same
doses were used to enable direct comparison. It should also be noted that in
each of the figures shown, the graph on the left shows the cytokine
concentration in terms of picograms per millilitre of medium at the collection
point forty eight hours after UV. The graph on the right shows the cytokine
concentration in picograms per million cells at the collection point. Cells
were plated at the same densities at the start of the experiment, but
supernatants were collected forty eight hours after irradiation, which was
seventy two hours after plating, so discrepancies in the number of cells in
each dish were inevitable. UV slows growth and kills cells at higher doses,
122
and the Erccl null cells are much more sensitive to these effects than the
wild type cells. For this reason, the total number of cells in each dish was
counted as soon as the supernatant was removed and the cell count at the
end of the 48 hour period is expressed as percentage of the cells seeded in
table 3.1.
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Table 3.1. Percentage of adherent cells remaining after 48 hours
Erccl +/+ PAM212 Erccl -/-
No UV 33% 8% 40%
12.5 Jm"2 - - 7%
50 Jm"2 36% 5% 7%
150 Jm'2 12% 4% 0.4%
500 Jm"2 3% 0.8% -
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Erccl deficient keratinocytes were expected to show a similar cytokine profile
to Erccl proficient keratinocytes, although we expected higher levels of
immunosuppressive cytokines to be released after lower UV doses. This
would correlate with DNA damage being a trigger for
photoimmunosuppression.
Data for the following inflammatory mediators will be discussed: tumour
necrosis factor-alpha, interleukin-6, interleukin-12, interferon-gamma,
interleukin-10 and macrophage chemotroattractant protein-1.
Tumour necrosis factor-alpha (TNF-a) is involved in local inflammation and is
released by keratinocytes as well as other cell types. TNF-a has been
shown to be present in greater quantities in repair deficient skin than control
skin after UV exposure in vivo. We hypothesised that our cells would release
increasing amounts of TNF-a in response to increasing UV doses, and that
Erccl null cells would produce more at lower doses. Figure 3.6 shows this is
in fact the case. Both Erccl wild type and null cells produced increasing
amounts of TNF-a as the UV dose increased. After 50 Jm"2 UV, Erccl null



















































Figure 3.6 UVB irradiation causes increased release of TNF-alpha by
repair deficient keratinocytes
Each value shown on the graphs is an average of two experiments. In each
experiment, supernatants were collected 48 hours after UV or sham exposure
and frozen immediately. These were then analysed in duplicate by cytometric
bead array.
Error bars depict the range of the two experiments.
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which translated to a twenty five fold increase in TNF-a after the correction
for cell numbers. However, unlike previously published data, we did not see
a large UV induced increase in TNF-a production in the PAM 212 cells,
which was unexpected.
Whichever UV dose the cells are exposed to, the amount of damage caused
is the same regardless of genotype. The difference between cell lines lies in
the ability of the cells to repair this damage. Therefore, we concluded that
TNF -a release after UVB exposure is triggered by the continued presence of
damaged DNA in the keratinocyte nuclei.
lnterleukin-6 (IL-6) is involved in the acute phase immune response. Its
release by keratinocytes has been linked with UV exposure, however there is
no data in the literature regarding IL-6 and NER deficient cells. With respect
to the TNF-a data mentioned above, we expected our Erccl deficient
keratinocytes to produce more IL-6 than wild type keratinocytes after UV
exposure due to the presence of unrepaired DNA damage in the nuclei.
Figure 3.7 shows that IL-6 production was significantly greater in Erccl
deficient keratinocytes than Erccl proficient keratinocytes after UVB
radiation. In both types of Erccl wild type cells, we found IL-6 production to
be negligible, and not affected by UV exposure.
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Fig 3.7
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Figure 3.7 UVB irradiation causes increased release of IL-6 by repair
deficient keratinocytes
Each value shown on the graphs is an average of two experiments. In each
experiment, supernatants were collected 48 hours after UV or sham exposure
and frozen immediately. These were then analysed in duplicate by cytometric
bead array.
Error bars depict the range of the two experiments.
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From this we can conclude that as predicted, IL-6 release by keratinocytes is
triggered by the persistence of unrepaired CPDs.
We expected to see negligible production of interleukin-12 (IL-12) by all the
keratinocytes in our experiments. This is because IL-12 is not a cytokine that
has been linked with UV exposure, and is in fact noted for its ability to
suppress the Th2 immune response, which UV is known to promote.
Figure 3.8 shows the results of the IL-12 experiments. The Erccl wild type
keratinocytes produced negligible IL-12 in response to UV, as expected. The
Erccl null keratinocytes appeared to produce some IL-12 in response to the
higher dose of UV. This could have been caused by an unsuccessful
attempt to upregulate NER in response to the presence of UV induced DNA
damage - as previously mentioned, IL-12 has been shown to upregulate
NER in vitro (Schwarz et al, 1996 and 2002). However, it is more likely that
this result is an aberration - the peak only showed when IL-12 was
measured in pg/million cells and not when it was measured in pg/ml, when in
fact the amounts of IL-12 detected were extremely low. This means that the
peak could have been due to a low number of surviving cells skewing the
pg/million cells value.
In conclusion, wild type and Erccl null keratinocytes produced negligible IL-
12 in response to UVB radiation.
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Fig 3.8























no UV 50Jm-2 150Jm-2 500Jm-2 no UV 50Jm-2 150Jm-2 500Jm-2
Repair deficient keratinocytes
i i«i













no UV 12.5Jm-2 50Jm-2 150Jm-2
Figure 3.8 UVB irradiation causes negligible IL-12 production in wild
type and Erccl null keratinocytes
Each value shown on the graphs is an average of two experiments. In each
experiment, supernatants were collected 48 hours after UV or sham exposure
and frozen immediately. These were then analysed in duplicate by cytometric
bead array.
Error bars depict the range of the two experiments.
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There is no evidence for interferon-gamma (IFN-y) being released by
keratinocytes in response to UV and as such we did not expect to see an
increase in IFN-y in our experiments.
Figure 3.9 shows the results of these experiments. As expected, UVB did
not affect IFN-y concentration in our cultures. However, as with IL-12 there
appeared to be a peak in IFN-y in the Erccl null keratinocytes after high
levels of UVB exposure, but again the overall concentration of cytokine was
very low and this result is likely to have been affected by the low numbers of
surviving cells present after Erccl null cells had been exposed to such a
relatively high UV dose.
lnterleukin-10 (IL-10) is a Th2 cytokine and a suppressor of cellular immune
responses. IL-10 release by keratinocytes has previously been linked with
DNA damage. In light of this work, we expected our Erccl null keratinocytes
to produce more IL-10 at lower UV doses than Erccl wild type keratinocytes.
The results of these experiments are shown in figure 3.10. Erccl null cells
produced IL-10 in a similar pattern to the wild types, but in greater quantities.
After 150 Jm"2, the amount of IL-10 in the supernatants from Erccl nulls and
wild types was similar, but when this was corrected for cell numbers, Erccl
nulls showed a twenty five fold increase in IL-10 concentration compared
with wild types. However, PAM 212 cells released much more IL-10 overall
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Figure 3.9 UVB irradiation does not affect IFN-g release by wild type or
Erccl null keratinocytes
Each value shown on the graphs is an average of two experiments. In each
experiment, supernatants were collected 48 hours after UV or sham exposure
and frozen immediately. These were then analysed in duplicate by cytometric
bead array.
Error bars depict the range of the two experiments.
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Fig 3.10
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Figure 3.10 UVB irradiation results in an increased production of 1L-10
by Erccl null and wild type keratinocytes
Each value shown on the graphs is an average of two experiments. In each
experiment, supernatants were collected 48 hours after UV or sham exposure
and frozen immediately. These were then analysed in duplicate by cytometric
bead array.
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Figure 3.11 UVB irradiation causes increased release of MCP-1 by repair
deficient keratinocytes but not wild type keratinocytes
Each value shown on the graphs is an average of two experiments. In each
experiment, supernatants were collected 48 hours after UV or sham exposure
and frozen immediately. These were then analysed in duplicate by cytometric
bead array.
Error bars depict the range of the two experiments.
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These results showed that IL-10 production in PAM212 cells was induced by
UV irradiation. However we were not able to show significant induction of IL-
10 in either of our Erccl cell lines.
The effects of UVB radiation on keratinocyte macrophage chemoattractant
protein-1 (MCP-1) expression have not been studied. With the knowledge
that this chemokine suppressed the cellular immune response, we expected
MCP-1 levels might be raised in response to UV.
The data obtained can be seen in figure 3.11. Although the PAM212 cells
had a higher base level of MCP-1 production than our wild type cell line, both
Erccl wild type cell lines showed little alteration in MCP-1 production in
response to UVB exposure. The Erccl null keratinocytes showed a
significant increase in MCP-1 production in response to UV.
From this result we can conclude that there is likely to be a link between
persistence of damaged DNA in keratinocytes and induction of MCP-1
expression in these cells.
In summary, we found that neither of our wild type cell lines, nor our Erccl
deficient cell line, produced IL-12 or IFN-y in response to UVB exposure and
only the PAM212 cells produced IL-10 in response to UVB exposure. We
found that TNF-a was produced in greater quantities at lower UV doses in
the Erccl deficient keratinocytes compared with the wild types. Finally, we
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found that both IL-6 and MCP-1 were produced by Erccl deficient
keratinocytes in response to UVB, but were not produced by either of the wild
type cell lines in response to the UVB doses used.
3.6 UVB exposure causes a tanning response in hairless, pigmented
mice
Murine skin differs from human skin with respect to melanocyte distribution.
In humans melanocytes are dispersed throughout the skin whereas in mice
melanocytes are clustered around the hair follicles. Due to this, there has
been some controversy over whether murine skin can in fact 'tan', and the
guinea pig is accepted as having a more similar skin structure to humans.
We used pigmented, hairless mice and found, in accordance with Quevedo
Jnr. et al, 2000, that following a chronic irradiation protocol involving three
doses of 2000 Jm"2 for a week and 4000 Jm"2 thrice weekly thereafter, these
mice did indeed develop a noticeable 'tan'. This started to appear after about
four to six irradiations, becoming steadily more noticeable over three to four
weeks, and is shown in figure 3.12. Furthermore, we found upon sectioning
and staining for melanin, that much more melanin was visible in the skin of
these animals, as seen in figure 3.13. This result meant that we were able to
use the tanning process to investigate the mechanism of tanning further,
using our repair deficient animals.
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Fig 3.12
Figure 3.12 Hairless black mice become tanned after
prolonged UVB treatment.
Long term thrice weekly irradiation of hairless, black mice results in
'tanning' of the skin. The animal on the left has not been exposed to
UV, whereas the one on the right has been.
137
Fig 3.13
Figure 3.13 Melanin in the epidermis of hairless, black mice
becomes more prolific after prolonged UVB exposure.
A shows a section taken from a hairless, black mouse with no UVB
exposure and stained with the Masson-Fontana stain for melanin. Some
melanocytes are visible in the dermis, although most will be congregated
around hair follicles.
B shows a section taken from a chronically irradiated hairless, black
mouse, stained as above. In this section the melanocytes are more
numerous throughout the dermis. Melanin is also visible inside
keratinocytes in the epidermal layers.
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3.7 Erccl ESKO animals tan more readily than wild type controls
As our Erccl ESKO mice were so much more sensitive to UV induced
erythema than controls, we expected that these mice, when crossed onto a
pigmented hairless background, would also be more sensitive to UV induced
tanning than controls.
We found that Erccl ESKO mice were significantly more sensitive to the
tanning effects of UVB than controls, as expected. An image of some of the
animals in the experiment can be seen in figure 3.14. Not only were Erccl
ESKOs more tanned than control mice receiving the same UV doses, they
were also more tanned than control mice receiving twelve-fold higher doses.
Figure 3.15 shows a graph of the melanin indices for each group of animals
throughout the duration of the experiment. These values confirm the
extreme sensitivity of the Erccl ESKO animals to UV induced tanning.
Histological examination of sections from these animals confirmed these
results. Sections were stained with Masson-Fontana stain for melanin and
representative images are shown in figure 3.16.
In summary, Erccl ESKO mice are significantly more sensitive to UV
induced melanogenesis than wild type mice. From this we can conclude that
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3.14
ESKO, low dose UV Control, low dose UV
Control, high dose UV Unirradiated animal
Figure 3.14 Epidermis specific knockout animals tan much more
readily than control animals.
This figure shows the extent to which the animals tan. Animals receiving
the low UV dose received 165Jrrr2 three times for the first week, then
330Jrrr2 three times a week for seven weeks. Animals receiving the high
UV dose received 2000Jrrr2 three times for the first week, then 40001m"2
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Figure 3.15 Epidermis specific knockout animals tan much more readily
than control animals.
This figure shows the melanin indices of skin specific knockout animals
receiving the low UV doses, control animals receiving low UV doses and control
animals receiving high UV doses over an eight week period.
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Fig 3.16
Hairless black mouse Hairless black, Erccl ESKO mouse
No UV
6%, ♦
» • *'• * *
l'-A* t- '
Low UV doses, 3x weekly
High UV doses, 3x weekly
Figure 3.15 Epidermis specific knockout animals accumulate more
melanin in the epidermis than controls
This figure shows accumulation of melanin in the epidermis during a chronic
irradiation protocol. Animals receiving the low UV dose received 165 Jnr2
three times for the first week, then 330 Jrrr2 three times a week for seven
weeks. Animals receiving the high UV dose received 2000 Jnr2 three times
for the first week, then 4000 Jrrr2 three times a week for seven weeks.
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DNA damage in keratinocytes plays a major role in the stimulation of
melanocytes.
3.8 Discussion
The central role of Erccl is its involvement in the nucleotide excision repair
pathway, and it is this role that is most important when considering the
downstream effects of UV induced DNA damage. However, Erccl is also
involved in other repair pathways, which may be relevant to the effects of
cutaneous UV exposure. For these reasons, it was our aim to investigate the
short term effects of UV exposure on our model mice. Our epidermis specific
Erccl knockout also enabled us to investigate the consequences of Erccl
deficiency in keratinocytes alone. Previous work on NER deficient models
has addressed the effects of loss of NER in whole skin, which includes
fibroblasts, Langerhans cells, mast cells, melanocytes and other cells of the
immune system as well as keratinocytes themselves.
Mouse models deficient in transcription coupled repair have shown that
erythema is linked with this form of NER (Berg et al, 1997 and 2000). UV
induced DNA damage stalls RNA polymerases, initiating a cascade of events
which result in erythema.
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Our Erccl ESKO mice were much more sensitive to UV induced erythema
than controls. The minimal erythemal dose (MED) for our control mice was
found to be 900 Jm'2, which is comparable with other hairless, albino, repair
proficient mice. The MED for our Erccl ESKOs was found to be 40 Jm"2,
which is around twenty fold lower than controls, and also lower than MEDs
reported for other NER knockout animals. Xpa and Csb knockouts have
been reported to have MEDs approximately eight fold lower than their
littermate controls (Berg et al, 2000).
This increased sensitivity in Erccl knockout mice compared with other NER
knockout mice implicates a role for the other types of damage that Erccl can
repair in the process that causes erythema. However, as erythema subsided
in a similar pattern and timescale in Erccl ESKO mice and controls, we can
conclude that the resolution of the local inflammation is controlled by
systemic factors and is not influenced by the persistence of DNA damage in
the keratinocytes.
UV radiation has been shown to induce the migration of LCs to the lymph
nodes in the absence of antigen (Toews et al, 1980), and other full NER
knockouts have been shown to be hypersensitive to UV induced LC
migration (Miyauchi-Hashimoto et al, 1996 and Kolgen et al, 2003).
Previously in our lab, fully Erccl deficient mice have been shown to have
fewer LCs present in the skin than wild types, although these were depleted
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normally following UV exposure. However, the LCs remaining in the
epidermis of the knockout animals were severely morphologically affected
(90% were damaged), compared with less extensive morphological damage
in the wild types (20% of cells damaged). Analysis of the draining lymph
node showed that the LCs did not accumulate there in the knockout after UV
as would normally be expected. It was suggested that these unexpected
results were due to the structural abnormalities of the skin that were seen in
these mice: subcutaneous fat was missing, the thickness of the dermal layer
was reduced and the nuclei of the epidermis appeared mis-shapen; and this
abnormal environment would contribute to epidermal LCs behaving
uncharacteristically (Jim Selfridge, PhD thesis, 1999).
This was the first study to use a conditional, epidermis specific knockout of a
DNA repair gene to investigate UV induced Langerhans cell (LC) migration.
We found Erccl ESKO mice to be approximately twelve fold more sensitive
to UV induced LC depletion compare with controls. This implies that the
presence of DNA damage in keratinocytes is crucial, rather than the
presence of DNA damage in LCs.
We can therefore conclude that factors produced by keratinocytes with DNA
damage are playing a major part in the migration of LCs in the absence of
antigen.
145
Other NER knockout mice have been shown to be more susceptible to UV
induced suppression of the CHS response compared with control littermates.
We had hoped to show an increased suppression of CHS response in our
mice compared with controls, however we were not able to do this, due to the
fact that as far as we were able to measure, the control mice were equally
sensitive. The increased sensitivity of our controls compared with other
studies may have been due to the fact our mice are hairless and albino,
whereas most other such studies were carried out on mice with fur and
pigment.
The studies carried out in vitro allowed us to concentrate on the effects of
Erccl deficiency in keratinocytes specifically, without the complicating factors
of other cutaneous components. Spontaneously transformed Erccl null
keratinocytes were compared with Erccl wild type keratinocytes, both of
which were isolated from our mouse stocks. A further comparison involved
PAM 212 cells, which are also Erccl wild type, and a well characterised
murine keratinocyte cell line (Shreedhar et al, 1998, Nishigori et al, 1996).
Erccl null keratinocytes could not be exposed to the highest doses used in
the experiment, as these cells are much more sensitive to the effects of UV
and show high levels of apoptosis at lower doses than the two wild type cell
lines. However, it is important to note that any given UV dose causes the
same amount of damage in all three cell lines. The differences in sensitivity
are caused by the fact that the Erccl nulls keratinocytes are unable to deal
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with the damage, whereas the two wild type cell lines can repair the damage
rapidly.
Firstly we found, as expected, that none of our cell lines produced IFN-y,
either constitutively or in response to UVB exposure. There has been no
suggestion previously that IFN-y, a potent suppressor of the Th2 immune
response, is induced in keratinocytes after UV, and we have found nothing to
challenge this.
IL-12 is also known to suppress the Th2 response and promote the Th1
response, and is in fact implicated in IFN-y production. Furthermore, IL-12
has been shown to rescue UV exposed cells from photoimmunosuppression
(Schwarz et al, 1996), presumably because of its ability to suppress Th2 and
promote Th1 immune responses. In wild type mice, IL-12 injection into the
skin reduces UV induced apoptosis; interestingly however, the same
procedure does not reduce apoptosis in Xpa knockout mice (Schwarz et al,
2002). This implies that IL-12 may have a role in upregulating DNA repair
pathways. We have concluded from our experiments that none of our cell
lines expressed IL-12 constitutively, nor was it upregulated by UVB
exposure. The Erccl null cells did appear to show a peak in IL-12
concentration after the highest UV dose, when this was expressed in
proportion to surviving cells. This is likely to be due to the low number of
surviving cells in these cultures, as the absolute levels of IL-12 detected were
very low. However this result was obtained both times the experiment was
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carried out, and there is a possibility it could be a real result. To investigate
this further, it would be necessary to carry out a more detailed set of
experiments with a wider range of UV doses. From this, it would be possible
to see whether there were a trend for increasing IL-12 release from the Erccl
null cells after UV.
In contrast to IL-12, IL-10 promotes the Th2 immune response. In mice,
keratinocytes have been shown to produce IL-10 in response to UV, which
contributes significantly to photoimmunosuppression. The addition of
liposome encapsulated DNA repair enzyme to cultured keratinocytes has
been shown to decrease IL-10 expression (Nishigori et al, 1996), implying a
link between DNA damage and IL-10 release. Xpa and Csb deficient mice
have been shown to upregulate IL-10 after UV exposure (Boonstra et al,
2001). This study was the first to investigate IL-10 production in NER
deficient murine keratinocytes, however we did not find induction of IL-10 in
either of our in-house keratinocyte lines. This was unexpected, however it
could be explained by the fact that we only analysed IL-10 in the supernatant
and did not consider any IL-10 that may be still within the cells. This could
be assayed by lysing cells after the supernatant has been removed, then
following a standard ELISA technique.
The release of TNF-a by UV exposed keratinocytes is well documented
(reviewed by Schade et al, 2005). Xpa knockout mice have been shown to
upregulate TNF-a production compared with controls after treatment with a
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systemic immunosuppressive agent (Miyauchi-Hashimoto et al, 2001). As
with our IL-10 experiment, this study was the first to investigate TNF-a
production in Erccl deficient murine keratinocytes, and our results correlated
with work carried out using human primary keratinocytes isolated from XPA
and XPD patients. These have been shown to release TNF-a at lower UV
doses than keratinocytes isolated from normal human skin (Petit-Frere et al,
2000). In our study, we have found that Erccl deficient mouse keratinocytes
released TNF-a at lower UV doses than control keratinocytes.
IL-6 has been linked with UV induced DNA damage in normal keratinocytes
(Kirnbauer et al, 1991 and Petit-Frere et al, 1998). Flowever, a recent study
showed that NER deficient primary human keratinocytes showed a lower
degree of UV induction than controls (Petit-Frere et al, 2000). This would
imply that IL-6 was in some way linked to the repair mechanism itself, rather
than the presence of DNA photoproducts. However, the data presented in
this paper showed cytokine release measured in supernatants twenty four
hours after UV exposure, and failed to take into account high levels of cell
death likely to be occurring in the NER deficient cultures. In taking this into
account, we have shown that Erccl deficient murine keratinocytes do in fact
release more IL-6 after UV exposure than controls, and we therefore
conclude that this is due to the presence of unrepaired DNA damage.
As far as we are aware, the effects of UV radiation on the expression of
MCP-1 have not been addressed previously. This chemokine is involved in
the maturation of monocytes and promotes a Th2 type immune response.
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We have shown that our Erccl deficient keratinocytes produced high levels
of MCP-1 after UV exposure, which was not replicated in our repair proficient
cells. It should also be noted that the levels of MCP-1 detected in this
experiment were higher than the levels of any other inflammatory mediator
assayed.
If the production of MCP-1 by Erccl deficient keratinocytes was caused by
the presence of damaged DNA, then we would expect to see some increase
in MCP-1 produced by the wild type cells, particularly after higher UV doses.
The fact that this does not occur implies that the release of MCP-1 in
response to UV is a specific trait of this cell line, i.e. the production of MCP-1
is caused by the absence of DNA repair, rather than the presence of DNA
damage. However, as these cell lines are spontaneously transformed,
aberrant MCP-1 expression cannot be ruled out at this stage. To confirm the
link between loss of NER and increased MCP-1 expression, the experiment
would need to be repeated using the Erccl null cell line containing an Erccl
replacement minigene. If restoring Erccl levels in the cells resulted in
lowered MCP-1 levels, we could conclude that loss of Erccl increased MCP-
1 production after UV exposure.
Finally, we wished to use our Erccl epidermis specific knockout mice to
address the tanning response. This was the first time a study investigating
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the effects of DNA damage in keratinocytes on melanogenesis had been
undertaken.
We found our mice to be extremely sensitive to UV induced melanogenesis.
In order to address whether they are also sensitive to melanocyte
proliferation, an assay requires to be developed which will allow the
melanocytes themselves to be counted, something which cannot be done
using the Masson-Fontana stain, as melanin in melanocytes and
keratinocytes cannot be differentiated. Due to the extent of the
hypersensitivity of our mice, we can infer that the majority of the sensitivity
seen in the Xpa knockout mice (van Schanke et al, 2005) was due to loss of
Xpa in the keratinocytes of these mice. Recent evidence suggests that the
induction of expression of melanocyte stimulating hormone (MSH) by
keratinocytes is crucial (D'Orazio et al, 2006), and this may be linked with
DNA damage. This would correlate with the data we have obtained. To
confirm this it would be necessary to compare our Erccl keratinocyte specific
knockouts with model with Erccl deficient melanocytes. This work is
currently being undertaken in our laboratory with a view to a future
publication. Furthermore, it would be interesting to investigate levels of MSFI
expression in Erccl deficient and proficient keratinocytes after UV exposure.
This could be carried out using northern blotting techniques to measure MSFI
mRNA transcript.
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In summary, the work in this chapter has addressed the consequences of
loss of Erccl in keratinocytes on the short term effects of UVB radiation.
The Erccl gene has proved to be very important in the short term response
to UV. Furthermore, our model has shown that unrepaired lesions in DNA
trigger multiple events in keratinocytes. We have shown that induction of
erythema is closely linked with DNA damage, although resolution follows a
normal pattern despite persisting damage. We have confirmed that
photoimmunosuppression is caused by DNA damage, and we have been
able to show that it is DNA damage specifically in keratinocytes that causes
LC depletion. We have also shown that factors released by keratinocytes
with DNA damage are responsible for inducing melanogenesis.
It would be useful to carry out the same mouse model experiments; including
erythema measurements, contact hypersensitivity and LC counts; detailed in
this chapter using a complete Erccl knockout mouse. This would allow a
direct comparison between a model with Erccl deficient keratinocytes only,
and a model with Erccl deficient keratinocytes, fibroblasts and dendritic
cells. At present, the only suitable model would be the Erccl liver corrected
null mouse, which has a life expectancy of ten to twelve weeks. The
intention was to carry out these experiments, but we were unable to obtain
sufficient animals - this was due to unsatisfactory breeding of the stock on
an albino and hairless background.
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As mentioned previously, the melanogenesis experiments are being carried
out using an Erccl melanocyte specific knockout mouse model, to confirm
the role of the keratinocyte in the melanogenesis process.
The results obtained and presented in this chapter have underlined the
important roles that keratinocytes play. Keratinocytes absorb the majority of
the UV insult, however, previously, the extent of their interactions with other
cells in their local and systemic environment was less clear. The work
detailed in this chapter has provided a unique view of the effects of UV
induced DNA lesions on keratinocytes and the factors and mediators that
these cells consequently release.
153
Chapter 4




This chapter will investigate the role of Erccl in UV induced skin
carcinogenesis. Nucleotide excision repair is crucial for the protection of the
organism against skin cancer, with xeroderma pigmentosum patients having
a one thousand fold increased risk of contracting skin cancer. Furthermore,
these patients develop skin tumours at a considerably younger age than the
general population (reviewed by Friedberg, 2001).
The NER pathway is essential for the removal of cyclobutane pyrimidine
dimers (CPDs) and 6-4 photoproducts from the genome, without which cells
are susceptible to malignant transformation. Furthermore, as mentioned in
chapter three of this thesis, exposure to UV causes suppression of the
immune system. Together with the mutagenic properties of UV, this
increases the likelihood of tumour development, as the host immune system
is compromised in its efforts to recognise and eliminate transformed cells.
To investigate the role of Erccl in UV induced skin cancer, we used our
epidermal specific Erccl knockout (ESKO). This model has a normal life
expectancy as Erccl deficiency is restricted to the epidermis, and allowed us
to carry out a long term UV irradiation protocol. It should be noted that by
using this model we were able to investigate non-melanoma skin cancer
(NMSC) specifically. Melanoma is a malignancy of melanocytes, and while
our mice had NER deficient keratinocytes, their melanocytes were repair
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proficient and therefore no more susceptible to transformation than the
melanocytes in control mice. For the experiments reported in this chapter,
we used the Erccl ESKO mice and control mice on an albino, hairless
background, so that there was no pigment or fur to interfere with the effects
of UV irradiation on the two genotypes.
Previous mouse model knockouts of NER genes are highly susceptible to UV
induced skin cancer, including Xpa knockouts (de Vries et al, 1995, Nakane,
et al, 1995,) an Xpc knockout, (Sands et al, 1995) and a Csb knockout (van
der Horst et al, 1997). Our hypothesis was that our Erccl epidermal specific
knockout mice would be much more susceptible to UV induced skin cancer
than wild type controls, and due to the additional repair functions of Erccl,
possibly even more susceptible to UV induced skin cancer than other NER
deficient model mice. At present Erccl has been shown to have roles in the
repair of inter-strand crosslinks (Chipchase and Melton, 2002 and
Niedernhofer et al, 2004) as well as recombination in mouse embryonic stem
cells (Niedernhofer et al, 2001) and haematopoiesis (Prasher et al, 2005);
however it was unclear whether this would have any relevance for UV
induced skin cancer.
The data in this chapter have been published recently (Doig et al, 2006) and
the full paper is included in an appendix to this thesis.
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4.2 Experimental design
To investigate the cancer susceptibility of our mice, we devised a chronic
irradiation protocol. This involved the mice being exposed to the appropriate
UV dose three times per week. To assess the susceptibility of the Erccl
ESKO mice compared with control mice, we compared a group of the Erccl
ESKO mice with two groups of control littermates. This was due to the vast
difference in UV sensitivity between the two genotypes, described in chapter
3 of this thesis. We were aware that the doses the Erccl ESKO mice were
due to receive were extremely low, and likely to have no effect on the control
mice. For this reason, we had a group of control mice receiving the same UV
doses as the Erccl ESKO mice, and also a second group of control mice
receiving a higher UV dose. We hoped that this second group of control
mice would develop tumours that would be comparable with the Erccl ESKO
mice.
For this experiment we used groups of animals that were age and sex
matched. We had observed that despite all our animals being albino, there
was a slight difference in colour between males and females in the stock, as
females appeared slightly more pink, compared with the males which were
whiter. We concluded after dissection that this was due to more
subcutaneous fat in the males, however to avoid any possible discrepancies,
we made sure all groups contained males and females.
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Experimental groups (age and sex matched):
Group 1: Erccl ESKO animals, n=6, receiving 125 Jm"2 three times weekly
for the duration of the experiment.
Group 2: Control animals, n=4, receiving 125 Jm"2 three times weekly for the
duration of the experiment.
Group 3: Control animals, n=3, receiving 1000 Jm"2 three times weekly for
the duration of the experiment.
Animals were monitored weekly for any changes in skin condition, tumour
development and tumour burden. Once tumours appeared, these were
measured weekly and their appearance noted. Animals were killed once any
single tumour measured over 10mm in diameter. Animals were also killed if
any tumour appeared ulcerated or bleeding.
When an animal was killed, all tumours were excised and processed for
histology, and sections of back skin with no obvious tumour development
were also excised and fixed.
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4.3 Erccl ESKO mice develop tumours much more rapidly than control
mice
During the experiment, weekly checks identified tumours early in their
development. The first Erccl ESKO animal to develop a tumour did so
during week eight of the irradiation programme, and all the Erccl ESKO
animals had developed at least one tumour by sixteen weeks. Median
tumour free survival time was ten weeks. By comparison, none of the control
mice receiving the same UV dose as the Erccl ESKO mice developed any
tumours at all throughout the experiment, until we ended the protocol at fifty
eight weeks, furthermore, none of these mice showed any adverse effects
due to chronic UV exposure. These animals were culled as a result of age
related deterioration rather than any adverse consequences of the prolonged
UV exposure, indicating that this low dose is tolerated well by the mice. The
other group of control mice, which were exposed to an eight fold higher dose,
developed tumours from twenty nine weeks of irradiation; median tumour
free survival for this group was thirty weeks. Tumour free survival data are
shown in figure 4.1. These results implied around a twenty five fold
increased sensitivity in the Erccl ESKO mice compared with controls;
calculated by multiplying the fold difference in median tumour free survival
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Erccl ESKO (125Jm 2, three times a week, n=6)
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Figure 4.1 Erccl ESKO animals develop tumours much more rapidly
than controls in a long term UV irradiation programme
The graph shows the percentage of mice remaining tumour free throughout the
course of the experiment.
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4.4 Erccl ESKO mice developed more tumours per animal than
controls
Animals were culled when they reached a pre-determined endpoint with
relation to tumour burden, as mentioned earlier. If any tumour was more
than 10mm in diameter or was ulcerated or bleeding, the animal was culled.
At this point the total number of tumours on each animal was recorded. We
found that at the experimental endpoint, Erccl ESKO animals had slightly
more tumours than controls in the higher dose group; p=0.09 by Mann-
Whitney test - as mentioned previously, none of the controls in the lower
dose group developed any tumours at all. Table 4.1 shows the average
number of tumours per animal at the time of culling.
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Table 4.1 Average number of tumours per animal
Group Genotype UV dose Average tumours per animal
1 Erccl ESKO 125 Jm^ 5.2
2 Control 125 Jm* 0
3 Control 1000 Jm* 3




Control mouse Erccl ESKO mouse
Figure 4.2 Erccl ESKO animals develop more tumours than controls
These images show mice from experimental groups 1 and 2. Panel A shows a
control animal from the lower dose UV exposure group. None of the mice in
this group developed tumours. Panel B shows an Erccl ESKO animal, also part
of the lower UV dose protocol. This animal has multiple skin tumours, and
furthermore, its skin is generally hyperkeratotic.
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4.5 Erccl ESKO mice developed tumours at a much lower cumulative
UV dose than controls
In order to make a legitimate comparison of tumours between Erccl ESKO
mice and controls, we set up a second irradiation protocol using control mice
only. The reason for this was that in the original experiment we obtained
insufficient tumours in control mice to report any significant difference in
tumour classification between genotypes, for which we required to harvest
more tumours from control animals. This second experiment consisted of six
control mice irradiated with 2000 Jm"2 three times weekly. Animals were
monitored weekly as described previously and the same experimental
parameters and endpoints were applied. Interestingly, we found that these
animals did not develop tumours in half the time of those irradiated with 1000
Jm"2 three times weekly, however they did develop tumours somewhat
earlier, starting at twenty one weeks. By thirty five weeks all the animals in
this group had tumours.
This third group of control animals allowed us to analyse tumour free survival
time between genotypes in terms of cumulative UV dose. The total amount
of UV to which the animals had been exposed before developing any
tumours was calculated and is shown graphically in figure 4.3. The
cumulative UV dose at which 50% of Erccl ESKO animals had developed
tumours was 3.75 kJm"2, whereas the cumulative UV dose at which 50% of















Figure 4.3 Tumour free survival with respect to cumulative UV dose
The individual UV doses to which the animals were exposed were added
together to give values for cumulative dose and this is plotted against the
percentage of mice remaining tumour free.
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approximately forty fold increased sensitivity to UV induced carcinogenesis in
Erccl ESKO animals compared with controls.
From this point on, animals from the 1000 Jm"2 and 2000 Jm"2 groups, and
their tumours, will be considered together as the controls.
4.6 Rates of tumour growth differed between Erccl ESKO mice and
control mice
During weekly monitoring of animals, growth of individual tumours was
tracked. Figure 4.4 shows data recorded for tumour sizes, two, three and
four weeks after those particular tumours were first identified. These graphs
include tumours from control animals in both of the higher UV dose groups.
It is also important to note that the data used to compile these graphs is by
necessity selective: tumours used had to grow for at least four weeks before
the animals were culled, while many of the tumours identified appeared less
than four weeks before animals were culled. However, we found that
tumours on Erccl ESKO animals grew more rapidly than those on control
animals, a conclusion we reached following the observation that a greater
percentage of the tumours on Erccl ESKO animals grew to larger sizes,
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Figure 4.4 Tumours in Erccl ESKO animals grow more rapidly than
those in control animals
These three graphs show the sizes of tumours from each of the genotypes,
showing their progression over a 4 week period from the point at which they
were initially observed. These figures include tumours from control animals in


































2 weeks 3 weeks 4 weeks
Time after identification of individual tumours
Figure 4.5 Erccl ESKO animals consistently have a greater number of
tumours over 2mm in diameter
Tumours were recorded from the time they were first observed, for 4 weeks.
This graph shows the same data as figure 4.4
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Two weeks after the initial identification of tumours, 15% of those tumours on
control mice exceeded 2mm in diameter, whereas 45% of tumours on Erccl
ESKO mice exceeded this threshold. At three weeks, these figures had
developed to 25% of tumours over 2mm in diameter in control mice,
compared with 65% in Erccl ESKO mice. The percentage of tumours
greater than 2mm in diameter over the time course for both genotypes is
shown figure 4.5. Furthermore, at 4 weeks after the detection of tumours,
10% of tumours in control mice exceeded 5mm in diameter, compared with
45% in Erccl ESKO mice. Tumour size distributions were significantly
different between the two genotypes at all three time points: 2 weeks, x2idf,
p=0.03; 3 weeks, x22df, p=0.03; 4 weeks, x22df, p=0.04.
4.7 Erccl ESKO mice developed a different spectrum of tumour types
compared with controls
All tumours were classified grossly and histopathologically. Grossly, tumours
were classified as papules, or raised masses of less than 2mm diameter;
exophytic lesions, or raised masses on stalks of 2mm or more in diameter; or
endophytic lesions, or raised masses without stalk of 2mm or more in
diameter. We found an equal distribution of papules, exophytic masses and
endophytic masses between the two genotypes.
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Tumours were classified histologically by Dr David Brownstein, Veterinary
Pathologist. We found that in both genotypes most of the tumours classified
grossly as endophytic masses were diagnosed histopathologically as
squamous cell carcinomas (SCCs). We also found that in both genotypes
most of the tumours grossly described as exophytic masses were diagnosed
histopathologically as precancerous lesions acanthosis (hyperplasia) or
actinic keratosis (isolated areas of dysplasia). However there was a
significant difference between genotypes in the group of tumours that had
been classified grossly as papules; p<0.01 by Fisher's exact test. In control
mice, ten out of the seventeen papules were classified as carcinoma in situ,
or full epidermal thickness dysplasia. However none of the fifteen papules
from Erccl ESKO animals were classified as carcinoma in situ. Eight of
these were classified as actinic keratosis, with the other seven classified as
SCCs. Furthermore, carcinoma in situ was diagnosed for only three of thirty
one lesions in Erccl ESKO mice, compared with fifteen of thirty four lesions
from control mice; p<0.002 by Fisher's exact test.





diagnosis Papule (<2mm) Endophytic Exophytic (>2mm)
(>2mm)
Control Erccl Control Erccl Control Erccl
ESKO ESKO ESKO
Acanthosis 1 - 1 - 1 -
Actinic keratosis 3 8 1 2 1 4
Carcinoma in situ 10 - - 1 5 2
see**
GNS* * * 2 5 3 2 1 1
Grade 1 1 1 1 1 - -
Grade 2 - - - 2 1 -
Grade 3 - 1 1 1 - -
Keratoacanthoma - - 1 - - -
Total 17 15 8 9 9 7
** Squamous cell carcinoma
*** Grade not specified
Table 4.2 Comparison of tumour gross classification with respective
histopathological diagnosis
Grossly, tumours were classified as papules, endophytic or exophytic. Upon
sectioning, these were then classified histologically as actinic keratosis,
carcinoma in situ, squamous cell carcinoma (grades 1-3) or keratoacanthoma.
This table includes all tumours identified from all animals, in particular both
higher dose groups of control animals. There are more tumours <2mm in size
in this figure compared with figure 4.4 because here we have included tumours














Figure 4.6 Tumours in Erccl ESKO animals progress differently
compared with tumours in controls
The image shown in panel A is taken from a control animal. This shows a
squamous cell carcinoma GNS arising from an area of carcinoma in situ.
The image shown in panel B is taken from an Erccl ESKO animal. This shows a
squamous cell carcinoma GNS arising from an area of actinic keratosis.
The enlarged boxes show individual epithelial cells (arrows) that have invaded
the dermis.
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4.8 Invasive tumours arise from less dysplastic areas in Erccl ESKO
mice compared with controls
Tumours identified as SCC, type grade not specified (GNS), were described
as cells or small groups of cells of the epidermis regarded to have invaded
the basement membrane and penetrated the dermis. In control mice, all six
SCC GNS that were described were found adjacent to areas of carcinoma in
situ. In Erccl ESKO mice, however, three of the eight SCC GNS arose from
areas of carcinoma in situ, or full thickness dysplasia, but four arose from
actinic keratoses, or partial thickness dysplasia. The other SCC GNS arose
from a keratoacanthoma, a benign type of tumour.
Figure 4.6 shows examples of SCC GNS arising from carcinoma in situ, in a
control mouse, and from actinic keratosis, in an Erccl ESKO mouse.
4.9 Erccl ESKO mice exhibit striking histological skin changes
compared with control mice
Sections of skin that did not have any overt cancerous masses were also
examined histopathologically, to compare epidermal hyperplasia between
Erccl ESKO and control groups.
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Control mice that had been exposed to the higher doses of UV displayed
mild, uniform epidermal hyperplasia, with no signs of dysplasia or
hyperkeratosis. Cells of the stratum granulosum contained more
keratohyalin granules than unirradiated mice and these were more dispersed
and larger than normal.
In Erccl ESKO mice, however, there were more striking changes as a result
of the chronic irradiation protocol, despite the lower doses. We found
epidermal hyperplasia was uneven although epidermal thickness reached
three times that in the control mice that had been exposed to the highest
doses. We observed diffuse hyperplastic actinic keratosis, as well as areas
of hyperkeratosis and parakeratosis. The stratum granulosum was
discontinuous with dispersed keratohyalin granules. In the cells of the basal
layer we found hyperplasia and dysplasia, with cells displaying cytomegaly,
karyomegaly and anisokaryosis. In the stratum spinosum cells were
hypertrophied and occasionally apoptotic, with some dyskeratotic cells
present. Furthermore, we observed dermal changes indicative of chronic
inflammation and fibrosis, including infiltration of cells of the immune system.
In summary, we found the entire dorsal skin of the Erccl ESKO animals to
be in a pre-cancerous state.
Images of skin sections showing the differences in epidermal hyperplasia
between the two genotypes are shown in figure 4.7.
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Fig 4.7
Figure 4.7 Erccl ESKO animals have pronounced epidermal
thickenening compared with controls after chronic UV exposure
The image in panel A is taken from a control animal that had been exposed to
2000 Jrrr2 three times weekly for 25 weeks.
The image in panel B is taken from an Erccl ESKO animal that had been
exposed to 125 Jrrr2 three times weekly for 12 weeks.
The epidermis is annotated 'E'.
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4.10 Discussion
The essential role of Erccl in NER was responsible for our hypothesis that
our Erccl epidermal specific knockout mice would be more susceptible to UV
induced non melanoma skin cancer than controls; further to this we believed
that the Erccl knockout may be more susceptible to UV induced tumours
than other NER knockout mice due to the role of Erccl in other repair
mechanisms. However, it was not fully clear whether the role of Erccl in
mechanisms other than NER would be important in protecting against UV
induced skin cancer.
We have shown that the Erccl ESKO mice are extremely sensitive to UV
induced carcinogenesis, significantly more so than controls. Tumours were
first detected on Erccl ESKO mice after 8 weeks, and at this dose no
tumours were detected on controls when the experiment was terminated
after fifty eight weeks, implying that the Erccl ESKO mice were at least
seven fold more sensitive than controls. However this data may be skewed
by the fact that this dose had no noticeable biological impact on the control
mice at all.
A more reliable comparison for animals that have been exposed to different
weekly doses can be made using the cumulative dose data. The cumulative
dose required for 50% of Erccl ESKO animals to develop tumours was 3.75
178
kJm"2, compared with 140 kJm"2 required for 50% of control animals to
develop tumours.
This is comparable with some of the published data for other NER knockouts,
although it is important to take into account that results from animals with
different genetic backgrounds and in different laboratories cannot be
compared without a degree of caution. The cumulative dose required for
50% of Xpa knockout mice to develop tumours, when exposed to 32 Jm"2
daily, can be calculated from data published to be equal to 3.1 kJm"2
(extrapolated from Berg et al, 1997) or 3.7 kJm"2 (extrapolated from de Vries
et al, 1998). However cumulative doses for control animals from this group
calculates to around 25 kJm"2, which is significantly lower than we found for
our control animals. This difference between control animals must be due to
differences in genetic background affecting UV induced tumour susceptibility.
Furthermore, when the Xpa knockout animals were exposed to higher doses
of UV, 80 Jm"2 daily, the cumulative dose required for 50% of these animals
to develop tumours increased by around 40%. This demonstrates, as we
found with our control animals, that UV carcinogenicity does not follow a
linear scale with respect to dose. In other words, in a chronic irradiation
protocol, doubling the dose to which the animals are exposed does not halve
the time required for tumours to develop, and this fact makes it difficult to
compare cumulative dose data from one experiment to the next. Certainly
without data obtained by exposing groups of mice to different UV dose
protocols, comparisons cannot be made reliably.
179
Other published data regarding UV induced skin cancer in NER mouse
models is impossible to compare with our own as it was carried out on mice
with fur (Sands et al, 1995, de Vries et al, 1995, Nakane et al 1995, van der
Horst, 1997), and despite the fact that the mice may have been shaved prior
to UV exposure, tolerance to UV is considerably higher than that observed in
hairless albino mice. This is likely to be due to pigment in the skin as well as
hair regrowth.
In summary, although our Erccl ESKO knockout mice appear to display UV
induced skin cancer sensitivity that is comparable with that of Xpa knockouts,
when compared with controls in the respective experiments, the Erccl ESKO
animals prove to be more susceptible than the Xpa knockouts.
Consequently, the second part of our hypothesis; that Erccl knockouts would
be more susceptible to UV induced skin cancer than other NER models, due
to the roles of Erccl outwith NER; is difficult to address. It would be
imprudent to make any conclusions about this without comparing our Erccl
mice directly with Xpa mice and other NER models directly in a single
experiment, with the animals on the same genetic background. It may be
that the genetic background is not relevant in the knockout animals but is
relevant in the control animals; this could be because there is such a large
difference in UV sensitivity brought about by NER deficiency and a relatively
small difference caused by genetic background discrepancies. Nevertheless,
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for any conclusions to be drawn it would be important to compare the
different NER deficient models directly.
Histologically, we have made interesting observations in the Erccl ESKO
mice. We found that not only did these mice develop more skin tumours than
controls, but we also found that the entire dorsal skin of these mice was in a
pre-cancerous state. This only underlines the extreme susceptibility of these
mice to skin cancers.
Furthermore, we found that the Erccl ESKO mice showed accelerated
tumour progression. Not only did tumours grow in size more rapidly on these
mice than controls, we also report abnormally rapid progression through the
normal tumour development steps, shown in figure 4.8. Specifically, we
found that in Erccl ESKO mice, malignant or invasive areas of tumour were
developing from areas of actinic keratosis, rather than areas of carcinoma in
situ. In control mice, we saw a normal pattern of tumour progression:
squamous cell carcinomas were preceded by carcinoma in situ, or full
thickness dysplasia, which was in turn preceded by actinic keratosis, or
partial dysplasia. In Erccl ESKO mice however, we saw squamous cell
carcinomas arising from actinic keratosis, implying that partially dysplastic
skin was giving rise to malignant development, effectively missing out the
development of full thickness dysplasia. This was corroborated by the fact
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Erccl ESKO animals able to
bypass normal step, resulting
in more rapid tumour
progression in these animals
Squamous cell carcinoma
Figure 4.8 Model for tumour progression in Erccl ESKO and control
animals
Tumours in Erccl ESKO animals become invasive more rapidly than those in
controls due to their ability to bypass normal steps in tumour progression.
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With regards to the detailed histopathological analysis carried out for this
experiment, we have reported phenomena previously unreported for other
NER knockouts. However it is unclear whether this is the case because
Erccl mice have a different pattern of tumour progression than other NER
knockouts, or whether this degree of detail simply has not been addressed
by other groups working with NER mice.
Despite the fact we are unable to comment reliably on comparisons with
other NER mice as yet, and therefore dissect the importance of the non-NER
related roles of Erccl in UV induced skin cancer, we have reported a novel
model for UV induced non-melanoma skin cancer. We have provided a
detailed histopathological analysis of tumour development in this model,
furthering insights into the importance of the NER pathway in tumour
initiation and progression. In addition, with its extreme susceptibility to skin








Topical thymidine dinucleotides (pTpT), when applied in combination with UV
exposure, have been shown to provide some protection against the
carcinogenic effect of UV. The mechanism of this protection is poorly
understood. It has been attributed to upregulation of DNA repair
mechanisms (Goukassian et al, 2004), and alternatively to increased
apoptosis - perhaps due to the telomere homology of the sequence (Eller et
al, 2002 and Puri et al, 2004).
Using our Erccl epidermis specific knockout mice we hoped to provide some
insight into the protective mechanism afforded by topical pTpT application.
These mice are entirely defective in nucleotide excision repair, and as such,
any level of protection conferred by pTpT against the carcinogenic effect of
UVB cannot be due to upregulation of DNA repair.
5.2 Topical pTpT application suppresses the contact hypersensitivity
response
As mentioned previously, topical pTpT has been shown to mimic some of the
effects of UV radiation. In order to confirm one of the published short term
effects of topical pTpT application and also to confirm a biological effect at



























Repair proficient Repair deficient
Figure 5.1 pTpT treatment alone suppresses the contact
hypersensitivity response
The contact hypersensitivity response (CHS) quantifies the immune
response by an elicitation step 5 days after sensitisation with an irritant.
Ear thickness is measured before and 24 hours after elicitation and
percentage increase calculated. A high percentage increase indicates a
strong immune response.
(A) shows the effect of UV irradiation on the CHS response. Animals were
either treated with a single 500 Jrrr2 UVB dose 48 hours prior to
sensitisation or sham-irradiated, with each group composed of 1 animal.
(B) shows the effect of pTpT on the CHS response. Animals were either
treated with pTpT for seven days prior to sensitisation or treated similarly
with vehicle alone, with each group containing 3 animals.
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investigated the effect of pTpT on the contact hypersensitivity (CHS)
response. In figure 5.1 we have shown that seven days of topical pTpT
treatment prior to sensitisation with hapten suppressed the contact
hypersensitivity response in a manner comparable with the suppression
resulting from UV irradiation; we observed an almost total suppression of the
CHS response in both cases. This result confirmed that application of the
oligonucleotide at this concentration and in this vehicle on to mouse skin was
having a biological effect.
5.3 The protective effect of pTpT is not caused by the oligonucleotide
acting as a sunscreen
Initially it was important to confirm that the protective effect of pTpT against
non-melanoma skin cancer (NMSC) was not caused by the dinucleotide
itself acting as a chromophore. Genomic DNA acts as a chromophore which
can lead to mutation, so there was precedent for the pTpT oligo being able to
absorb UV radiation, thereby effectively shielding the cellular DNA. Nucleic
acids absorb radiation in the UV spectrum under normal circumstances, and
furthermore, we might expect pTpT to form pyrimidine dimers during UV
exposure. It is unclear from the literature whether the pTpT oligonucleotide
is able to absorb ultraviolet energy and dimerise in a similar manner to an
adjacent pair of chromosomal thymidine bases. It is possible that for the
dimerisation reaction to occur, the bases must be in a certain orientation
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which is made possible by being part of a DNA double helix, and therefore
dimerisation would not occur in a dinucleotide molecule.
Figure 5.2 shows that pTpT is not acting as a sunscreen. In this experiment,
the erythema profile of Erccl ESKO animals treated with pTpT for two days
was compared with the erythema profile of Erccl ESKO animals treated with
vehicle alone, prior to a single 500 Jm"2 UVB dose. These in turn were
compared with the erythema profile of untreated, control mice exposed to the
same dose. The control mice showed no increase in erythema in response
to this dose, which is well below the MED for these mice. Both groups of
Erccl ESKO animals showed a dramatic increase in erythema after this
dose, which equates to around twelve MED, with comparable peak increases
in erythema index and similar time courses for peak erythema and
subsidence of the response. However there was no significant difference
between groups, implying that pTpT is not acting as a sunscreen.
With this information we were able to proceed to a long term carcinogenicity
experiment knowing that any protection we found to be conferred by topical
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Figure 5.2 pTpT is not acting as a sunscreen
In this experiment, erythema index was measured after a single 500 Jnr2
UVB dose. Erccl ESKO mice treated with pTpT were compared with similar
mice treated with vehicle alone, and with untreated control mice.
Erythema was measured once before exposure, to set a baseline level, and
regularly thereafter, until erythema index had returned to pre-UV levels.
Each group contained five animals. Values shown here represent the mean
erythema index for the group ± SEM.
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5.4 Topical thymidine dinucleotide application affects UV induced
carcinogenesis in Erccl epidermis specific knockout animals
To determine whether pTpT application would protect Erccl ESKO mice from
UV induced carcinogenesis, the following experiment was set up:
Erccl ESKO animals were separated into two age and sex matched groups,
with five animals in each group.
Group 1: Erccl ESKO animals - one week of three treatments with pTpT
vehicle only, then 125 Jm"2 UVB three times weekly, with pTpT vehicle
applied after each UV dose.
Group 2: Erccl ESKO animals - one week of three treatments with pTpT,
then 125 Jm"2 UVB three times weekly, with pTpT applied after each UV
dose.
Animals were monitored weekly for any changes in skin condition, tumour
development and tumour burden. Once tumours appeared, these were
measured weekly and their appearance noted. Animals were killed once any
single tumour measured over 15mm in diameter. This new limit on tumour
size was agreed with the veterinary staff in the animal house, after the
experiment described in chapter 4 of this thesis, hence the difference in
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endpoints between the two experiments. Animals were also killed if any
tumour appeared ulcerated or bleeding.
When an animal was killed, all tumours were excised and fixed and
processed for histology. Sections of back skin with no obvious tumour
development were also excised and fixed.
5.5 pTpT treated animals remained tumour free for longer than
untreated animals
Figure 5.3 depicts how long the animals in each group remained tumour free.
The untreated group had a median tumour free survival of seven weeks
compared with ten weeks for the pTpT treated group. Median tumour free
survival was increased by three weeks in the pTpT treated group, equating to
nearly 50% increase in tumour free survival. However the p-value for these
groups is large, implying little statistical significance. This is mainly due to
the small sample sizes, in combination with the only slightly longer tumour
free survival of the UV plus pTpT group, compared with UV only controls. To
increase the statistical significance of these results it would be necessary to




















































Figure 5.3 pTpT increases tumour free survival in chronically
irradiated Erccl ESKO mice
This figure shows the percentage of mice remaining tumour free against the
weeks of UV irradiation. We compared tumour free survival for Erccl ESKO
mice treated with pTpT 3x weekly as well as undergoing 125Jnr2 UV doses
3x weekly, with animals undergoing the same UV regime without pTpT,
treated with vehicle alone. Each group consisted of five animals.
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5.6 pTpT treated animals had fewer tumours than untreated animals
The weekly total number of tumours per group was divided by the number of
animals remaining in each group, to give an average number of tumours per
animal, on a weekly basis, and these results are shown in figure 5.4.
At 15 weeks, the values for the UV only group appeared to dip. This
aberration was caused by the fact that animals were culled when they
reached certain welfare related endpoints, rather than at the end of a set
period of time. Consequently, if an animal with an above average number of
tumours were culled, the average for the group would drop. There was no
20-week value for the UV only group as all the animals in this group had
been culled by this stage. In fact at 18 weeks only one animal in this group
remained, explaining the lack of standard error data for this value.
The pTpT treated group had a lower average number of tumours per animal,
particularly in the later stages of the experiment. At twelve weeks, p=0.059
by Mann-Whitney test for the null hypothesis that the average number of
tumours in the UV only group was not greater that the average number of
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Figure 5.4 Erccl ESKO mice treated with pTpT developed fewer
tumours during the chronic UV protocol than untreated mice
This figure shows average number of tumours per animal in both
experimental groups. This figure was calculated using the total number of
tumours per group, divided by the number of animals in the group.
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5.7 pTpT treated animals develop a lower proportion of endophytic
tumours compared with the UV only group
Gross tumour classification revealed a difference between the UV only and
UV plus pTpT groups. Tumours that were 2mm or greater in diameter were
classified as exophytic or endophytic depending on their macroscopic
appearance. Tumours smaller than 2mm were recorded as macules or
papules. Areas of discoloured skin were noted as macules, and raised areas
were recorded as papules. Tumours with a 'stalk like' appearance, similar to
papillomas, were classified as exophytic. Tumours that appeared simply as
a raised mass within the skin, without a stalk, were classified as endophytic.
Figure 5.5 shows the types of tumours present in each group when animals
were culled. The absolute number of exophytic tumours per animal was not
significantly different in the UV only and UV plus pTpT groups, as p=1 using
the Mann-Whitney test. However the absolute number of endophytic
tumours per animal was much lower in the pTpT treated group and this
difference was significant, as p=0.016 using the Mann-Whitney test. Thus,
for the pTpT treated group, the proportion of exophytic tumours to endophytic
tumours was significantly higher than in the UV only group, where
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Figure 5.5 Erccl ESKO mice treated with pTpT developed a
different spectrum of skin tumours compared with untreated mice
These graphs compare gross tumour classification according to experimental
group. The graph on the left shows the average tumour burden upon
culling, per mouse for both groups. The graph on the right shows the same
data expressed as a percentage of the total tumour burden per mouse.
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Figures 5.6 Gross appearance of tumours differ between UV only and
UV + pTpT mice
Panel A shows a mouse treated with UV and vehicle. Panel B shows a mouse
treated with UV and pTpT.
X shows an example of an exophytic tumour
N shows an example of an endophytic tumour
It should be noted that these photographs were not taken on the same day and
as such are not intended as a comparison of tumour numbers, simply as a
representation of the different types of tumours that were present in the two
groups.
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Figure 5.6 shows photographs of representative animals from the two
experimental groups. The animal from the UV only group had a
preponderance of endophytic lesions. The animal from the pTpT treated
group had a much higher proportion of exophytic lesions. It should also be
noted that there is a marked difference between the non-lesioned dorsal skin
of these two animals. The skin of the animal from the UV only group had a
very poor overall appearance, with almost no areas free from lesions. In
comparison, the skin of the animal from the UV plus pTpT group had a much
better macroscopic appearance, and grossly at least, appeared to be less
affected by the chronic UV exposure. These observations were consistently
noted for the other animals in the two groups.
5.8 Histopathological observations confirm a difference in the
distribution of tumours between the two experimental groups
Tumours that had been classified as papules and exophytic or endophytic
lesions on their gross appearance were classified histopathologically as
actinic keratoses, carcinomas in situ, squamous cell carcinomas of grades 1
to 3, or keratoacanthomas. The tabulated data are shown in table 5.1.
A total of thirty six skin lesions from five UV only mice and twenty three




Papule ( <2mm) Endophytic (>2mm) Exophytic ( >2mm)
Histopathological UV UV+ UV UV+ UV UV+
diagnosi s only pTpT only PTpT only PTpT
Actinic keratosis 0 4 3 0 4 4
Carcinoma in situ 6 3 10 0 0 3
SCC* L21 £3) £2) £6} £3} £01
Grade 1 0 1 4 2 2 -
Grade 2 - 2 1 3 0 -
Grade 3 2 0 2 1 1 -
Keratoacanthoma - - 1 - - -
Total 8 10 21 6 7 7
* SCC: squamous cell carcinoma
Table 5.1 Comparison of tumour gross classification with respective
histopathological diagnosis
Grossly, tumours were classified as papules, endophytic or exophytic. Upon
sectioning, these were then classified histologically as actinic keratosis,
carcinoma in situ, squamous cell carcinoma (grades 1-3) or keratoacanthoma.
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well as grossly. The gross classification of lesions differed between UV only
and UV plus pTpT mice (x22df=6.68, P<0.05).
There were 8/36 (22%) papules in UV only mice and 10/23 (43%) papules in
UV plus pTpT mice. There were 21/36 (56%) endophytic lesions in UV only
mice and 6/23 (26%) endophytic lesions in UV plus pTpT mice. There were
7/36 (19%) exophytic lesions in UV only mice and 7/23 (30%) exophytic
lesions in UV plus pTpT mice. Thus, there were proportionately more
papules and exophytic lesions and fewer endophytic lesions in UV plus pTpT
mice than in UV only mice. From this we were able to conclude that
treatment with pTpT inhibited conversion of papules to endophytic lesions
and/or it encouraged exophytic versus endophytic growth.
Histopathological examination of the sections was carried out by Dr David
Brownstein, veterinary pathologist. The histopathological classification of
lesions (actinic keratosis (AK), keratoacanthoma, carcinoma in situ (CIS) or
squamous cell carcinoma (SCC)) did not differ significantly between UV only
and UV plus pTpT treated mice (x23df=2.64, P>0.10). Actinic keratosis
comprised 7/36 lesions (19%) in UV only mice and 8/23 lesions (35%) in UV
plus pTpT mice. CIS comprised 16/36 lesions (44%) in UV only mice and
6/23 lesions (26%) in UV plus pTpT mice. SCC comprised 12/36 lesions
(33%) in UV only mice and 9/23 (39%) in UV plus pTpT mice. There was no
difference in SCC grades between UV only and UV plus pTpT mice.
Although these differences were not significant the higher prevalence of AK
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and lower prevalence of CIS in UV plus pTpT mice compared with UV only
mice suggests that pTpT may inhibit conversion of partial thickness dysplasia
(AK) to full thickness dysplasia (CIS).
Actinic keratosis was classified as endophytic (3) or exophytic (4) in UV only
mice and as papules (4) or exophytic (4) in UV plus pTpT mice. Therefore
actinic keratosis lesions beyond the papule stage grew endophytically or
exophytically in UV only mice and exophytically in UV plus pTpT mice.
Carcinoma in situ was classified as papules (6) or endophytic (10) in UV only
mice and papules (3) and exophytic (3) in UV plus pTpT mice, which
indicates a tendency of CIS to grow exophytically in UV plus pTpT mice and
endophytically in UV only mice when greater than 2mm in diameter.
Squamous cell carcinomas were classified as papules, endophytic and
exophytic in UV only and UV plus pTpT mice, with no significant difference
between groups.
Taken together the results suggest that the reduced prevalence of
endophytic lesions in UV plus pTpT mice compared to UV only mice resulted
in part from a tendency of CIS and AK to grow exophytically rather than
endophytically in pTpT treated mice.
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5.9 Non lesional epidermis was more hyperplastic in UV only mice
compared with UV plus pTpT mice
Epidermis of non-lesional irradiated skin was more hyperplastic in UV only
mice than in UV plus pTpT mice, as shown in figure 5.7, although both
groups displayed some degree of hyperplasia. Mean epidermal thickness in
four UV only mice was found to be 119±31 |im compared with 58±19 in
three UV+pTpT mice (P=0.032, t-test). These data are shown graphically in
figure 5.8. Epidermal changes in UV only mice consisted of regions of
hyperplastic actinic keratosis, regions of carcinoma in situ and in two mice,
early Grade 1 squamous cell carcinomas. Epidermal changes in UV plus
pTpT mice consisted of regions of epidermal hyperplasia, actinic keratosis,
and carcinoma in situ. There were no squamous cell carcinomas. Epidermis
in regions of actinic keratosis and carcinoma in situ were far less hyerplastic
than similar regions in UV only mice. In the images in figures 5.6 it is
possible to see that the non lesional skin of the UV only animal was in very
poor condition, whereas the non lesional skin of the UV plus pTpT treated
animal appeared much more normal. We were therefore able to infer that
treatment with pTpT of UV irradiated skin effects reduces either epidermal
proliferation or promotes apoptosis and also inhibits dysplasia.
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Fig 5.7
Sections from UV only mice
Sections from UV plus pTpT mice
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Figure 5.7 Mean epidermal thickness is greater in UV only mice than
UV plus pTpT mice
The top two sections are taken from UV only animals, and the bottom two
sections are taken from UV plus pTpT animals. Sections were stained with
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Figure 5.8 Average epidermal thickness was reduced in pTpT
treated animals in carcinogenesis experiment
Mean epidermal thickness per animal was calculated by measuring a length
of skin, measuring epidermal area over that length and dividing area by
length to give an average thickness. The number of readings taken per
animal varied depending on the amount of non-lesional skin available to
measure, however around ten readings were calculated per animal. For
these measurements, there were four animals in the UV only group and
three in the UV plus pTpT group.
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5.10 pTpT treatment does not appear to increase levels of apoptosis in
the skin
Due to the fact that there was so little non lesional skin in the UV only
animals, we were unable to do a full comparison of levels of apoptosis in
normal skin using the skin biopsies taken. In the animals in the UV only
group the majority of the skin was hyperplastic, so there were insufficient
areas where numbers of apoptotic or sunburn cells could be counted.
However we could not see an unusually high number of apoptotic cells in the
UV plus pTpT group. It should also be noted that pTpT application alone
does not induce erythema (data not shown), which implies that neither is it
inducing apoptosis.
5.11 Analysis of skin by flow cytometry shows no increase in
apoptosis in pTpT treated animals
In order to address the mechanism of pTpT conferred protection we
investigated in which stage of cell cycle epidermal cells could be found. We
saw no differences between UV only and UV plus pTpT groups, or between
either of these groups and a group of age and sex matched animals that had
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Figure 5.9 No increase in apoptosis levels in cells from back skin
from animals treated with pTpT as well as UV
Epidermal cells were isolated and nuclei stained with propidium iodide.
Nuclear DNA content was determined by flow cytometry. Each group




In this chapter we have used our Erccl epidemis specific knockout animals
to investigate the mechanisms of pTpT induced UV protection.
We confirmed, firstly, that pTpT suppresses the contact hypersensitivity
response (Cruz Jnr et al, 2000 and Curiel-Lewandrowski et al, 2003). This
gave us confidence that the oligonucleotide was having a biological effect at
the dose and in the vehicle used, and it initially backed up the assertion that
pTpT mimics UV irradiation.
Importantly, we also showed that pTpT is not acting as a sunscreen. Without
this result, or measuring DNA damage directly, and in the absence of a
complex structural biochemical analysis into the action of UV on an adjacent
pair of thymidine bases outwith a double helix, it would be impossible to
conclude that the oligonucleotide is providing a protective effect by any other
means.
We then went on to show that pTpT is protective against UV induced skin
cancer in NER deficient skin, proving that the mechanism of pTpT protection
is not solely attributable to the upregulation of NER.
Previously, work carried out investigating the action of pTpT on NER models
used Xpc heterozygous mice (Goukassian et al, 2004). This study showed a
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reduction in UV induced mutation rate as well as photocarcinogenesis in the
Xpc heterozygotes as well as wild type mice. The study found a small
increase in median tumour free survival time in pTpT treated Xpc
heterozygotes compared with the untreated group, and the results found in
the wild type mice were very similar. The writers concluded therefore that by
mimicking UV exposure, pTpT enhanced DNA repair capacity in the absence
of DNA damage. Our results do not support this conclusion. By using a
model with a completely NER deficient epidermis, we have been able to
show that pTpT confers protection that is not reliant on DNA repair
mechanisms.
Furthermore, we have shown that the protection conferred by pTpT is not
likely to be due to an increase in apoptosis. We have not seen increased
apoptosis histologically nor have we seen erythema, a sensitive marker for
cutaneous apoptosis. The effect of pTpT on apoptosis will be investigated
further using a cell culture system. We plan to look at the effects of pTpT on
the replicative cycle of spontaneously transformed Erccl null and wild type
keratinocytes. We will also use these cells to assess the effects of pTpT on
UV induced apoptosis. Preliminary data suggest that pTpT alone does not
induce apoptosis.
The differentiation status of keratinocytes in culture is not easy to control.
Primary keratinocytes initially proliferate, and cell cycle arrest can be induced
by several mechanisms (Chaturvedi et al, 1999). Withdrawal of growth
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supplements or addition of transforming growth factor-|3 (TGF-p) causes
reversible growth arrest. Exposure to phorbol ester or interferon-y, or
addition of calcium ions to the medium, results in irreversible growth arrest.
Lastly, primary keratinocytes may undergo irreversible replicative
senescence. Immortalised keratinocytes may have varied states of
differentiation. These cells by their very nature have disrupted cell cycle
control machinery, and as such may behave in unexpected ways.
Characteristically, UV exposure leads to caspase dependent apoptosis in
proliferating keratinocytes. A paper published giving a comprehensive
insight into apoptosis and senescence in keratinocytes showed that cell cycle
activity is crucial for susceptibility to apoptosis, as keratinocytes in cell cycle
arrest are resistant to UV induced apoptosis (Chaturvedi et al, 1999).
Furthermore, a study using a human melanoma cell line, MM-AN, in
comparison with normal human melanocytes has suggested that t-oligo
(oligonucleotides with telomere specific homology) induced apoptosis may
preferentially affect transformed cells (Puri et al, 2004). It should be noted,
that although MM-AN cells lack p53, the p53 homologue p73 induces
apoptosis (Eller et al 2002). Therefore, if UV induced apoptosis and t-oligo
induced apoptosis follow the same molecular pathways, this implies that cells
that are cycling more rapidly are more susceptible to these types of
programmed cell death.
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Our hypothesis for the protective action of pTpT against UV induced
carcinogenesis is that pTpT causes reduced proliferation in normal cells.
The reduced epidermal thickness seen in the UV plus pTpT group compared
with the UV only group backs this up, however it would be interesting to
compare these results with epidermal thickness in completely untreated
animals as well as animals treated with pTpT alone, with no UV exposure.
This hypothesis is in agreement with several publications (Pedeux et al,
1998, Eller et al, 2003, Puri et al, 2004) and also correlates with what we
have seen experimentally in our long term irradiation experiment: pTpT
reduced UV induced epidermal hyperproliferation and hyperplasia, and
encouraged hyperplastic areas to grow exophytically rather than
endophytically; but had no effect on the severity of squamous cell
carcinomas that were present in the two experimental groups. In other
words, topical pTpT application was able to protect normal skin from
neoplastic transformation to some degree; we found less dysplasia
throughout the skin, together with an tendency of papules to develop into
exophytic rather than endophytic tumours in pTpT treated mice; but once an
SCC had formed, pTpT application did not modify the aggressive nature of
the tumour. It should be noted that the Erccl epidermal specific knockout
mice used in these experiments are extremely sensitive to UV induced
carcinogenesis (Doig et al, 2006 and chapter 4 of this thesis).
The reason that pTpT may be able to protect normal skin from malignant
transformation is that keratinocytes in vivo form a complex structure known
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as stratified epithelium (reviewed by Haake and Polakowska, 1993). Cells in
the basal layer divide, but those that are pushed towards the outer layers of
the skin become more differentiated as they reach the surface.
Differentiating cells do not cycle, and become terminally differentiated before
undergoing programmed cell death. The cells nearest to the surface of the
skin, which absorb the majority of the UV insult, are therefore least likely to
be cycling. By ensuring that these cells do not begin to divide uncontrollably,
pTpT may prevent transformation. However, once an invasive tumour has
formed, topical pTpT may not have much effect. This may be due partly to
penetrance, because although it has been shown that pTpT in the vehicle
used penetrates the stratum corneum effectively (Goukassian et al, 2004), it
is conceivable that insufficient pTpT reaches the centre of a growing tumour
to have an effect. That which does penetrate may induce some apoptosis,
but from our results it would appear that this is insufficient to halt tumour
growth.
From our experiments, as well as those carried out by other groups, it would
appear that pTpT does provide some protection from UV induced
carcinogenesis, and is worthy of further investigation. Further work could
include immunohistochemical staining to investigate levels of proliferation in
pTpT treated and untreated skin after chronic UV exposure.
It is worth noting that there are several other putative protective substances
that may in future be used to protect us from UV induced skin cancer. These
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include resveratrol, silibinin, caffeine, caffeine sodium benzoate, sodium
salicylate, acetylsalicylic acid and dihydroxyacetone, which are outlined
briefly below.
Resveratrol is a plant derived antioxidant substance found particularly in
grapes and believed to have strong anti cancer properties. This substance
has recently been shown to prevent UV induced skin carcinogenesis in
hairless mice after topical application (Aziz et al, 2005). This study
compared the effects of resveratrol treatment before and after UV exposure,
and concluded that as the protective effect conferred when the substance
was applied after UV exposure was at least as great as when the substance
was applied before exposure, that the substance was not acting as a
sunscreen. They concluded that its protective effect was due to the
activation of a protective signalling cascade and propose the inhibition of
Survivin phosphorylation as a putative mechanism. Tumour protection was
quantified in terms of median tumour free survival time, which was
significantly longer in resveratrol treated mice, and average tumour number
per mouse, which was lower in resveratrol treated mice, however tumour
spectrum was not addressed (Aziz et al, 2005).
Silibinin is another plant derived antioxidant that has been shown to protect
against the effects of UV in hairless mice. Topical application of this
substance reduces thymidine dimers in the skin and upregulates p53
activation (Dhanalakshmi et al, 2004). Furthermore, topical or oral
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administration of silibinin has been shown to reduce UV induced
carcinogenesis by inhibition of DNA synthesis and cell cycle progression
(Mallikarjuna et al, 2004), and increased levels of UV induced apoptosis after
silibinin treatment are purported to be due to DNA protein kinase dependent
p53 activation (Dhanalakshmi et al, 2005). The authors report moderate
increases in median tumour free survival time after topical and oral silibinin
treatment during the UV protocol, but significant decreases in tumour
multiplicity and volume (Mallikarjuna et al, 2004). The tumour spectrum was
not addressed.
Oral administration of caffeine, either by itself or as a constituent of green tea
has been shown to enhance the p53/p21 response to UV in mice, and
increase the formation of sunburn or apoptotic cells (Lu et al, 2000). More
recently, topically applied caffeine and caffeine sodium benzoate have been
reported to have both a sunscreen effect and increase UV induced apoptosis
in the skin, thereby reducing UV induced carcinogenesis. Tumour initiation
and growth was slowed in UV irradiated mice (Lu et al, 2006). These
substances are able to act as sunscreen agents because their molecular
structure enables them to absorb UVB. The induction of apoptosis is
reported to be p53 independent, and the proposed mechanism involves the
induction of premature mitosis by the inactivation of the G2/M checkpoint (Lu
et al, 2006).
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Sodium salicylate (NAS) and acetylsalicylic acid (aspirin) have also been
shown to protect against UV induced skin cancer in mice (Bair et al, 2004).
NAS appeared to delay tumour formation as well as reduce tumour
multiplicity, while aspirin delayed tumour formation but did not affect numbers
of tumours formed. NAS absorbs UVB light and therefore appears to be
acting as a conventional sunscreen. Aspirin, however, does not absorb UVB
light yet still provides some protection against UV induced skin cancer,
although not as effectively as NAS. The authors speculate that the
protection conferred is due to the ability of aspirin to inhibit COX-2 and the
oncogene AP-1. NAS, another non-steroidal anti-inflammatory drug with
similar properties to aspirin, may therefore be protecting against skin cancer
both by acting as a sunscreen, absorbing UVB rays, as well as acting at a
molecular level to prevent tumour promotion (Bair et al, 2004). This makes it
a particularly interesting prospective therapy for the prevention of skin
cancer. It would be of interest to investigate the effects of these two
substances on tumour spectrum, and our Erccl ESKO mouse would be an
appropriate model with which to investigate any beneficial effects of these
substances on the types of tumours induced by UV exposure.
Dihydroxyacetone (DHA) is a substance found in sunless tanning lotions.
These products are not marketed as protective against skin cancer in any
way, but a recent study has shown some degree of protection in mice
(Petersen et al, 2003). DHA causes the Maillard reaction to occur in the skin,
where amine groups are glycosylated and which results in the formation of a
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brown colour. Although the complex formed absorbs visible light and some
UVA, it appears that DHA itself may absorb in the UVB spectrum. It was
shown that 20% DHA lotion (commercially available preparations contain 5%
DHA) did provide protection against UV induced carcinogenesis when mice
were exposed to moderate UV doses (Petersen et al, 2003). However, in
vitro work suggests that DHA causes redox reactions which may result in
DNA damage. In human keratinocytes, G2 arrest was reported, followed by
apoptosis (Petersen et al 2004). Implications of long term use of this
substance must be addressed, and whilst it is unlikely that commercially
available preparations have sufficient DHA to cause carcinogenesis at
present, if this substance is to be considered for long term use as a
sunscreen, the molecular events must be thoroughly investigated.
Bacteriophage T4 endonuclease 5 (T4N5) has been shown to protect against
UV induced immunosuppression (Kripke et al, 1992) and to repair CPDs in
keratinocytes (Nishigori et al, 1996). The enzyme is encapsulated in
specially formulated liposomes, and has recently been commercialised as
Dimericine® by AGI Dermatics. This product has been shown to reduce the
incidence of actinic keratosis and basal cell carcinoma in XP patients
(Yarosh et al, 2001), and currently trials are underway testing the benefits of
Dimericine® for renal transplant patients, as these have elevated risk of
developing skin tumours due to the immunosuppressive medication they are
required to take. The T4N5 enzyme recognises CPDs in the DNA and
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creates nicks in the DNA adjacent to these, so it is likely that this enzyme
functions by stimulating DNA repair mechanisms.
Of the above substances, DHA appears to have least potential, not least
because of its potential mutagenic effects. It seems likely that the amount of
the substance needed to create a protective effect is higher than that
available on the market at present. It is questionable whether lotions with
higher levels of DHA, and hence higher self-tanning properties, would be
desirable or marketable. Furthermore, the protection offered by DHA
appears to be solely a sunscreen effect, and therefore interest in this
substance may be limited. Caffeine and caffeine compounds also appear to
be acting mainly as sunscreens. There are many effective sunscreens
available currently, and in future skin cancer protection is likely to be focused
on substances that act at a cellular level, and therefore not only have a
longer lasting effect, but may also be used as a post-exposure treatment.
Of the other substances; plant derived anti-oxidants reservatrol and silibinin,
non-steroidal anti-inflammatories (NSAIDs) NSA and aspirin, T4N5
liposomes and pTpT; all may have future roles in skin cancer prevention.
However, before this can be considered, it will be important to rule out any
adverse effects from the long term application of these substances. The
NSAIDs in particular, are a powerful group of drugs with many effects on the
body. Aspirin is currently widely used as a blood thinning agent, and the
effect of topically applied aspirin on blood clotting would need to be
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addressed. T4N5 creates single strand DNA breaks, and although this
substance has performed well in clinical trials to date, its long term effects
remain to be seen. Use of this product may be clinically advantageous for
patients with higher than normal risk of developing skin tumours, as is the
case for XP sufferers and transplant patients; however before the product is
available to the general population further assessment of long term risk will
need to be addressed. All of the above agents seem to exert their effects by
regulating the cell cycle, and investigation into the long term consequences
of their use is a priority.
It is also important to consider the main benefit we derive from sun exposure,
the stimulation of vitamin D3 synthesis. The amount of UV to which we
should be exposed is an area courting great controversy at present. This is
because despite the undesirable effects of UV, chiefly the development of
skin cancers, a certain amount of UV exposure is beneficial.
Exposure to UV has been linked with increased vitamin D levels, indeed
members of the population that regularly use sun beds have been shown to
have higher levels of vitamin D and increased bone mineral densities than
other members of the population (Tangpricha et al, 2004), and although the
validity of this study has been questioned (Weinstock and Lazowich, 2005,
Holick and Tangpricha, 2005), there seems to be plenty of evidence that
some exposure to sunlight is invaluable. People living far from the equator,
especially those with heavily pigmented skin, may not be synthesising
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sufficient vitamin D3 on a chronic basis (Webb and Engelsen, 2006).
Epidemiological studies have reported an increased risk of certain internal
tumours allied with insufficient vitamin D levels (reviewed by Lucas et al,
2006). Finally, lack of sunlight has also been associated with seasonal
depressive episodes.
The link between insufficient UV exposure and internal cancers, as well as
other diseases, may in future drive preference towards a protective agent
that doesn't act as a sunscreen. In this case, interest in pTpT and the other








This chapter will describe a novel fur phenotype reported in our TTRv.Ercd
transgenic animals. As previously mentioned in the introduction to this
thesis, these animals are Erccl null but carry an Erccl transgene controlled
by the transthyretin (TTR) promoter. This transgene is highly expressed in
the liver and restores NER function in this organ. These animals have a life
expectancy of around three months, allowing us to study some of the
consequences of Erccl deficiency in organs apart from the liver.
It was noticed that some of the animals in the stock were suffering from
varying degrees of alopecia. The stock was maintained as heterozygote
crosses, and on closer inspection, it became obvious that all of the transgene
containing Erccl heterozygote and homozygous null animals in the stock
were affected to a greater or lesser degree. Erccl wild type animals were
unaffected. The mildest phenotype was a subtle darkening of the coat, only
visible in agouti animals. The agouti coat is composed of dark hairs, with a
fair band near the tip - known as a sub-apical pheomelanin band - and in the
affected animals it seemed that these fair bands were missing. In these
animals the fur also had a greasy quality. In the moderately affected animals
the greasiness and darkening of the coat was more visible, along with some
thinning of the fur. In the more severely affected animals, hair was sparse on
the body, although the hair on the head and around the tail was unaffected.
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Mouse hair and follicle structure is similar to that of humans, and therefore
there are many useful mouse models of human diseases of the skin and hair.
Mouse hairs fall into several categories: truncal (pelage), vibrissae (also
known as whiskers), cilia, tail hairs, feet hair, and genital/perianal hairs
(reviewed by Sundberg and King, 2001). The hairs affected in these mice
are the truncal or pelage hairs.
Pelage hairs are divided into four distinct sub-categories, first defined in
1926. These are guard, awl, auchene and zig-zag and microscopic images
of these hairs are shown in figure 6.1. Guard hairs, also known as tylotrichs,
are long and straight, with a graduated tip, and are scattered throughout the
pelage. They differ from the other pelage hairs as they are a type of tactile
hair, similar to vibrissae. In agouti mice these hairs lack the characteristic
sub-apical pheomelanin band that causes the yellow appearance of the coat
of these animals, this is only found in the other three types of pelage hairs.
Awls are also straight, though shorter than guard hairs. Awls and guard hairs
usually have three rows of medullary septae, as shown in the high
magnification images in figure 6.1. Auchenes have a single constriction, or
bend, and have two rows of medullary septae, shown in figure 6.1. Lastly,
zig-zag hairs, which make up the majority of the pelage and are also known
as underfur, have several constrictions or bends and only one row of
medullary septae, again shown in figure 6.1. It should be noted that any hair










Figure 6.1 Hair types found in mouse pelage
Awl and guard hairs are straight hairs that are short and long respectively. Zig¬
zag and auchene hairs are constricted and therefore bend. Zig-zags normally
make up 75% of the coat.
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There is some precedent for proteins involved in NER to affect hair quality,
which is why we decided to explore this phenotype. Trichothiodystrophy
(TTD) is a syndrome characterised by brittle hair and nails (reviewed by Itin
and Pittelkow, 1990), and has been attributed to various mutations in the
XPD gene. Patients with TTD have ichthyosis and brittle hair due to a lack of
cysteine rich matrix proteins, vital for creating the cross-linked structure
necessary for normal hair development and growth. As mentioned
previously, a mouse model exists for this disease, in which a point mutation
has been mimicked from a human patient (de Boer et al, 1998). This Xpd
mouse has brittle hair as shown by scanning electron micrograph, consistent
with the human syndrome. Furthermore, hair from these mice has been
reported to be deficient in sulphur, a key component of the cysteine rich
cross-linking proteins present in normal hair. However, this disease is likely
to be due to defects in the transcriptional role of the XPD protein rather than
its role in NER. Keratinocytes from the TTD mouse model do not express
normal levels of Sprr2 mRNA; Sprr2 is a gene associated with terminal
differentiation of keratinocytes and as such is transcribed late compared with
other genes (de Boer et al, 1998). The extremely low levels of Sprr2
transcription in the TTD mouse model is purported by the authors to
represent an exhaustion of the transcription machinery in the absence of
XPD, and therefore they conclude that the TTD phenotype is caused by
transcriptional insufficiency. No other NER deficient mice have been
reported to show a TTD phenotype so it is unlikely that loss of NER is the
causative factor in the disease.
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Despite this, we were interested to investigate the hair phenotype in these
mice further and perhaps uncover a novel role for Erccl. As Erccl
heterozygotes and homozygous nulls were affected while wild types were
not, we felt that there was a strong possibility that the Erccl gene was
involved in the phenotype.
6.2 Categorisation of the phenotype
When the phenotype was first recognised, a scoring system was developed
with which to categorise the animals. The parameters used are described in
table 6.1.
224
Table 6.1 TTR::Ercc1 stock fur phenotype
Category Phenotype
0 Shiny, full coat - no abnormalities
1 Darkened coat, only visible in agouti animals
2 Coat dark and dull, some long straggly hairs
3 Coat dark, dull, greasy and thinning
4 Moderate hair loss, remaining hairs dark and greasy
5 Coat very sparse, few hairs remain on body





Shiny full coat with no abnormalities
Category 1 (left)
Darkened coat only visible in agouti animals
(Category 0 animal on right)
Category 2
Coat dark and dull, some long straggly hairs
Category 3
Coat dark, dull, greasy and thinning
Category 4
Moderate hair loss, remaining hairs dark
and greasy
Category 5
Coat very sparse, few hairs remaining on
body
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6.3 Animals were distributed throughout the five categories
Using the guidelines outlined above, animals were put into categories at
around four to six weeks, when they were mature enough to have their first
full adult coat. Figure 6.3 shows the distribution of Erccl heterozygotes and
homozygous null animals within these categories, for a cohort of 92 animals.
As a result of the mixed genetic background of this line, coat colour was
segregating in the stock. It is important to note that this stock contained
some black animals on which it was not possible to distinguish the mild
phenotype. The more severe phenotypes were easily seen in either coat
colour. As the category 1 phenotype was only visible in agouti animals, the
few black animals have been omitted from the classification.
All Erccl wild type animals seen in the stock were determined to be
unaffected by the phenotype, and classified as category 0. None of the
Erccl heterozygous or null animals were classified as category 0, as all were
affected by the phenotype to some degree. More than half of the Erccl
heterozygous animals were classified as category 1, as they had the mildest
phenotype, which presented as a simple darkening of the coat. Around one
tenth of heterozygous animals fell into each of the other categories, apart
from category 4, which only contained one animal of the sixty in the cohort.
Considering categories 3, 4 and 5 as 'severely phenotypic' resulted in one
fifth of Erccl heterozygous animals falling into this classification.
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6.3










□ Erccl wild types
Erccl heterozygotes
■ Erccl liver corrected nulls








nulls (n = 20)
0 12 0 0
1 0 29 3
2 0 7 12
3 0 5 1
4 0 1 0
5 0 6 2
Total: 12 60 20
Figure 6.3 Distribution of unusual fur phenotype in TTR::Erccl stock
Animals were put into categories according to the parameters shown in table 6.1
at 4-6 weeks of age. The graph and table above show the absolute numbers of
animals in each group.
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No Erccl null animals were classified as category 0, as all were affected by
the phenotype to some degree. More than half of the animals in the cohort
were classified as category 2, with significant darkening of the coat
presenting with some long hairs showing through. Approximately one tenth
of animals fell into each of the other categories, apart from category 4, into
which none of the Erccl homozygous null animals were classified. Just
under one fifth of the animals fell into the severely phenotypic categories.
6.4 Microscopic examination of hairs
Tufts of hairs were plucked from the dorsum of the animals and placed on a
glass slide. These tufts were teased apart, then carefully fixed in place using
clear nail polish. Once this had dried, the hairs could be examined
microscopically. Zig-zag hairs could be identified by their characteristic
constrictions.
In animals from categories 3 to 5, zig-zag hairs were found to be
morphologically abnormal. They were found to be reduced in diameter, with
irregular septae and disrupted cuticles. This can be seen in figure 6.4, where
hairs from a category 0 animal are compared with hairs from a category 5
animal. Keratin appears white when viewed with polarised light, so images
were also recorded using a polarised light source. These can be seen in
figure 6.5, where hairs from a category 0 animal are compared again with
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Fig 6.4
Wild type: Erccl het:










Figure 6.4 TTR::Erccl animals show narrowed zig-zag hairs
Panel A shows an image of a zig-zag hair from a wild type animal. The
hair is thick, the septae are ordered (S) and the cuticle is intact (C)=
Panel B shows an image of a zig-zag hair from an animal with the unusual
fur phenotype. The diameter of the hair is reduced, the septae are
irregular and the cuticle is disrupted.
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Figure 6.5 TTR::Erccl animals have visibly dystrophic zig-zag hairs when
viewed using polarised light
Panel A shows two hairs from a wild type mouse. The septae are ordered and the
keratin in the cuticles looks white in the polarised light (C). Panel B shows two
hairs from a mouse with the abnormal hair phenotype. The septae are disordered
and the cuticles have almost disappeared.
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hairs from a category 5 animal. In these images, disruption of the septae
and cuticles in the category animal is even more obvious.
6.5 Zig-zag hairs from phenotypic animals have a smaller diameter
than those from non-phenotypic animals
From the microscopic images it was clear that zig-zag hairs from phenotypic
animals were narrower than those from non-phenotypic animals. We
quantified the difference by measuring the thickness of randomly selected
hairs that were fixed onto glass slides using measurement tools in DP Soft
image analysis software. As mentioned previously, zig-zag hairs have
characteristic constrictions which cause them to bend by around 90°. In
order to ensure a valid comparison, each hair was measured across the
thickest point, equi-distant between constrictions.
The data obtained were analysed using analysis of variance (ANOVA) and
are shown in figure 6.6. It is clear from this graph that the phenotype shows
continuous variation throughout the stock. Animals in category 5 have
significantly thinner zig-zag hairs on average than animals in category 0, with








Figure 6.6 Animals with the abnormal fur phenotype have smaller
diameter zig-zag hairs
This graph shows average hair diameters for each fur phenotype category.
Each category contains at least five animals, and 20 measurements were taken
from each animal.
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Furthermore, auchene and guard hairs were also seen to be narrower and
less regular in the phenotypic animals, compared with non-phenotypic
animals. These were not analysed in as much detail as the zig-zag hairs
because it was not possible to ensure measurement was taken in exactly the
same way for every hair, as was possible for the zig-zag hairs, thanks to their
structure.
6.6 Phenotypic animals have abnormal follicle and skin morphology
The tufts of hair that had been removed from the animals for analysis of the
hairs also allowed us to examine the roots of the hairs. We found that hairs
from the phenotypic animals had fewer roots attached, and those roots that
were visible were shorter than those from non-phenotypic animals. The
average length of roots in wild type animals was 292^m ±11|im, while the
average root length in animals severely affected by the phenotype was
255^im ±8|im. Examples of these are shown in figure 6.7.
We also examined sections of skin from the animals, stained with
haematoxylin and eosin. We found the phenotypic animals to have some
abnormal skin features, shown in figure 6.8. Throughout the sections
examined we found evidence of follicular keratosis and ectatic, or dilated,
infundibuli (slides examined by Dr D Brownstein). This correlated with the












Figure 6.7 Animals with the abnormal fur phenotype have shortened
roots compared with controls
The roots of zig-zag hairs were examined for differences. A shows images of







Figure 6.8 Animals with the abnormal fur phenotype show altered skin
histology
Panel A shows an H&E stained section from an animal with normal fur. This
animal has normal skin features. Panel B shows a similarly stained section from
an animal with the abnormal fur phenotype. In this image we can see ectatic
infundibuli (I) and evidence of follicular keratosis (F).
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After characterising the phenotype itself, we began to search for a possible
molecular explanation for the observations that had been made. The
following sections of this chapter address this issue.
6.7 ERCC1 protein levels do not appear to correlate with phenotype
Firstly, we decided to investigate whether there was any correlation between
levels of ERCC1 protein in the skin and the severity of the phenotype. To do
this we used Western blotting techniques together with phospo-imagery to
quantify protein levels, and the results of this analysis are shown in figure
6.9. We found no link between levels of ERCC1 in the skin with the severity
of the phenotype.
6.8 Copy number of the TTR::Erccf transgene does not appear to
correlate with phenotype
In order to rule out the possibility that the TTR\\Ercc1 transgene had
integrated into a site in the genome where it was disrupting a gene involved
in skin or hair structure, we decided to investigate whether there was any
correlation between the copy number of the transgene and the hair
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Figure 6.9 Western blot analysis of ERCC1 protein
We compared ERCC1 protein levels in the skin of Erccl heterozygous animals
from different fur categories by Western blot, a-tubulin was used as a loading
control, and the ratio of ERCC1 to tubulin calculated after signal intensities were
measured using ImageQuant Controller and analysed using ImageQuant TL
software.
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We already had a reliable genotyping PCR for the TTR::Ercc1 transgene,
and this was used to identify its presence in the animals. This PCR gives a
170bp band for the transgene, however if the wild type endogenous Erccl
gene is also present, the PCR gives a second, 600bp band. For this
experiment, we used another PCR assay as an internal control. This was a
PCR used in our laboratory to identify the DNA ligase I wild type allele, as we
knew that our animals would all have the same number of copies of this
allele, regardless of their Erccl status. This PCR was ideal as an internal
control, as the PCR product was a similar size, 300bp, and the primers used
had a similar melting temperature to the ones used for the TTR::Ercc1
transgene.
Firstly, tests were carried out to determine the number of PCR cycles that
were needed to give a quantitative estimate of DNA levels; normally, this
PCR is run for 35 cycles. To do this, PCR assays were run using a DNA
sample undiluted, and at a 1:2 dilution. These samples were run at 16, 18,
20, 22, 24, 26, 28 and 30 cycles to determine the point at which signals were
detectable and the difference in band intensity or signal strength between the
two samples was two-fold. Using this technique, we found that 24 cycles was
the optimum, as shown in figure 6.10.
Using this information, we were able to set up a PCR using
spectrophotometrically determined quantities of DNA from animals with the
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Fig 6.10
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Band intensities (values measured using inverted figure):
A 1:1 A 1:2 Ratio B 1:1 B 1:2 Ratio
Lig 1 0.14 0.27 1.93 0.15 0.29 1.93
Erccl TG 0.26 0.42 1.62 0.1 0.22 2.2
Figure 6.10 Quantitative analysis of Erccl transgene PCR band
intensity is optimum at 24 cycles
We compared lig I and Erccl TG band intensities using samples A and B
undiluted and diluted 1:2. Intensity ratios of the diluted and undiluted samples
were calculated, and both the ratios obtained were very near 2.
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mild phenotype and animals with the severe phenotype, to compare the
signal for the Erccl transgene.
The results of this experiment can be seen in figure 6.11. Ten Erccl
heterozygous, transgene positive animals were tested. Band intensities for
the ligase I products and the Erccl wild type products were found to be
similar for all ten animals tested, indicating that the amount of DNA present
was comparable for each sample. Erccl transgene band intensities were
similar for seven of the ten samples, and approximately doubled for the
remaining three. It is likely that these three animals were homozygous and
carried two arrays of the transgene insertion sequence, and the other seven
were hemizygous, carrying one of the transgene insertion sequences. Of the
three animals likely to be homozygous for the transgene, two were mildly
phenotypic animals and one was a severely phenotypic animal, whilst of the
seven animals likely to heterozygous for the transgene, three were mildly
phenotypic and four were severely phenotypic. From these results, it
appears that Erccl transgene copy number bears no relation to the hair









Band intensity ratios Erccl TG ratio
compared with Iig1
















Figure 6.11 Semi-quantitative PCR analysis of Erccl transgene
reveals no correlation between transgene copy number and hair
phenotype
The graph shows band intensity measured in optical density units using
image analysis software after a 24 cycle PCR assay. The table shows the
ratios of the Erccl transgene band compared with the two internal controls.
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6.9 The origin of the Erccl wild type allele in the animals does not
appear to correlate with phenotype
As this stock has had genetic input from a number of different strains of
mouse, including Balb/C, C57BL/6J and Ola129, we decided to investigate
whether the origin of the Erccl wild type allele the animals were carrying had
any bearing on the phenotype. We were able to do this using previously
identified polymorphisms in the promoter region of the endogenous Erccl
gene (David Melton, personal communication).
Figure 6.12 shows sequence upstream of and including Erccl exon 1. The
locations of two primers, Gen6 and Gen9-3', are shown in burgundy.
Between these two primers is a repeat sequence which varies slightly in size
between species. Figure 6.13 shows PCR products from C57BL/6J, Balb/C
and Ola129 animals run out on an agarose gel.
Using this PCR assay, we investigated some animals from the TTRv.ErccI
stock, and the results can be seen in figure 6.14. Twelve animals were
assayed, including two liver corrected null animals (with no copy of the Erccl
wild type allele), four severely phenotypic and four mildly phenotypic
heterozygotes (with one copy of the Erccl wild type allele each), and two
Erccl wild type animals (with two copies of the Erccl wild type allele each).
The Erccl knockout allele in the stock was generated using cells from an




















Figure 6.12 Polymorphisms found in Erccl upstream sequence are
mouse strain specific
In this sequence, taken from C57BL/6J, Erccl exon 1 is shown in blue, and
the sequence used to determine mouse strain is upstream of this exon. The
primers used are Gen6 and Gen9-3', and are shown in burgundy. The area
of repeats shown in bold is the area where the strain specific differences
occur. Using these primers, Olal29 mice give a 314bp product, C57B1V6J
mice give a 294bp product and Balb/C mice give a ~400bp product.
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Figure 6.13 Primers Gen6 and Gen9-3' give different sized products
in different mouse strains
The PCR assay was run on the following program:
94°C 5 mins, (94°C 1 min, 58°C 1 min, 72°C 1.5 mins) x 35, 72°C 10 mins
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Figure 6.14 The strain of origin of the wild type Erccl allele does not
correlate with severity of hair phenotype
Samples were assayed as described in figure 6.12.
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and null alleles, the null allele was detected as an Ola129 allele in these
results.
Both of the liver corrected null animals were positive for the Ola 129 allele, as
expected. The two Erccl wild type animals tested appeared to have one
Ola129 derived wild type allele and one Balb/C derived allele each. Of the
eight Erccl heterozygous animals investigated, all had positive signals for
Ola129, representing the one Erccl null allele they carried. Six had a Balb/C
derived wild type allele and two had an Ola129 derived allele. Furthermore,
of the two with Ola129 derived wild type Erccl alleles, one was severely
phenotypic and one was mildly phenotypic. None of the animals carried a
C57BL/6J derived Erccl wild type allele.
These results showed that the origin of the wild type Erccl allele the animals
inherited bore no relevance to the status of their hair phenotype.
6.10 Discussion
It is of prime importance when considering the work presented in this chapter
to know that although the TTRv.Erccl mouse stock has been in existence
since the late 1990s, this phenotype has only been recognised relatively
recently. The stock was being kept at a very low level, as the animals were
not being used for any particular experiments, and animal numbers had
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dropped drastically. Towards the end of 2004 we restarted a breeding
program in order to produce more animals for use in experiments mentioned
in the discussion of chapter 3 of this thesis, and to invigorate the meagre
stock we crossed the remaining animals that were suitable for breeding with
C57BL/6J stock mice. This meant that we had two breeding pairs with which
to generate new stock.
It was in the following months that the hair phenotype described in the
chapter was noticed. Prior to the bottleneck in the stock described above, no
abnormal hair or skin features had been reported. It is highly unlikely that the
severe features detailed here would have been missed. However, it is
conceivable that the milder phenotype would not have been recognised, as
the most striking feature of this is a darkening of the agouti coat. Unless the
animals are seen next to an unaffected agouti animal, this change could go
unrecognised. Furthermore, as mentioned earlier, this mild phenotype is not
visible on a black coat, neither is it visible on chinchilla or other coat colours;
and there may have been fewer agouti animals in previous generations.
There was a chance that Erccl was involved directly with this phenotype;
however the details underlying the mechanism, if in fact there was one, were
far from straightforward. With this in mind, the characterisation of the
phenotype in these mice has followed a system of elimination, where
possible causes of the phenotype have been examined and discounted
systematically.
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One of the most obvious features of the mice, apart from the alopecia, were
the long straggly hairs that were visible in the coats of the animals. The
Ragged phenotype is caused by mutation in Sox18 (Pennisi et al, 2000a)
and is characterised by a sparse coat, which is abnormally dark with long
guard hairs standing out from the rest of the coat (Carter and Phillips, 1954).
The Ragged mouse was heterozygous for the Ra mutation, with the majority
of homozygous mutants dying shortly after birth with a severe oedematous
condition (Carter and Phillips, 1954). Those that survived were naked, with
few hairs anywhere on their bodies. Although the phenotype of our mice
seemed initially similar to the Ragged phenotype, we saw nothing that
resembled the homozygous Ragged mutant described. This was despite
paying particular attention to pups born to parents both of which were
displaying the hair phenotype. Recent work has shown that despite the
severity of the Ra mutation in Sox18, Sox18~/' mice are in fact viable and
suffer only mild features of gene deficiency (Pennisi et al, 2000b). This
indicated that the Ra phenotype is in fact caused by a dominant negative
mutation, where the Ra mutated Sox18 gene product causes a negative
effect, with consequences more severe than complete absence of Sox18
gene product. The hair phenotype in the Sox1&A mice did bear some
resemblance to that which we saw in our stock. These mice have a lower
proportion of zig-zag hairs compared with wild types, but normal proportions
of guard and awl hairs. They also lack the sub-apical pheomelanin band
characteristic of the agouti coat colour, and therefore appear darker than wild
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type littermates. However, morphologically the hairs are normal (aside from
pigmentation differences) and there is no suggestion that the skin of these
mice is adversely affected (Pennisi et al, 2000b). Taking all the evidence into
account, it seems unlikely that our mice have a Sox18 mutation, especially
as Sox18 is located on mouse chromosome 2 and is therefore not linked with
Erccl, so a mutation in this gene could not explain the Erccl linked
phenotype we have observed. However, it would be valuable to perform a
western blot on skin samples from the mice from this stock, to investigate
potential differences in SOX18 levels. It would also be interesting to
sequence the Sox18 gene in the mice to see if any mutation is present.
Without this we cannot be sure that our phenotype is not caused by a Sox18
mutation.
However, we have looked at hairs microscopically and concluded that the
darkening of the fur seen in agouti animals is likely to be due to a loss of the
tips of the hairs, rather than a pigment abnormality. We have not shown data
that confirm this theory, as this difference is difficult to demonstrate, but we
believe that hairs from severely affected animals often have blunt ends
consistent with a brittle hair phenotype. This would result in shortening of
hairs, particularly zig-zag hairs which seem to be most affected in our
animals, and potential loss of the sub-apical pheomelanin band by breakage.
We considered the possibility that the animals with the more severe
phenotype were expressing a lower level of ERCC1 protein than less
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severely affected animals. However, after analysing protein extracted from
skin samples, we found no correlation between levels of ERCC1 in skin and
the severity of the phenotype.
The TTR:\Ercc1 mouse was generated by cloning Erccl cDNA into a TTR
vector. The construct generated was used for pronuclear injection, and mice
expressing the transgene were used to create the stock (Selfridge et al,
2001). It was clear that the transgene had integrated into the genome as it
was inherited through generations, however the integration site itself was
unknown. For this reason we decided to investigate whether there was any
correlation between the copy number of the transgene and the hair
phenotype. It is important to note that a single integration site of the
transgene is estimated to consist of four Erccl cDNA sequences (Jim
Selfridge, PhD thesis, 1999). Therefore, animals that are homozygous for
the transgene, that is have received copies of the transgene from both
parents, should have eight copies, and animals that are hemizygous should
have four copies. However, using a semi-quantitative PCR technique, we
found no correlation between transgene copy number and severity of the hair
phenotype. The technique used can only be relied upon to give a rough
estimate of sequence quantity and the result is far from authoritative.
However, as we were looking for a doubling in the ratio of Erccl transgene
product compared with two internal control products, we felt that this was a
simple assay worth trying. The results obtained indicated that we were able
to use this technique to distinguish between homozygotes and hemizygotes,
as there was a clear difference in transgene band intensity between two of
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the animals and the other seven that we assayed, with only one animal
giving an inconclusive result. To confirm these results there are two main
options. Firstly, a real-time PCR assay could be developed to quantify Erccl
transgene DNA present in the samples. Secondly, an extensive breeding
plan could be carried out to identify animals' transgene copy number by the
genotypes of the offspring they produce, however this would be particularly
consuming of time and resources.
In this chapter we have documented a phenotype that is present in Erccl
heterozygotes and Erccl liver corrected null animals, but not in Erccl wild
types, and this was one of the main reasons that we suspected Erccl
involvement. However, the Erccl liver corrected null animals certainly were
not more severely affected than the heterozygous animals. Furthermore, the
Erccl liver corrected null animals are generally quite sick and die before
reaching twelve weeks of age, so we were unsure whether the features
noticed in these mice were indeed a real phenotype or were simply a
consequence of general malaise and loss of condition, despite the narrowed,
brittle hair phenotype characterised in these mice being unusual, and as far
as we are aware, undocumented apart from in the TTD model mice (de Boer
etal, 1998b).
This led us to query the integrity of the Erccl wild type alleles present in the
stock. Thanks to work carried out previously in the laboratory, we were
aware of a repeat sequence in the promoter region of Erccl that varied
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slightly between mouse strains. As we knew that the stock contained a
genetic mix from a number of different inbred mouse strains, we considered
the possibility that a mutation in the wild type allele in combination with a
renewed genetic background had given rise to the hair phenotype.
Our stock was carrying two Erccl wild type alleles: an Ola129 derived allele
and a Balb/C derived allele. There were distributed in the stock in a 1:2 ratio
with no link to the severity of the phenotype.
During the course of the investigation, we came across an alarming trend.
We found that the stock had ceased to produce Erccl wild type animals. As
Erccl liver corrected null animals have limited viability and in any case, are in
fact infertile (Hsia et al, 2003), breeding pairs are heterozygote crosses.
Therefore, according to Mendelian ratios, we expected a quarter of all
animals to be Erccl wild types.
One possible explanation for this again revolved around the copy number of
the liver replacement transgene. The transgene was originally designed to
alleviate the severe liver phenotype seen in the absence of Erccl, and in this
respect it fulfilled its objective. However, overexpression of Erccl has been
notoriously difficult to achieve (Jim Selfridge, personal communication). We
considered the possibility that the combination of two endogenous copies of
Erccl combined with two copies of the Erccl liver replacement transgene
may be incompatible with life. This could create a level of ERCC1 in the liver
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that is simply not sustainable, and the animals die early in embryonic
development. This would explain why when we first restarted the stock we
saw wild type animals, but they subsequently disappeared - at the beginning,
as we had crossed the stock out onto C57 mice, most animals that did have
the transgene were hemizygous. However, as time went on we selected for
the presence of the transgene, and it is likely that more and more animals in
the stock were homozygous for the transgene. This could have coincided
with the gradual loss of wild type animals from the stock. This idea was
dismissed, however, when we revisited the levels of expression of Erccl
transcript from the transgene. Not only was there likely to be four copies of
Erccl cDNA in each transgene insertion site, but the mRNA levels produced
by the transgene in the liver were several times greater than the levels
produced by endogenous Erccl. This meant that our hypothesis was
extremely unlikely to be correct. To illustrate, we can compare an Erccl wild
type mouse that was hemizygous for the transgene with an Erccl wild type
mouse that had two copies of the transgene, under the two conditions: if the
level of expression from the transgene were similar to that from the
endogenous gene, we would be comparing expression levels of three times
that of an endogenous gene with four times that of one endogenous gene.
At these ratios, there is possible biological significance. However, if levels of
expression from the transgene were around four times that of the
endogenous gene, as is likely to be the case, we would be comparing
expression levels of nine time that of an endogenous gene with expression
levels of ten times that of an endogenous gene. As there is little difference
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between these two levels of expression, we believe this hypothesis to be
incorrect. Furthermore, northern blot analysis carried out when the mice
were initially created found that levels of Erccl mRNA transcribed by the
transgene were in actual fact around ten times higher than endogenous liver
Erccl mRNA (Jim Selfridge, PhD thesis, 1999). This was because the TTR
promoter that controls liver specific transgene expression is more active than
the Erccl liver promoter. In summary, although there could have been some
silencing of transgene expression over time, we feel that the likely levels of
expression preclude this explanation for the loss of Erccl liver corrected wild
type animals from the stock.
Another possible explanation for the phenomenon revolved around the
relative proximity to Erccl of the gene responsible for TTD: Ercc2 or Xpd.
Xpd null mice are embryonic lethals (de Boer et al, 1998a), however there is
a mouse model for TTD which mimics a point mutation point in a TTD patient
(de Boer et al, 1998b). Although it seemed extremely unlikely, we
considered the possibility that our stock may have picked up an Xpd mutation
that caused a TTD-like phenotype in one copy and was an embryonic lethal
in two copies. If this were the case, the mutation would be closely linked to
one of the Erccl wild type alleles in our stock. Erccl and Ercc2IXpd are
separated genetically by 25.5kb, and using this information we are able to
calculate the chance of a recombination event occurring between these
genes. One centimorgan distance equates to approximately 2000kb in the
mouse (JAX Mouse Genome Informatics website; Genetics: Principles and
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Analysis, 1998), meaning that on average one recombination even will occur
in every 2000 kilobases of genetic code. Therefore, the recombination
frequency between these two loci is approximately 1.3%.
For this hypothesis to be correct, the linked mutation in Xpd would have had
to be a very specific type. Although the Xpd homozygous null mouse is an
embryonic lethal, the heterozygous animals reported in the aforementioned
publication are viable and do not shown symptoms of TTD. Our hypothesis
required the Xpd mutation to be lethal in two copies and to cause a TTD
phenotype in one copy, and such a mutation has not been reported.
However, this would explain the absence of wild type animals in our stock, as
well as the severity of the hair phenotype in the Erccl heterozygotes, as
these would also be heterozygous for the putative Xpd mutation. Erccl liver
corrected null animals would have two wild type Xpd alleles, so the hair
phenotype seen in these animals would have to be attributed to the general
lack of condition in these animals.
To test this hypothesis incontrovertibly required analysis of the Xpd
sequence from the animals in this stock. However, as the only samples we
had available were from animals that were heterozygous for the putative
mutation, we decided first to expand the breeding scheme to analyse litters
from a variety of different crosses. If this analysis correlated with our
hypothesis, we planned to carry out the sequence analysis of Xpd.
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We reasoned that if our hypothesis were correct, if we crossed a severely
phenotypic, Erccl heterozygous animal from our stock with wild type animals
from other stock, we would see the following offspring: Firstly, we would see
Erccl wild types again. 50% of pups would be Erccl heterozygotes and the
other 50% would be Erccl wild types. None of the Erccl heterozygotes
would show the hair phenotype, as these would have one functional Xpd
allele that was linked with their Erccl null allele, and a second functional Xpd
allele linked to the Erccl wild type allele from the parent from the new stock.
All of the Erccl wild types would have the hair phenotype, as these would
have one defective Xpd allele linked to the wild type Erccl allele from the
TTR::ERCC1 stock, and a functional Xpd allele linked to the Erccl wild type
allele from the new stock, and effectively be heterozygous for the Xpd
mutation as the Erccl heterozygotes had been previously.
With this in mind, we set up pairs consisting of one Erccl heterozygote from
the stock and one animal that was either inbred C57BL/6J or Ola129,
obtained from the animal house stock. We analysed the pups from the
crosses for genotype as well as phenotype. We found, in short, that after
crossing the stock out to either inbred strain, that the hair phenotype
disappeared in all the progeny regardless of genotype. This result disproved
the hypothesis that our stock harboured an Xpd mutant allele.
In summary, despite the fact that we identified a clear and consistent
phenotype in this stock, we have been unable to find a molecular explanation
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for the phenomenon. All the evidence points towards a 'background effect' -
something characteristic of the stock in question relating to the overall
genetic mix of the animals. In this case, although the phenotype may relate
to Erccl status, other unknown genes create a modulatory effect. It would
be extremely difficult to identify candidate modulator genes. This explanation
is particularly likely in this stock, where numbers of animals had dwindled
and the current stock was expanded from a very small genetic pool.
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Chapter 7
Characterisation of a novel neurological phenotype found in Erccl
liver corrected null mice
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7.1 Introduction
NER deficiency has a strong association with neurological disease in human
patients. All Cockayne syndrome patients, as well as many xeroderma
pigmentosum and trichthiodystrophy patients, present with moderate to
severe neurological symptoms (reviewed by de Boer and Hoeijmakers,
2000). The explanation for this revolves around the unique characteristics of
cells that make up the central and peripheral nervous systems. These cells
do not replicate as do cells in other tissues, and are extremely reliant on their
repair systems. The cells of the nervous system are not exposed to UV
induced DNA lesions in the same way as the skin, but they are susceptible to
oxidative DNA lesions of endogenous metabolic source. Classically, base
excision repair (BER) is considered to be of prime importance in the repair of
such lesions, but it is likely that NER also plays an important role, as
demonstrated by the neurological symptoms in XP patients. As neurons are
terminally differentiated and no longer divide, they are able to dispense with
global genome repair and rely on transcription coupled repair (reviewed by
Nouspikel, 2006), although this differs from other terminally differentiated cell
types, such as cardiac myocytes (van der Wees et al, 2006). It is unclear
whether BER is able to act coupled with transcription (reviewed by Mellon,
2005), which may explain the importance of NER in neurons, as the
existence of transcription coupled NER is well documented.
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Due to the non-proliferative nature of neurons, un-repaired lesions in these
cells are less likely to result in carcinogenesis, but instead lead to the
blocking of transcription and programmed cell death. Aberrant loss of
neurons is a factor in a number of serious human illnesses, including
Alzheimer disease, Huntington disease and motor neuron disease (reviewed
by Dickson, 2004 and Bursch and Ellinger, 2005). The mechanisms involved
are extremely complex, and there are many stimuli that can lead to
neurodegeneration, however there is an emerging body of work that
implicates synaptic changes as early events in neurodegenerative
processes, and it appears that loss of synaptic function may be an important
initiator of neuron loss, as loss of synapses appears to be a very early
pathogenic marker (reviewed by Wishart et al, 2006). Changes at the
synapse are now considered a crucial early marker for neurodegeneration,
and are a prime target for novel therapies aiming to prevent and treat the
onset of these debilitating diseases.
A Csb mouse model for Cockayne syndrome appears to have mild
neurological features (van der Horst et al, 1997), and a double Xpa/Csb
knockout mouse has been reported to have severe neurological features,
including tremors, clasping and abnormal gait, together with a life expectancy
of less than three weeks (Murai et al, 2001). Xpg'A mice have been reported
to have significant atrophy of Purkinje cells (found in the cerebellum, an area
of the brain involved in coordination and movement), with a life expectancy of
around one month (Sun et al, 2001). Due to the short lifespan of these mice
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it is not clear whether this is a neurodegenerative feature, or a failure in
development.
With this information, we believed that our Erccl liver corrected null mice
would be a good model in which to further the study of the effects of NER
deficiency on the central and peripheral nervous systems.
As reported earlier (Selfridge et al, 2001), Erccl liver corrected null mice
have normal hepatic appearance and function at the time of death. Kidney
abnormalities were detected in the post mortem examination of these
mice, specifically polyploidy, and plasma creatinine levels were slightly
elevated, an indication of kidney malfunction. It appeared initially that these
animals were dying at around three months of age from kidney failure.
However, in unpublished work carried out in our laboratory, animals with
the floxed Erccl gene (as found in the epidermal specific Erccl knockouts)
were crossed with a Nestin-Cre expressing line. The nestin promoter is a
neuronal specific promoter, and this line expresses Cre recombinase in
neuronal cells. It was found that the nestin Erccl mice died at around the
same time as the liver corrected nulls, prompting speculation as to the
neurological effects of loss of Erccl. Due to a lack of neurobiology
expertise in the laboratory and an absence of collaborators, the breeding
scheme for these animals was not continued.
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In 2005, we noticed that the Erccl liver corrected null mice were displaying
gait abnormalities indicative of ataxia, as well as the clasping reflex, an
indicator of cerebellar abnormalities. This reawakened an interest in the
possible neurological implications of defective nucleotide excision repair
and loss of Erccl, which led to the work described in this chapter.
7.2 Erccl liver corrected null animals clasp when suspended by their
tails
When mice are picked up by their tails the normal response is to hyper
extend the rear limbs. We found that Erccl liver corrected null mice do not
do this, and instead they clasp their hind limbs together, as seen in figure
7.1. We found that this abnormal reaction progressively worsened with
age, and by the time the animals were around ten weeks of age, the
clasping was severe. The animals also showed signs of ataxia, displaying
a lack of coordinated movement. This lack of coordination became so
severe in the last month of the animals' three month lifespan that animals
picked up by their tails and then lowered towards a surface were unable to
stretch out their fore limbs and 'land' on the surface. Instead the animals
clasped all four limbs together and when placed on a surface tended to
remain on their back for a short time, before struggling to right themselves
successfully. Furthermore, these animals displayed almost no self-
initiated movement around their cage or when placed on an open surface.
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Fig 7.1
Figure 7.1 Clasping reflex seen in Erccl liver corrected null mice
When held by the tail and lowered towards a surface, Erccl liver corrected null
mice clasped their hind limbs (b) rather than stretching them out as a control
animal would (a). Clasping progressively worsened with age, often involving
front limbs as well as hind limbs - this animal is around 10 weeks of age.
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7.3 Erccl liver corrected null animals perform poorly on the Roto-Rod
As we suspected that the Erccl liver corrected null animals suffered from
ataxia, we analysed their performance on the Roto-Rod. This is an
apparatus which allows analysis of the animals' level of coordination and
motor function. Animals were placed on a slowly rotating rod of around four
centimetres in diameter, with the surface of the rod covered with ridged
rubber to facilitate grip. The animals are therefore induced to walk forward
continuously in order to maintain their balance on the rod, and the speed of
rotation of the rod increases slowly but steadily. Measurements of time
were recorded from the moment animals were placed on the rod until they
were unable to maintain their forward motion and balance, and fell off onto
the surface below the rod. The results of this experiment are shown in
figure 7.2. Erccl liver corrected null animals performed significantly worse
than littermate controls at four and at eight weeks of age; p<0.001, t-test. At
four weeks of age, Erccl liver corrected null animals were able to stay on
the Roto-Rod for approximately half the time that their littermate controls
were able to manage. However at eight weeks of age, the performance of
the Erccl liver corrected nulls had declined further, whereas the
performance of the controls had remained similar. At eight weeks, Erccl
liver corrected nulls were able to stay on the Roto-Rod for around a quarter
of the time that the control littermates recorded. From these data, we
concluded that Erccl liver corrected null animals have defective
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Figure 7.2 Erccl liver corrected null mice perform poorly on the Roto-
Rod compared with wild type littermates
Animals were tested on the Roto-Rod at 4 weeks and 8 weeks of age. There
were ten animals in each group, and readings for each animal were averaged
over three consecutive days.
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7.4 Erccl liver corrected null animals have a proportionately smaller
cerebellum than littermate controls
Roto-Rod performance is generally recognised to be an indicator of
cerebellar function, and as such we decided to investigate gross size of the
cerebellum in Erccl liver corrected null and control animals.
Measurements were taken after whole brains were dissected and fixed.
Images of the brains were taken from above for analysis, with readings
obtained as two-dimensional measurements of surface area. Using this
method of analysis, we were able to show that Erccl liver corrected nulls
appear, on average, to have a slightly smaller cerebellum in proportion to
total brain size, compared with control littermates, as shown in figure 7.3;
p<0.0001. It was imperative to make the comparison of cerebellar size as
a percentage of the total brain size: as the Erccl liver corrected null
animals have somewhat retarded growth, the gross size of their brains is
significantly smaller than that of wild type littermates.
7.5 Erccl liver corrected null animals perform poorly in the opto-kinetic
response (OKR) test compared with wild type littermates
We felt that the Erccl liver corrected null animals did not respond to visual
stimuli in the same way as controls, so we assayed the visual acuity of the














Figure 7.3 Erccl liver corrected null mice have a smaller cerebellum
relative to total brain compared with wild type littermates
Measurements were taken using a two dimensional image capture system
and surface area values compared. There were 12 animals in each group.
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rotating drum to ascertain whether the mice are able to follow, or 'track' the
movement of the stripes (first described by Thaung et al, 2002, used as an
indicator of phenotype by Hart et al, 2005). We tested animals at four and
eight weeks of age, and we used three different categories of stripe size:
these different stripe sizes form stripes subtending angles of 2°, 4° and 8°
on the retina of the animals, with 8° stripes the easiest for the animals to
focus on and 2° the hardest. We found that the Erccl liver corrected null
animals performed extremely poorly in all the tests we carried out
compared with littermate controls. The results obtained are shown in
figure 7.4. At four weeks of age, both the Erccl liver corrected null animals
performed slightly better with 4° stripes than the other two sizes, although
in all categories Erccl liver corrected null animals recorded about a quarter
of the number of tracks of their littermate controls. At eight weeks of age,
the littermate controls performed similarly across all categories, and
similarly to how they had at four weeks of age. The Erccl liver corrected
nulls performed extremely poorly at this age, with none of the animals
recording any tracks at the 2° stripe category, and very few tracks at 4° or 8°
either. In the 4° stripe category, Erccl liver corrected null animals
performed significantly worse than controls at 4 weeks of age; p=0.0049 by
Mann-Whitney test, as well as at 8 weeks of age; p=0.0043 by Mann-
Whitney test. From these data, we were able to conclude that Erccl liver
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Figure 7.4 Erccl liver corrected null mice perform poorly in the
optokinetic response (OKR) test compared with wild type littermates
Animals were tested in the optokinetic response (OKR) drum at 4 weeks (a) and
8 weeks of age (b). There were six animals in each group. Each animal was
tested using three different stripe sizes (narrower stripes are more difficult for
the animals to see), and Tracks' or head movements following the stripes were
counted over a two minute period. The stripes were rotated for one minute
clockwise followed by one minute anti-clockwise. Animals were monitored
using video equipment and counts were carried out later whilst watching the
footage on a television.
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7.6 Erccl liver corrected null animals have normal anterior
compartments of the eye
In order to investigate the cause of the apparent loss of visual acuity in the
Erccl liver corrected nulls, we used a slit lens camera to assess the
anterior compartment of the eye. The mice were held in front of a
magnifying lens and a small light source was moved close to the eye. This
allowed us to assess the constrictory capacity of the pupil, and once the
light was shining onto the eye, we were able to look for any evidence of
cataract. Images taken of the eyes of some of the animals can be seen in
figure 7.5, and these appear normal in both controls and Erccl liver
corrected nulls. We found no evidence of cataracts or loss of dilatory or
constrictory capacity of the iris, and concluded that loss of visual acuity in
these animals is not due to a defect in the anterior compartment of the eye.
7.7 The retinas of Erccl liver corrected null animals appear grossly and
microscopically normal
We analysed the retinas of the Erccl liver corrected null animals
macroscopically as well as microscopically. Images of retinas in live mice
were taken using an ophthalmoscope, and no evidence of degeneration
was noted in any of the mice investigated. We then went on to analyse the








Figure 7.5 Erccl liver corrected null mice have normal dilation and
constriction of the pupils of the eyes
Animals were photographed using a slit lens camera and a movable light source
to assess constriction of the pupil in response to light. All these images show
constricted pupils (P).
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Image of retina taken using
ophthalmoscope
(Courtesy of Dr A. Hart)
Figure 7.6 Erccl liver corrected null mice have normal retinal
structure
Firstly, retinas were imaged in vivo using an ophthalmoscope, and were found
to be normal in Erccl liver corrected nulls and controls, similar to that shown
in (a). Secondly, eye orbits were fixed, embedded and serially sectioned
before staining with H&E. These images were taken at the level of the optical
nerve, (b) is an image taken from an Erccl heterozygote, and (c) is an image
from a liver corrected Erccl null. The liver corrected Erccl null does appear to
have a slight loss of cells in the ganglion cell layer (shown as G) although this
difference is unlikely to be significant. Retinas were examined in animals of
approximately eight weeks of age.
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fixed from some animals, and serially sectioned to provide a view of the
entire retina, particularly that around the optic nerve, shown in figure 7.6.
We found no evidence of retinal degeneration microscopically either. We
did find evidence of some cell loss in the ganglion cell layer of the Erccl
liver corrected null animals, although on further inspection this was
determined to be insignificant. From this investigation we were able to
conclude that loss of visual acuity in the Erccl liver corrected null animals
is not due to degeneration of the retina.
7.8 No evidence of degeneration of neuromuscular junctions (NMJs) in
Erccl liver corrected null mice
We considered the possibility that the neurological phenotype seen in the
Erccl liver corrected null mice, was due to degeneration of the
neuromuscular junctions (NMJs), as this is implicated as an early event in
many neurodegenerative disorders (reviewed by Gllingwater and
Ribchester, 2003). We examined neuromuscular innervation of the
transversus abdominis (TA) muscle, from the abdomen, and the deep
lumbrical muscle, from the hind paw, in animals often weeks of age, when
the neurological phenotype was advanced. Using immunofluorescence
techniques we were able to visualise muscular endplates together with
incoming axons (carried out by Dr Tom Gillingwater). Firstly, we found





Figure 7.7 Erccl liver corrected null mice have normal axonal bundles
Animals were culled at 10 weeks of age, when severely atactic. Axon bundles
were detected using a-bungarotoxin.
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7.8
Erccl liver corrected null Erccl liver corrected null
TA muscle Lum muscle
Figure 7.8 Erccl liver corrected null mice do not show degeneration of
neuromuscular junctions
Animals were culled at 10 weeks of age, when severely atactic, and transversus
abdominis (TA) and deep lumbrical (Lum) muscles were dissected and stained.
Acetylcholine receptors appear red and axons green. Both these images show
normal synapses, as all the endplate receptors, stained red (E), are covered by
incoming axons, stained green (A).
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Furthermore, we found that NMJs in these animals were normal, shown in
figure 7.8. In normal NMJs, the incoming neuron branches and covers an
entire muscular endplate; whereas in abnormal NMJs the axons start to
retract, failing to cover the endplates (c.f Gillingwater and Ribchester,
2003). We saw no evidence of this in any of the Erccl liver corrected nulls
analysed, despite the advanced ataxia observed in these animals.
7.9 Slight differences found in timing of synapse elimination between
Erccl liver corrected nulls and Erccl heterozygotes
Using the same immunofluorescence techniques mentioned above, we
were able to investigate the process of developmental synapse elimination
at the neuromuscular junction in post-natal Erccl liver corrected null mice.
Synapse elimination occurs in the days after birth in all mammals, where
synapses which are initially innervated by more than one motor neuron are
progressively pruned until they become mono-innervated. In mice this
process is completed by around 15 days post partum. We compared
Erccl liver corrected null animals with Erccl heterozygotes at five and ten
days after birth, and found differences between the genotypes. At five days,
we found that in the Erccl liver corrected null animals, more NMJs were
mono-innervated than in the Erccl heterozygous animals, implying slightly
accelerated synapse elimination in the Erccl liver corrected nulls. This is














Control Erccl liver corrected null
Figure 7.9 Synapse elimination is slightly accelerated in a Erccl liver
corrected null mouse compared with a control at 5 days of age
Around 100 synapses were counted for each mouse and categorised as mono-




























Control Erccl liver corrected null
Figure 7.10 Synapse elimination is delayed in a Erccl liver corrected
null mouse compared with a control at 10 days of age
Around 100 synapses were counted for each mouse and categorised as mono-
innervated or multiply-innervated. Two mice of each genotype were assayed.
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case. As can be seen in figure 7.10, we found fewer mono-innervated
NMJs in the Erccl liver corrected null animals compared with the Erccl
heterozygous animals. At fifteen days we found no difference between the
genotypes.
7.10 Our Erccl liver corrected null mouse stock does not carry the
C57BL/6J linked a-synuclein mutation
It has been reported that C57BL/6J animals from a specific UK source
carry a mutation in a-synuclein (observed by Specht and Schoepfer, 2001),
a gene linked with Parkinson's disease and cerebellar abnormalities. In
order to rule out the possibility of our stock carrying this mutation and it
thereby affecting their neurological characteristics, we checked seven
animals from the stock, of differing genotypes, for the presence of the
mutated a-synuclein allele. We used PCR to amplify two genetic markers
in the a-synuclein sequence, D6Mit122 and D6Mit357, which are separated
by approximately 1cM genetic distance. D6Mit357 had been found to be
deleted in the mutated allele, while D6Mit122 was not deleted and
therefore served as a positive control for the a-synuclein gene. In all the
animals tested we obtained positive results for both markers, as shown in
figure 7.11. From this we concluded that our stock did not carry the
reported mutated a-synuclein allele.
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Fig 7.11
Figure 7.11 Our stock does not carry the a-synuclein mutation carried
by some C57BL/6J mice
DNA from 7 animals from the stock, including 3 Erccl liver corrected nulls, were
tested for the presence of the a-synuclein mutation reported in some C57BL/6J
animals. Two genetic markers were amplified by PCR; D6Mitl22 which falls
outwith the reported deletion, and D6Mit357 which falls within the deletion.
Therefore, all animals should be positive for D6Mitl22, but only those which
don't carry the mutation will be positive for D6Mit357.
Primers used:
D6Mitl22a and D6Mitl22b, 139bp product
D6Mit357a and D6Mit357b, lOObp product
PCR program:
94°C 5mins, (94°C 30secs, 55°C 30secs, 72°C 30secs)x30, 72°C lOmins
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7.11 Erccl liver corrected null mice have swollen brains consistent with
uraemic disease
Post-mortem analysis carried out by Dr David Brownstein revealed brain
swelling in the Erccl liver corrected null mice. We found evidence of
oedema throughout the brain, as indicated by areas appearing as gaps in
the tissue, particularly around capillaries. Gaps seen in brain tissue upon
histological examination are not uncommon, often caused by the
processing of the tissue, particularly when brains are immersion fixed
rather than perfused with fixative, however we felt we saw evidence of
lesions aside from those which may have occurred through processing. In
any case, all brains analysed were fixed concurrently and in the same
manner. It should be noted that during this post-mortem analysis, no
cerebellar abnormalities were observed.
Figure 7.12 shows images taken from the hippocampus, an area of grey
matter. In the brains from the Erccl liver corrected nulls we observed a
spongey, moth eaten appearance, which was not seen in controls despite
similar processing. This appearance is characteristic of an accumulation
of fluid in the brain. In figure 7.13 similar features can be seen in the
periaqueductal grey matter, an area deep in the centre of the brain. Figure
7.14 shows images of white matter from controls and Erccl liver corrected
nulls. White matter not only contains neurons, but also glial cells including





Figure 7.12 Evidence of oedema in hippocampus of Erccl liver
corrected null brains
These images are taken of sections from the hippocampus, part of the grey
matter of the brain after staining with H&E.
(a) is a section from a control brain. Gaps can be seen in the images as white
spaces, however these are an artefact of the dehydration process.
(b) is a section from an Erccl liver corrected null brain. Gaps can also be seen
that are probably artefacts of processing, however there are more gaps and




Figure 7.13 Evidence of oedema in the periaqueductal grey matter of
Erccl liver corrected null brains
These images are taken of sections from the periaqueductal grey matter after
staining with H&E.
(a) is a section from a control brain. Gaps can be seen in the images as white
spaces, however these are an artefact of the dehydration process.
(b) is a section from an Erccl liver corrected null brain. Gaps can also be seen
that are probably artefacts of processing, however there are more gaps and




Figure 7.14 Evidence of oedema in white matter of Erccl liver
corrected null brains
These images are taken of sections from the corpus callosum, part of the
white matter of the brain, after staining with cresyl violet.
(a) is a section from a control brain. Some gaps can be seen in the images as
white spaces, however these are an artefact of the dehydration process.
(b) is a section from an Erccl liver corrected null brain. Astrocyte swelling (A)
is visible as well as separation of myelin fibres (M).
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Fig 7.14
Figure 7.14 Evidence of oedema in white matter of Erccl liver
corrected null brains
These images are taken of sections from the corpus callosum, part of the
white matter of the brain, after staining with cresyl violet.
(a) is a section from a control brain. Some gaps can be seen in the images as
white spaces, however these are an artefact of the dehydration process.
(b) is a section from an Erccl liver corrected null brain. Astrocyte swelling (A)
is visible as well as separation of myelin fibres (M).
observed swelling of astrocytes, characterised by expansion of the
cytoplasm and swollen nuclei with visible vesicles in these cells;
astrocytes affected in this way are commonly known as Alzheimer type 2
cells, named after the man who first described them and not linked with
Alzheimer disease. In these images we also observed separation of
myelin fibres, a further characteristic of oedema.
7.12 Erccl liver corrected null mice suffer from proteinuria from a
young age
In order to confirm the diagnosis of uraemia in these mice, we measured
levels of protein in urine samples collected. Colorimetric strips were used
which identified protein urine concentrations as Omg/ml, 0.3mg/ml, 1mg/ml
or 5mg/ml. Animals were tested at 3-4 weeks of age and 8-10 weeks of
age and results are shown in figure 7.15. We found that Erccl
heterozygotes had protein urine concentrations of 0.3mg/ml at both time
points, in accordance with evidence suggesting a baseline protein urine
concentration in mice higher than humans (Lorraine Rose, personal
communication). At 3-4 weeks two of the ten Erccl liver corrected nulls had
protein urine concentrations of 1mg/ml and the other eight animals in the
group had protein urine concentrations of 5mg/ml. At 8-10 weeks of age all
ten Erccl liver corrected null animals had protein urine concentrations of
5mg/ml. When analysed using the x22df test, these data gave p=0. The
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Controls Erccl nulls Controls Erccl nulls
3-4 weeks 8-10 weeks
Figure 7.15 Erccl liver corrected null mice have high concentrations of
protein in the urine compared with control mice
Protein in the urine was tested using Combur strips which change colour
according to protein concentration. Results fall into one of four categories. Ten
animals were tested in each group, at each timepoint.
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high levels of proteinuria we found in these animals are consistent with
impaired kidney function and systemic uraemia.
7.14 Discussion
The inability of Erccl liver corrected null mice to remove bulky DNA lesions
from the cells of the central and peripheral nervous systems has made
them an interesting model with which to investigate the neurological
system. We had observed certain features that were indicative of
neurological abnormalities, and these features seemed to worsen with
age. This chapter has addressed the characterisation of these features.
The neurological abnormalities in the mice were first noted when we
observed the clasping reflex. Although this reflex has been used as an
indicator of neurological dysfunction (recently in Komatsu et al, 2006 and
Pang et al, 2006), this is controversial, because other transgenic mouse
lines have been reported to clasp without showing other neurological
symptoms (Tom Gillingwater, personal communication). However, it was
this feature of the mice that persuaded us to look at the performance of the
mice in more rigorous neurological assays.
Firstly, we addressed the motor abilities of the Erccl liver corrected null
animals, and found, as expected, that they performed extremely poorly on
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the Roto-Rod from the time they were first tested, shortly after weaning, and
that their performance deteriorated further with increased age. These data
appeared to correlate with a relatively small cerebellar size in the Erccl
liver corrected null animals compared with controls, although this analysis
was carried out by a fairly crude method; an improvement on this would be
to section the entire brains of the mice and use specialised computer
software to create a virtual three-dimensional model of the brain. This
would enable an accurate volumetric measurement of appropriate brain
compartments to be made.
We found that Erccl liver corrected null mice appear to have impaired
visual function, as assayed using the opto-kinetic response test, however,
we found no evidence of cataract formation, retinal degeneration or any
other structural abnormalities in the eyes. The opto-kinetic response test
requires the mice to 'track', or move their heads as they follow the moving
stripes, and we considered the possibility that the Erccl liver corrected
nulls lacked sufficient mobility to comply. Certainly as the mice approach
three months of age their mobility is extremely compromised, and for this
reason the results obtained for the older group of mice may be unreliable.
However, at four weeks of age, when we first tested the mice, we still found
that the Erccl liver corrected null mice performed very poorly compared with
control littermates, and at this age their mobility does not differ noticeably
from their littermates. Taking this into account, together with the absence
of structural pathology in the eyes, would suggest that the visual
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impairment in the Erccl liver corrected null mice is due to a functional
abnormality. This could be assayed by measuring neuron firing in the optic
centre of the brain, although to do this would require specialist expertise.
Loss of neurological synapses plays a part in several neurodegenerative
disorders, including Alzheimer disease, Huntington disease, motor neuron
disease and prion disease, as well as cerebral ischaemia, and for this
reason we decided to investigate neuromuscular junction (NMJ) structure
in the Erccl liver corrected null mice. As far as we are aware, this type of
assay has not been carried out in other NER knockout mice. Initially we
looked at older mice, with severe neurological features, and we found no
evidence of synapse loss or degeneration in these animals; furthermore,
axons and axon bundles appeared normal. This has implications for the
weight loss seen in these animals, as this is therefore not due to lack of
innervation of the muscles leading to wasting.
We went on to use the same immunocytochemical techniques to
investigate the process known as synapse elimination in the Erccl liver
corrected null mice. Initially in development, muscular endplates are multi-
innervated by several axons. In the days after birth, axonal inputs are lost in
a carefully regulated process known as synapse elimination, leaving all
muscular endplates mono-innervated (reviewed by Gllingwater and
Ribchester, 2003). The regulation of this process is poorly understood,
although a limited supply of neutrotrophic factors has been implicated
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(Nguyen et al, 1998) and there is evidence that disruption of the carefully
coordinated elimination process can result in pathology. It has been
suggested that adult neuropathies may be caused by aberrant synapse
elimination processes (Gillingwater and Ribchester, 2003); consequently
there is a great interest in dissecting the synapse elimination mechanism.
We found some differences in synapse elimination timing between Erccl
liver corrected null mice and controls. At five days post-partum, Erccl liver
corrected nulls appeared to have slightly accelerated synapse elimination
compared with controls, however when we looked at mice ten days post¬
partum, we found that Erccl liver corrected nulls had significantly delayed
synapse elimination. At fifteen days post-partum, we found no differences
between Erccl liver corrected null mice and controls. Although we counted
at least one hundred synapses in each mouse, and categorised these as
multiply- or mono-innervated, we looked at only two mice of each genotype
at each timepoint, and to improve this experiment it would would be vital to
look at a greater number of mice, ideally at a range of timepoints post¬
partum. From the experiments carried out thus far, we have found an
indication that the synapse elimination process is altered in the Erccl liver
corrected null mice, so to consider a greater cohort of mice would now be
both useful and interesting.
Post-mortem investigation revealed unusual brain features in the Erccl
liver corrected null animals. We saw no evidence of neuronal loss, which
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we had expected to see due to apoptosis of neurons with DNA damage.
Furthermore, we saw no cerebellar abnormalities, which we had expected
to see due to the ataxia we had observed in the animals. Instead we found
evidence of encephalopathy, or non-inflammatory brain disease.
Encephalopathy is due to organ failure, usually hepatic, and is a relatively
common side effect of liver cirrhosis or cancer in human patients. Less
commonly, encephalopathy can be caused by kidney failure, or systemic
uraemia. This is rarely reported in humans as kidney failure is usually
treated before it is sufficiently severe to cause uraemia (reviewed by Burn
and Bates, 1998). Uraemic encephalopathy is therefore more common in
animals, and has been described mainly in the rat, however mild
behavioural defects have been reported in partially nephrectomised mice
and linked with uraemic encephalopathy (Al Banchaabouchi et al, 1999).
In the brains of Erccl liver corrected null mice we observed features of
oedema. In grey matter we saw spaces in the neuropil, or extracellular
matter, characteristic of fluid accumulation. In white matter we also saw
spaces between cells and separation of myelin fibres, as well as astrocyte
swelling. Astrocytes are a class of glial cell that are particularly susceptible
to the effects of metabolic encephalopathy, primarily because they form an
important part of the blood-brain barrier. We did not observe any necrosis
of the cerebral cortex, another characteristic of metabolic encephalopathy,
although as this is due to prolonged swelling of the brain pressing the
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extremities of the cortex against the skull, it may be that the mice do not live
long enough for us to observe this feature.
We believe the Erccl liver corrected null mice suffer from uraemic
encephalopathy as a result of deteriorating kidney function. Previously, our
laboratory has reported a kidney phenotype in these mice (Selfridge et al,
2001) consisting of generalised nuclear polyploidy, particularly in the
proximal tubules; which was reported to be due to an accumulation of
endogenous damage similar to that which had caused liver polyploidy in
the simple Erccl knockouts. These data, along with evidence for raised
levels of plasma creatinine in these mice (Selfridge et al, 2001) and the
increased proteinuria reported here, strengthen this model.
In order to confirm oedematous brain swelling, precise measurement of
animal weight and brain weight could be taken at the time of post-mortem.
This would enable calculation of the ratio of brain weight to body weight,
and we would expect to see an increased brain weight compared with body
weight in the Erccl liver corrected nulls, which would correlate with fluid
accumulation in the brain. However, this would require extremely precise
weighing apparatus. Another possible procedure involves injecting
fluoresceinated albumin intravenously shortly before culling the mice, and
looking for evidence of fluorescence in the brain; normally the
fluoresceinated albumin should not enter the brain, but in oedema, the
passage of fluid into the brain results in fluorescence appearing there.
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Levels of blood urea nitrogen could also be assayed in the mice, as this
constitutes the most accurate test of uraemia. Proteinuria is likely to be
raised before the onset of uraemia, and as such is a less accurate
indicator.
The time course of the neurological symptoms observed in the Erccl liver
corrected null mice requires careful consideration. We have documented
behavioural abnormalities in the mice from four weeks of age, and
although we know that brain oedema is significant by ten weeks of age, it is
unclear at what point in time this becomes the case. Diagnosis of brain
oedema is not straightforward, as processing artefacts complicate matters,
and due to this, diagnosis can only be made reliably when the symptoms
are fairly advanced. Therefore it is unclear whether the animals have
uraemia when the behavioural abnormalities were first reported; if they do
not, the case for alternative consequences of Erccl deficiency in the central
nervous system is strengthened. Measurement of blood urea nitrogen in
animals of a range of ages would prove invaluable in pin-pointing the onset
of uraemia. A previous experiment showed that the Erccl liver corrected
null animals had elevated plasma creatinine at 7 weeks of age but not at 3
weeks of age (Selfridge et al, 2001), and this is an area which warrants
further investigation.
The logic behind looking for an explanation for the neurological phenotype
observed in these mice was largely rooted in the anecdotal results
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obtained from the Erccl Nes::Cre mice mentioned at the start of this
chapter. These mice died at the same time as the Erccl liver corrected
nulls and had Erccl knocked out specifically in the central nervous system;
or so we believed. Recently, evidence of nestin expression has been
reported in adult podocytes as well as at certain developmental stages of
the kidney and heart (Wagner et al, 2006), a fact which undermines our
hypothesis that Erccl deficiency has consequences for the neurological
system itself, apart from indirectly. The breeding scheme for the Erccl
nestin mice was discontinued some time ago, and unfortunately we have
no access to these mice or samples from them. Had we access to
kidneys and brains from these mice, it would be extremely useful to look at
the kidneys for evidence of polyploidy and enlarged nuclei, as well as the
brains for evidence of oedema. Such evidence would resolve the mystery
of why the Erccl nestin mice died at the same age as the Erccl liver
corrected nulls, in the absence of any clear indication that Erccl deficiency
in the central nervous system was solely and directly to blame.
We have documented a clear neurological phenotype in Erccl liver
corrected null mice, with reference to behavioural as well as
histopathological abnormalities. We have concluded that the mice die with
secondary effects of kidney failure, namely uraemic encephalopathy. We
have been unable to show conclusively any direct effects of Erccl
deficiency on the central nervous system itself; and although this by no
means proves that there are no effects, it does suggest that this may be the
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case. The ability of NER to function in a transcription coupled manner,
where stalled RNA polymerases initiate the repair process, may underline
its importance in the repair of DNA damage in neurons and other terminally
differentiated tissues. It is plausible that Erccl deficiency has dual effects
on the central nervous system, with direct and indirect influences. As
detailed above, there are further experiments that could be carried out to
clarify the issues raised, and these issues must be addressed before we




Nucleotide excision repair (NER) deficiency has many consequences on the
organism, as shown by the range of symptoms displayed by xeroderma
pigmentosum, trichothiodystrophy and Cockayne syndrome patients. Over
the past fifteen years, proteins involved in the NER pathway have been
assigned to seven xeroderma pigmentosum complementation groups,
however, despite the essential role of Erccl in NER, this has not been
assigned an XP group. This is because until very recently, Erccl deficiency
had not been recognised in humans, and was suspected to cause early
embryonic lethality. A single human patient has been identified with Erccl
deficiency in the Netherlands, and this patient displayed very severe
developmental abnormalities and died shortly after birth. Analysis on the
genetic and phenotypic features of this patient is ongoing (personal
communication, Dr Nicolaas Jaspers); although it is clear that Erccl
deficiency in humans results in severe pathology.
Erccl was the first NER protein to be knocked out in the mouse, and was
found to cause severe runting and a very short life expectancy, with mice
dying from liver failure (McWhir et al, 1993). Other groups have created
knockouts and mutated forms of other NER proteins (as detailed in the
introduction to this thesis), whilst our group has concentrated on creating
Erccl models with a longer life expectancy on which to study the effects of
Erccl deficiency in tissues other than the liver.
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This thesis has addressed the consequences of Erccl deficiency in the
mouse by further characterising two particular mouse models created in our
laboratory: the Erccl liver corrected null and the Erccl epidermis specific
knockout. Briefly, the Erccl liver corrected null uses an Erccl transgene
controlled by liver specific promoter transthyretin to alleviate liver pathology
on an otherwise Erccl null background; while the Erccl epidermis specific
knockout uses the Cre-loxP system with epidermal specific promoter K5 and
a floxed Erccl to create a mouse with Erccl deficiency solely in the
epidermal layers of the skin.
Chapter 3 addressed the differences in the short term responses of the Erccl
ESKO mouse, compared with controls, to UV irradiation. We found that
Erccl ESKO mice were extremely sensitive to UV induced erythema,
photoimmunosuppression and tanning, compared with Erccl proficient
controls. These results confirmed the importance of DNA damage in the
development of these responses, and underlined the role of the keratinocyte
as an initiator of a cascade of events involving cytokine release and
activation of various other cell types. Previous work carried out has shown
NER deficient mice to be more susceptible to UV induced erythema (Berg et
al, 1997 and 2000), photoimmunosuppression (Miyauchi-Hashimoto et al,
1996, Boonstra et al, 2001, Kolgen et al, 2003) and tanning (van Schanke et
al, 2005) than control mice. However, the mice used in these studies were
NER deficient throughout their organ systems, and as such the roles of the
different compartments of the skin could not be addressed. We have shown
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that persistent, UV induced DNA damage in keratinocytes is responsible for
erythema, Langerhans cell migration, suppression of the contact
hypersensitivity response and melanocyte activation.
Perhaps the most striking feature of NER deficiency is the cancer
susceptibility of a large proportion of patients, and chapter 4 utilised the UV
sensitivity of the Erccl ESKO mice to address their susceptibility to UV
induced skin tumours. The results presented in this chapter were published
earlier this year as part of a paper describing the creation and phenotype of
the mice (Doig et al, 2006). We found that the Erccl ESKO mice were
extremely sensitive to UV induced skin cancer compared with controls, and
when compared with other NER knockouts, at least as sensitive if not more
so. This supported our hypothesis, which was that not only would Erccl
ESKO mice be more susceptible to UV induced skin cancer than controls,
but also that due to roles of ERCC1 in other repair processes, they would be
more susceptible than simple NER knockouts such as Xpa null mice (Berg et
al, 1997 and de Vries et al, 1998). ERCC1 is involved in the repair of inter-
strand crosslinks (Bessho et al, 1997) and homologous recombination repair
(Sargent et al, 2000), however it is unclear how important these roles are in
the context of UV exposure. Not only did we find that Erccl ESKO mice
were more sensitive to UV induced carcinogenicity than controls in terms of
median tumour free survival time; we also found accelerated tumour
progression in the Erccl ESKO mice. This has not been reported for other
NER knockouts, although it may be simply that a histopathological study of
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the depth that we have reported has not been undertaken with the other NER
mice.
In chapter 5 we have used the proven skin cancer sensitivity of the Erccl
ESKO mice to consider the protective mechanism of action of topical
thymidine dinucleotide (pTpT) application. As we have shown that Erccl
ESKO animals are protected to some degree from UV induced skin cancer,
we have concluded that pTpT does not exert its protective action through the
upregulation of NER. We have not been able to identify increased apoptosis
in response to pTpT in the skin of animals exposed to UV; nor have we
identified increased apoptosis in keratinocytes in vitro after pTpT treatment,
with or without UV (personal communication, Anne-Marie Ritchie).
Therefore, we hypothesise that pTpT exerts its protective effect by
decreasing cellular proliferation. This correlates with results obtained in our
long term UV carcinogenicity experiment where we saw reduced epidermal
hyperproliferation in pTpT treated mice compared with mice treated with
vehicle alone, as well as with a report that pTpT induces S phase arrest
(Pedeux et al, 1998). There is speculation that this could be due to the
telomere homology of pTpT (Eller et al, 2002, Puri et al, 2004), however both
of these reports suggest increased apoptosis rather than cell cycle arrest as
the outcome. Regardless of its mechanism of action, pTpT appears to be an
effective protective agent against UV induced skin cancer, and with further
investigation may in future prove an important therapy, in particular for
individuals with elevated skin cancer risk.
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In chapter 6 we addressed a novel phenotype identified in the Erccl liver
corrected null mice, which concerned an abnormal appearance of the fur of
the animals in the stock. This phenotype occurred in Erccl heterozygous
animals as well as Erccl nulls, but not in wild types; and bore similarities to
the brittle hair phenotype observed in human trichothiodystrophy patients that
carry mutations in XPD, as well as the Xpd mouse model for
trichothiodystrophy (de Boer et al, 1998b). Despite this, we were unable to
link the phenotype with Erccl deficiency, and when we out-crossed the
animals in the stock, we did not observe the phenotype in the offspring in a
predictable manner. For these reasons, we concluded that the phenotype
we had observed was due to a background effect, caused by the mix of
mouse strains that have contributed to the Erccl liver corrected null stock
over the years.
Chapter 7 concerned the abnormal neurological features observed in the
Erccl liver corrected null mice. We found that these mice displayed features
including clasping, poor motor ability and impaired vision, and these
symptoms appeared to worsen with age. We concluded after extensive post¬
mortem examination that these mice suffered from uraemic encephalopathy,
resulting from kidney pathology. Kidney pathology has been reported
previously in these mice (Selfridge et al, 2001), and we now conclude that
this is having secondary effects on the neurological system. Uraemic
encephalopathy causes brain oedema and swelling and results when a
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failing renal system is unable to filter toxins from the blood, which effectively
poison the brain. Although we have been unable to identify neuropathology
caused directly by Erccl deficiency in the nervous system, we cannot rule
out functional disorders, furthermore, there are more analyses that could be
carried out on younger animals, as detailed in chapter 7 itself.
In summary, the work detailed in this thesis has used tissue specific Erccl
knockout mouse models to characterise further the consequences of
nucleotide excision repair deficiency, adding to a large body of work from
laboratories around the world which should enable us to help not only those
patients suffering from repair deficiency syndromes, but also to deepen our
understanding of cancer - one of the most common and devastating diseases
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Mice with skin-specific DNA repair gene (Erccl) inactivation are
hypersensitive to ultraviolet irradiation-induced skin cancer and show more
rapid actinic progression
J Doig', C Anderson2, NJ Lawrence1, J Selfridge1, DG Brownstein3 and DW Melton1
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Erccl has an essential role in the nucleotide excision
repair (NER) pathway that protects against ultraviolet
(UV)-induced DNA damage and is also involved in
additional repair pathways. The premature death of
simple Erccl mouse knockouts meant that we were unable
to study the role of Erccl in the skin. To do this, we have
used the Cre-lox system to generate a skin-specific Erccl
knockout. With a Cre transgene under control of the
bovine keratin 5 promoter we achieved 100% recombina¬
tion of the Erccl gene in the epidermis. Hairless mice with
£rcc7-deficient skin were hypersensitive to the short-term
effects of UV irradiation, showing a very low minimal
erythemal dose and a dramatic hyperproliferative re¬
sponse. Ultraviolet-irradiated mice with £Vcc7-deficient
skin developed epidermal skin tumours much more rapidly
than controls. These tumours appeared to arise earlier in
actinic progression and grew more rapidly than tumours
on control mice. These responses are more pronounced
than have been reported for other NER-deficient mice,
demonstrating that Erccl has a key role in protecting
against UV-induced skin cancer.
Oncogene advance online publication, 08 May 2006;
doi: 10.1038/sj.onc. 1209642
Keywords: Erccl; nucleotide; excision repair; skin
cancer; ultraviolet irradiation
Introduction
The nucleotide excision repair (NER) pathway has
evolved to deal primarily with ultraviolet (UV)-induced
DNA damage. In man, the lack of a functional NER
pathway has severe consequences, principally a 1000-
fold increased incidence of skin cancer. This, among
other features, is a characteristic of the human inherited
Correspondence: Professor DW Melton, Sir Alastair Currie Cancer
Research UK Laboratories, Molecular Medicine Centre, University of
Edinburgh, Western General Hospital, Crewe Road, Edinburgh EH4
2XU, UK.
E-mail: David.Melton@ed.ac.uk
Received 6 January 2006; revised 7 March 2006; accepted 20 March 2006
NER deficiency disease, xeroderma pigmentosum
(reviewed by Friedberg, 2001). ERCC1 plays an essential
role in the NER pathway, acting as an endonuclease, in
conjunction with XPF, to make the 5' incision at the
lesion site. Erccl is essential for NER, but is also
involved in homologous recombination, double-strand
break repair and the repair of interstrand crosslinks
(discussed by Chipchase and Melton, 2002). Elevated
levels of the commonest oxidized base, 8-oxoguanine, in
Erccl-deficient tissues also implicate Erccl in the repair
of oxidative DNA damage (Selfridge et al., 2001; Hsia
et al., 2003). Unlike the situation for many of the NER
genes, there are no known cases of ERCC1 deficiency in
man, suggesting that this mutation may be an embryo¬
nic lethal, perhaps because of the additional repair
functions of the gene. To investigate the role of Erccl in
mice, we targeted the gene and found that Erccl-
deficient animals were born severely runted and died by
3 weeks of age with liver failure (McWhir et al., 1993).
We found a novel phenotype, with the development of
premature hepatocyte polyploidy, that was more remi¬
niscent of a premature ageing disorder than an NER
deficiency disease (Nunez et al., 2000). The liver
phenotype was corrected by an Erccl transgene
controlled by a liver-specific gene promoter, but liver-
corrected nulls now died by 12 weeks of age with kidney
and additional abnormalities (Selfridge et al., 2001).
The premature death of Erccl knockouts meant that
we were unable to study the role of Erccl in the skin. To
do this, we have utilized the Cre-lox system (reviewed
by Kuhn and Torres, 2002) to produce a skin-specific
Erccl knockout mouse. We have generated a mouse line
that has loxP sites inserted into its Erccl gene (floxed
Erccl) to mark it for subsequent inactivation. To
achieve Erccl gene inactivation, we used a transgenic
line where Cre recombinase is under the control of the
promoter from the bovine keratin 5 (K.5) gene (Ramirez
et al., 2004). Expression from this promoter is largely
restricted to the basal layer of stratified epithelia
(Ramirez et al., 1994).
Simple knockout mice for the NER genes Xpa, Xpc
and Csb have been produced (de Vries et al., 1995;
Nakane et al., 1995; Sands et al., 1995; van der Horst
et al., 1997). These mice are viable and, although the
Mice with DNA repair-deficient skin
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Figure 1 Skin-specific and constitutive recombination of the Erccl floxed allele, (a) Schematic representation of floxed and
recombined Erccl alleles. Erccl exons are numbered. The grey squares represent the probe used in Southern blots to distinguish the
floxed (5.5 kb EcoRI fragment) and wild-type alleles (5.5 or 4.5 kb fragment depending on the presence of a polymorphic EcoRI site in
intron 2 in the wild-type allele of our mice) from the recombined allele (3.05 kb fragment). See Supplementary Information Figure 1 for
the location of this EcoRI polymorphism. Small arrows represent the positions of the polymerase chain reaction (PCR) primers used to
detect the recombined allele. Large arrowheads represent loxP sites, (b) Constitutive recombination in Ercclwith K5CreM mice
detected by PCR analysis. DNA from the tissues indicated, showing the 250bp PCR product, diagnostic for recombination of the
floxed allele, in all tissues, (c) Skin-specific recombination in Erccl"'*1* mice with K5Cre fathers detected by PCR analysis, (d) Skin-
specific recombination in ErccV°"+ with K5Crep mice detected by quantitative Southern analysis. DNA (10/rg) from the tissues
indicated was digested with EcoRI alongside a titration curve with the indicated levels of recombination. The probe used is indicated
above. The 5.5 kb band is from the wild-type (and floxed) alleles, and the 3.05 kb band is from the recombined allele, (e) Estimate of
skin-specific recombination in Erccl/,°"n with K5Crep mice. The intensity of the bands from the wild-type (and floxed) and recombined
alleles was determined by phosphorimagery and the (recombined/recombined and wild-type bands) x 100 was plotted against the
percent recombination. Simple regression analysis was used to draw the line for the recombination standards, from which the level of
recombination (67% in this skin sample) was estimated, (f) Epidermis-specific recombination in Erccl"°'l+ with K5Crep mice detected
by quantitative Southern analysis. Southern analysis was carried out as in (d). The 5.5 kb band is from the floxed allele, the 4.5 kb band
is from a wild-type allele with a polymorphic EcoRI site in intron 2 and the 3.05 kb band is from the recombined allele. Note the
complete absence of the floxed allele in the epidermis, indicating 100% recombination.
degree of sensitivity differs, are generally highly sensitive
to UV irradiation. Our hypothesis is that, because of the
additional repair functions, the consequences of Erccl
deficiency in UV-irradiated mouse skin will be more
severe than for simple NER deficiency alone. Here, we
report the production of viable mice with high levels of
Erccl inactivation in their epidermis. The Erccl skin-
specific knockout mice are hypersensitive to the short-
term effects of UV irradiation. The mice develop
UV-induced epidermal skin tumours much more rapidly
than controls. The tumours arose earlier in actinic
progression and grew more rapidly than tumours on
control mice.
Results
Generation of Erccl skin-specific knockout mice
The Erccl gene was floxed using the double replacement
gene targeting strategy, devised for use with the Hprt-
deficient embryonic stem (ES) cell line, HM-1, and Hprt
minigenes (Stacey et al., 1994; Moore et al., 1995;
Selbert et al., 1998). In the first step, the exon 3-5 region
of the Erccl gene was replaced with an Hprt minigene to
inactivate the Erccl allele (see Supplementary Informa¬
tion, Figure 1). Although a new line of Erccl knockout
mice was generated from these cells, the original
knockout line with a neo gene insertion (McWhir
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et al., 1993) was used for the matings described below to
generate skin-specific Erccl gene inactivation. In the
second round of gene targeting, the Hprt marker in the
knockout clone was replaced with the Erccl exon 3-5
region, flanked by loxP sites, and a new strain
homozygous for the Erccl floxed allele was established
(Figure la).
To obtain skin-specific Erccl inactivation, we used a
line containing a Cre transgene under the control of the
bovine keratin 5 promoter (K5Cre transgene; kindly
provided by Dr Jose Jorcano, CIEMAT, Madrid,
Spain). Ercclflox,~ with K5Cre mice served as our
experimental animals in the UV irradiation experiments
described below, Ercclfioxl+ with K5Cre littermates
served as controls. To facilitate our irradiation studies
mice were produced on a hairless (hr) and albino
background.
Erccl flox/~ mice with K5Cre mothers show runting and
early death and recombination of the floxed allele in all
tissues
We have demonstrated previously that progeny from
K5Cre-containing mothers show constitutive recombi¬
nation of a floxed allele as a result of Cre expression in
oocytes (Ramirez et al., 2004). As expected, all Ercclfloxh
progeny of mothers with the K5Cre transgene were born
severely runted and died before weaning with identical
premature polyploidy in hepatocytes to that seen in
simple Erccl knockouts (see Supplementary Informa¬
tion, Figure 2; McWhir et al., 1993).
Polymerase chain reaction (PCR) analysis on DNA
extracted from Ercclfloxl+ K5CreM (transgene inherited
from mother) littermates, which are perfectly viable,
revealed recombination in all tissues sampled
(Figure lb). The extent of recombination was quantified
by Southern blotting. Varying amounts of DNA from
an ES cell line heterozygous for a recombined floxed
allele (Erccl"cl+) were added to wild-type tissue DNA
to provide a titration curve for the level of recombina¬
tion. Phosphorimagery was used to determine the
ratio of recombined/recombined and non-recombined
alleles. Recombination levels ranged from 80 to 100% in
all the tissues examined (data not shown), demonstrat¬
ing widespread recombination in Ercclfloxl~ K5CreM
mice.
Ercclmice with K5Cre fathers show skin-specific
recombination of the floxed allele
All Ercclfloxl~ progeny with K5Cre derived from their
fathers (K5Crep) developed normally into adulthood
and showed normal viability. Polymerase chain reaction
analysis on tissues from these animals revealed skin-
specific recombination of the floxed allele and only very
low levels of recombination in other tissues (Figure lc).
Although not visible in this figure, faint bands were
sometimes detected in the lung, pancreas and brain from
some animals. Southern blotting indicated that the level
of recombination in the skin of these animals was
50-70% (Figure Id and e) and <5% in any internal
tissue. Skin consists of epidermis and dermis and K5Cre
is expressed only in the basal layer of the epidermis. The
efficiency of Cre-mediated recombination was more
accurately estimated after separation of the epidermis
from the dermis (Figure If). This determination was
facilitated by the exploitation of a polymorphism in
intron 2 of the wild-type Erccl gene segregating in our
stock that allowed recombined, floxed and wild-type
alleles to be distinguished. In the absence of this
polymorphism (see Figure la and Supplementary
Information Figure 1), the wild-type and floxed alleles
are indistinguishable by Southern analysis. In the
separated epidermis, the floxed band was undetectable,
indicating 100% recombination. The low level of
recombination detected in the dermis sample
probably reflects the presence of epidermally derived
hair follicles.
Ercclfioxh mice with paternally inherited K5Cre will
now be described as Erccl skin-specific knockout, or
experimental animals and Ercclfioxl+ K5Crep littermates
will be described as controls.
Erccl skin-specific knockout mice show an extreme short-
term response to UVB irradiation
The minimal erythemal dose (MED) for control mice
was 900 J m 2, within the range reported previously for
repair-proficient animals. However, the MED for Erccl
skin-specific knockouts was only 40 J m~2, a 20-fold
difference and lower than values reported previously for
NER knockout mice.
Erccl skin-specific knockout and control mice
were UVB-irradiated (500 J m 2) and the epidermal
thickness on the outer surface of the ear was determined
at varying times thereafter (Figure 2). As expected,
there was a minimal response to this dose in
control animals, but there was pronounced epidermal
hyperplasia in the mutants, peaking 7 days after
irradiation with a sevenfold increase in epidermal
thickness. Proliferation within the epidermis was
also measured using 5-bromo-2'-deoxyuridine (BrdU)
incorporation (Figure 2). Again proliferation in the
Erccl skin-specific knockouts peaked at day 7, with a
20-fold increase in the positively stained nuclei over
controls.
Unirradiated skin from the back and upper surface of
the ear were indistinguishable histologically between
experimental and control mice (Figure 3a and b).
Epidermis from the ear of UVB-irradiated (500 J m~2)
control mice showed mild, uniform hyperplasia on day
7; by day 10 epidermis was indistinguishable from
unirradiated controls. Epidermis from irradiated Erccl
skin-specific knockouts showed the expected undulation
of the basal layer and was irregularly hyperplastic on
day 7, far in excess of that seen in controls. Basal cells
and spinous cells were hypertrophied and nuclei were
larger than those of control mice at day 7, but flow
cytometry on isolated propidium iodide-stained nuclei
provided no evidence of increased ploidy as seen in
£Vcc7-deficient liver and kidney (Selfridge et al., 2001).
There was prominent hypergranulosis in the stratum
granulosum and prominent hyperkeratosis. On day 10,
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Figure 3 Acute and chronic UVB-induced skin changes in Erccl
skin-specific knockout mice, (a) Control and (b) Erccl skin-specific
knockout, haematoxylin and eosin (H&E)-stained sections through
the upper surface of the ear of non-irradiated mice, (c) Control and
(d) Erccl skin-specific knockout, ear sections on day 10 following a
single dose (2000Jm~2) of UVB irradiation, (e) Control and (I)
Erccl skin-specific knockout, H&E-stained sections through back
skin of chronically UVB-irradiated mice (control, 25 weeks,
2000Jrrr2, three times a week; experimental, 12 weeks, 125Jm~2,
three times a week). For all images the original magnification was
x 190. The bar indicates the extent of the epidermis in each figure.
Days post UV irradiator!
Figure 2 Erccl skin-specific knockouts show an extreme short-
term response to UVB. Erccl skin-specific knockout and control
mice were UVB irradiated (500 Jm and the mean epidermal
thickness on the upper surface of the ears (panel a) and the number
of 5-bromo-2'-deoxyuridine-positive nuclei per mm of epidermis
(panel b) was determined at varying times thereafter. Unshaded
bars, control; shaded bars, Erccl skin-specific knockout. Each
point is the mean from two ears. CONT, non-irradiated sample.
epidermis from experimental mice had continued
hypertrophy and hyperplasia of basal/spinous cells and
hypergranulosis and hyperkeratosis was more exagger¬
ated than on day 7.
Ear epidermis from control mice responded in
the same way to a higher dose of UVB (2000 J m~2).
There was transient mild acanthosis which had
returned to normal on day 10 (Figure 3c). Epidermis
from Erccl skin-specific knockouts responded
similarly to that of mice that received the lower
dose with the following differences: The hyperplasia
was even more pronounced and there were multiple
intracorneal pustules and diffuse intercellular
epidermal oedema on day 7 and less hypergranulosis
on days 7 and 10 (Figure 3d). The increase in epidermal
thickness in Erccl skin-specific knockouts was more
pronounced than that reported for other NER gene
knockouts.
Erccl skin-specific knockouts are hypersensitive to
ultraviolet-induced skin cancer
To investigate the longer term effects of UVB irradia¬
tion Erccl skin-specific knockouts were irradiated with
125 J m~2 three times a week. Higher, or more frequent,
doses produced a level of erythema that was too severe
for a chronic irradiation protocol. All (n = 6) Erccl skin-
specific knockouts contracted multiple skin tumours.
The earliest tumour was seen at 8 weeks and all animals
had tumours at 17 weeks (Figure 4a). Control mice
(n = 2) receiving the same dose remained tumour free
until they were finally killed owing to age-related
deterioration after 58 weeks of continuous irradiation.
Control mice (n = 6) receiving a 16-fold higher dose
(2000 J m 2) started to develop tumours at 21 weeks and
all had tumours at 35 weeks. The cumulative UVB dose
icogene
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Figure 4 Ultraviolet-induced skin tumour production in Erccl
skin-specific knockout mice. Mice were UVB irradiated three times
a week and the time to appearance of the first skin tumour on each
animal was recorded, (a) Tumour-free incidence against elapsed
time from start of irradiation protocol, (b) Tumour-free incidence
against cumulative UVB dose.
for 50% of the Erccl skin-specific knockout mice to
develop tumours was 3.75 kJirr2. The equivalent dose
for control mice was 140kJ m~2 (Figure 4b). The average
number of tumours/animal was 5.2 for Erccl skin-
specific knockouts and 3.7 for controls. This value for
controls was calculated from the six mice in this
experiment and three additional mice from an earlier
experiment.
Skin tumours grow more quickly in Erccl skin-specific
knockout mice
Throughout the chronic irradiation experiments, tu¬
mours were measured weekly, consequently we were
able to compare tumour growth in the two genotypes
(Figure 5). Two weeks after first detection, only 15% of
tumours from control mice exceeded 2mm in diameter,
compared to 45% from Erccl skin-specific knockouts.
Three weeks after first detection, 25% of tumours from
control mice exceeded 2mm, compared to 65% for
experimental mice. The size difference was still present 4
weeks after first detection, where only 10% of tumours
from control mice exceeded 5 mm, compared to 45%
from experimental mice. These tumour size distributions
were significantly different between genotypes at all
three time points (2 weeks, x2 idf, P = 0.03; 3 weeks,
X2 2df> P = 0.03; 4 weeks, x2 2df» P = 0.04). It was not
possible to monitor tumour growth for more than
4 weeks as the presence of tumours exceeding 10mm in
diameter on Erccl skin-specific knockouts necessitated
termination of the protocol.
Chronic irradiation-induced skin changes in Erccl skin-
specific knockout mice
The back skin of chronically irradiated control mice (25
weeks, 2000 Jm~2 UVB, three times a week) showed
mild, uniform hyperplasia to a maximum thickness of
32/mi (Figure 3e). Two or three layers of cells now
formed the stratum granulosum and these were flattened
to polygonal and had more keratohyalin granules,
which were more dispersed and larger, than unirradiated
mice. There was no dysplasia or hyperkeratosis.
In chronically irradiated Erccl skin-specific knockouts
(12 weeks, 125 Jm~2 UVB, three times week) more
pronounced changes were present in both the epidermis
and dermis (Figure 31). There was diffuse hyperplastic
actinic keratosis. Epidermal hyperplasia was uneven
resulting in surface irregularity with epidermal pegs
extending into the dermis, and epidermal thickness was
increased to a maximum of 97 pm. There was patchy
hyperkeratosis and parakeratosis. The stratum granu¬
losum was highly variable. Although discontinuous, in
areas where it occurred it was two or three cells thick.
Cells containing keratohyalin granules varied from
flattened to polygonal. In polygonal cells of the stratum
granulosum, keratohyalin granules were dispersed and
variable in size. The most striking epidermal changes
were in the stratum basale where basal cells were
hyperplastic and dysplastic. The stratum basale ranged
from one to four cells thick. Basal cells were polygonal
with prominent intercellular spaces traversed by inter¬
cellular bridges. Polygonal basal cells exhibited cyto-
megaly, karyomegaly and anisokaryosis. Cells of the
stratum spinosum were hypertrophied and occasionally
apoptotic. Rare dyskeratotic cells were also present.
Changes in the dermis consisted of fibrosis and chronic
inflammation.
A different skin tumour spectrum in Erccl skin-specific
knockout mice
Proliferative UV-induced skin lesions were classified
based on their gross and histopathological appearance
(Table 1). All tumours scored in the experiment
described in Figure 4 appear in Table 1. There was an
equal distribution of papules, endophytic masses and
exophytic masses between genotypes. In both groups the
majority of endophytic masses (> 2 mm) were squamous
cell carcinomas (SCC). Similarly, in both groups, most
exophytic masses were precancerous lesions (acanthosis
or actinic keratosis), or carcinoma in situ. However,
among the smallest tumour class, papules (<2mm),
there was a striking difference in the prevalence of
carcinoma in situ. Whereas 10 of 17 papules were
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Table 1 Histopathological classification of actinic and neoplastic lesions in Erccl skin-specific knockout and control mice
Histopathologica! diagnosis Gross appearance
Papule ( <2mm) Endophytic (> 2mm) Exophytic ( > 2mm)
Control Erccl' Control Erccl Control Erccl
Acanthosis 1 1 1
Actinic keratosis 3 8 1 2 1 4
Carcinoma in situ 10 — - 1 5 2
SCC
GNS 2 5 3 2 1 1
Grade 1 1 1 1 1 — —
Grade 2 — — — 2 1 —
Grade 3 — 1 1 1 — —
Keratoacanthoma — — 1 — — —
Total 17 15 8 9 9 7
Abbreviations: GNS, grade not specified; SCC, squamous cell carcinoma. 'Erccl skin-specific knockout.
carcinoma in situ in control mice (Figure 6a), none of
the 15 papules were carcinoma in situ in Erccl skin-
specific knockout mice (Figure 6b) (/><0.01, z-test).
Combining results for all the gross categories, carcino¬
ma in situ was only diagnosed in three of 31 lesions in
Erccl skin-specific knockout mice, versus 15 of 34
lesions in controls (P< 0.002, z-test). In the eight
tumours identified as SCC grade not specified (GNS)
in Erccl skin-specific knockout mice, four appeared to
arise from areas of adjacent actinic keratosis (partial
thickness dysplasia) (Figure 6d) and three appeared to
arise from adjacent carcinoma in situ (the remaining
tumour arose from a keratoacanthoma). By contrast, all
six SCC GNS identified in control mice were adjacent to
carcinoma in situ (Figure 6c).
Discussion
Erccl is essential for NER, but is also involved in other
repair pathways relevant to the repair of UV-induced
DNA damage in the skin. This led to our hypothesis
that the consequences ofErccl deficiency in the skin will
be more severe than those reported for other NER gene
knockouts. Until now the early lethality in both simple
and liver-corrected Erccl knockouts (McWhir et al.,
1993; Selfridge et al., 2001) has prevented investigation
of this hypothesis. Here we have used the Cre-lox
system to generate mice with EVccJ-deficient skin. The
Cre transgene used was under the control of the bovine
K5 gene promoter, which is expressed in the basal layer
of the epidermis (Ramirez et al., 2004). Southern
analysis on epidermis from Ercclflo*h mice, where the
K5Cre transgene was inherited from the male parent,
indicated 100% recombination with only low levels
(<5%) detected in other tissues.
We have previously shown that Erccl is essential for
normal liver (McWhir et al., 1993) and kidney function
(Selfridge et al., 2001) and for gametogenesis (Hsia
et al., 2003). The Erccl skin-specific knockouts have
normal viability and, in the absence of UV irradiation,
their skin was indistinguishable from controls, so we
conclude that Erccl is not a skin-essential gene.
However, Erccl skin-specific mice were hypersensitive
to both the short- and long-term effects of UVB
irradiation. Hypersensitivity to UV has been reported
previously for NER knockout mice, most notably for
A'pa, Xpc and Csb (Nakane et al., 1995; Sands et al.,
1995; de Vries et al., 1995; van der Horst et al., 1997).
Erythema is triggered by cytokines in response to
stalled RNA polymerases at sites of UV-induced DNA
damage in keratinocytes. This conclusion was reached
from the low MEDs shown by Xpa (complete NER
knockout) and Csb (defective transcription coupled
repair only) knockout mice and the higher MED
reported for Xpc knockouts (defective global genome
repair only) (Berg et al., 1997, 2000). The MED for our
Erccl skin-specific knockouts was lower and the 20-fold
difference from our control mice, which are themselves
heterozygous for Erccl deficiency, was also greater than
reported for other NER knockouts. The MED of Xpa
and Csb mutants was between 135 and 270 J m~2 and the
MF.D of Xpc knockouts and control mice was between
1080 and 2160Jm 2 (Berg et al., 2000). A lower MED
for Xpa mice (62.5 Jm 2) was reported by van Schanke
et al. (2005), but the MED for control mice was also
lower (500 Jm-2).
Another acute effect of UVB is to elicit epidermal
hyperplasia. The resulting skin thickening reduces UV
penetration to the basal layer of the epidermis and
underlying dermis. At the peak of the response to
500 Jm 2 UVB, the epidermis was sevenfold thicker in
Erccl skin-specific knockouts than controls. Epidermal
thickening (10-fold more than controls) and cellular
abnormalities were even more pronounced at 2000 Jm 2.
Acute UV-induced epidermal thickening has not been
studied so thoroughly in other NER knockouts.
Examination of irradiated skin sections in reports for
other NER knockouts shows the strongest response in
Xpa knockouts following 1200 Jm2 (de Vries et al.,
1995), where the thickening was only around half the
icogene
Mice with DNA repair-deficient skin













Figure 5 Skin tumour growth in Erccl skin-specific knockout
mice. Tumour diameter (mm) was determined 2, 3 and 4 weeks
after each tumour was initially detected. The frequency (%) of
tumours in the different size categories is indicated. Unshaded bars,
control; shaded bars, Erccl skin-specific knockout. Two-week
measurements: control, n = 22 tumours; Erccl skin-specific knock¬
out, « = 18. Three-week measurements: control, n = 22; experi¬
mental, n=\l. Four-week measurements: control, n = 20;
experimental, n= 15.
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Figure 6 Rapid actiic progression in skin tumours from Erccl
skin-specific knockout mice, (a) Typical papule from control mouse
showing carcinoma in situ, (b) Typical papule from Erccl skin-
specific knockout mouse showing actinic keratosis, (c) Squamous
cell carcinoma (SCC) grade not specified (GNS) from control
mouse with adjacent carcinoma in situ, (d) Squamous cell
carcinoma GNS from Erccl skin-specific knockout mouse with
adjacent actinic keratosis. In (c) and (d) high-power insets of the
regions indicated by the boxes show individual epithelial cells
(arrows) invading the dermis, upon which the diagnosis of SCC
GNS was based. For all images the original magnification was
x 100 (insets x 400).
maximum level reported here for Erccl skin-specific
knockouts. Thus, the epidermal thickening and cellular
abnormalities in our Erccl skin-specific knockouts are
more pronounced than reported for other NER knock¬
outs.
Erccl skin-specific knockout mice were also hyper¬
sensitive to UV-induced skin cancer. The simple
comparison of tumour yield understates the difference
between Erccl skin-specific knockout and control mice
because the more rapid growth of tumours on mutant
mice meant that the maximum tumour size end point
was reached far earlier after the first tumour was
detected on mutant compared to control animals. As
the carcinogenic effect of UVB is not directly propor¬
tional to dose, the most rigorous comparisons of
sensitivity require equivalent doses. At the lowest dose
(125 Jm~2, three times a week) tumours were first
detected on Erccl skin-specific knockouts after 8 weeks.
At the same dose no tumours were detected on control
mice up to 58 weeks when the protocol was terminated,
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indicating that Erccl skin-specific knockouts were
> sevenfold more sensitive than controls. Based on the
ratio of median tumour induction times at the same
dose, Xpa mice were only fourfold, Xpc mice threefold
and Csb mice were twofold more sensitive than controls
(Berg et al., 1997, 2000). A much higher dose
(2000 Jm2) was required to generate a comparable
number of skin tumours in our control mice. The
cumulative UVB dose for 50% of Erccl skin-specific
knockout mice to develop skin tumours (3.75 kJm2)
was 37-fold lower than for controls. This sensitivity is
comparable to that reported for Xpa knockouts where,
at 32 J nr2 day-1, 50% of mice developed tumours at a
cumulative dose of 3.1 kJm-2 (Berg et al., 1997), or
3.7 k J m-2 (de Vries et al., 1998). At the higher dose of
80Jm-2day~' the corresponding cumulative doses were
5.5kJrrr2 (Berg et al., 1997) and 7.7kJm 2 (de Vries
et al., 1998). Many of the other skin carcinogenesis
protocols have used much higher UVB doses, or shaven
as opposed to hr mice, or different UV sources with
possible discrepancies in dosimetry, making comparison
with our data difficult. Cumulative UVB doses under
these high daily dose conditions for 50% of mice to
develop tumours (or for a high frequency of tumour
production) were: Xpc 300kJm 2 (Sands et al., 1995);
Ddb2 210kJm-2 (Itoh et al., 2004); TTD {Xpcl point
mutation modelling trichothiodystrophy) 103 k J rrr2 (de
Boer et al. 1999); Xpa 84 k J rrr2 (Nakane et al., 1995)
and 22 k J irr2 (de Vries et al., 1995); Csb 45 KJm 2 (van
der Horst et al., 1997). Thus, in a similar protocol and
not withstanding that the genetic backgrounds are
different, sensitivity to UV-induced skin cancer in Erccl
skin-specific knockouts is comparable to that seen in
Xpa knockouts and exceeds that reported for other
NER knockouts. In addition to an increased frequency,
tumours on Erccl skin-specific knockout mice were
larger and grew more quickly than on control litter-
mates. This has not been reported for other NER
knockouts.
One explanation for the decreased frequency of
carcinoma in situ in Erccl skin-specific knockout mice
is that SCCs arise earlier in actinic progression in
these animals, before full-thickness actinic dysplasia,
which was our criterion for a diagnosis of carcinoma in
situ. Support for this hypothesis comes from comparing
the histological environment in which SCC GNS
occurred in Erccl skin-specific knockout and control
mice. Squamous cell carcinoma GNS was the classifica¬
tion given to tumours in which individual epidermal
cells or small nests of epidermal cells had clearly
penetrated the basement membrane and invaded the
dermis. Half the tumours identified as SCCs GNS in
Erccl skin-specific knockout mice appeared to arise
from areas of adjacent actinic keratosis, whereas all
SCCs GNS identified in control mice were adjacent to
carcinoma in situ. Further evidence for earlier progres¬
sion to SCC in Erccl skin-specific knockout mice was
the trend towards a higher prevalence of SCC among
papules: 7/15 for Erccl skin-specific knockouts and 3/17
for controls. Larger cohorts will be necessary to confirm
this trend.
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In Erccl skin-specific knockout mice, half (12/24) of all
raised epidermal masses (papules and exophytic masses)
were hyperplastic actinic keratosis (actinic papillomas).
By contrast, only four of 26 raised epidermal masses were
diagnosed as actinic keratosis in control mice. This
difference in the prevalence of hyperplastic actinic
keratosis could have resulted from a greater tendency
for focal hyperplasia to occur in actinic lesions of
experimental versus control mice. Alternatively, or in
addition, the diffuse background of actinic keratosis in
Erccl skin-specific knockout mice, revealed in samples
from non-gross lesional skin, provided a far greater
opportunity for superimposition of focal exuberant
hyperplasia than in control mice in which the background
skin histopathology was non-dysplastic acanthosis.
Thus, in addition to the expected increased frequency
of UV-induced epidermal skin tumours in Erccl skin-
specific knockout mice, the tumours are also larger,
grow more quickly and show more rapid actinic
progression to SCC than in control mice. Increased
skin tumour frequency in NER knockout mice has been
reported previously, but the more rapid actinic progres¬
sion has not. We do not know whether this is specific to
Erccl deficiency, or is a previously undetected general
feature of NER-deficient epidermis, that could result
from increased UV-induced mutagenesis and the pro¬
nounced proliferative response. This could be a direct
effect of Erccl deficiency on progression, or an indirect
effect of the increased tumour growth rate.
We have shown that Erccl has an essential role in
protecting the skin against the short- and long-term
effects of UVB irradiation. The combined erythemal,
hyperproliferative and skin tumour responses in Erccl
skin-specific knockout mice are stronger than reported
for other NER gene knockouts. In addition, we have
demonstrated more rapid actinic progression in Erccl-
deficient skin. Molecular analysis of mutations arising in
these tumours will be necessary to confirm our hypoth¬
esis that the consequences of Erccl deficiency in skin are
more severe than for other NER genes.
Materials and methods
Generation of hairless Erccl skin-specific knockout mice
Hairless (hr) mice on an MF-1 background were obtained
from Harlan UK Ltd, Bicester, Oxan, UK. These were crossed
separately with our K5Cre (Ramirez et al., 2004), Erccl floxed
and original Erccl knockout lines (McWhir et al., 1993) and
albino progeny were intercrossed to produce albino hairless
K5Cre, Erccl floxed and Erccl knockout lines. K5Cre
containing Erccl*1' males from a cross between albino hairless
K5Cre and Erccl knockout lines were mated with albino
hairless ErccE0*1-"0* females to produce experimental (Ercclf,oxl'
with K5Cre) and control (Ercclfl°x'* with K5Cre) littermates
on a segregating background.
Mouse genotyping
Erccl. The Erccl null (Erccl') allele was the original knockout
allele with a neo gene insertion (McWhir et al., 1993), rather
than the new knockout allele described here, which was
generated as an intermediate in the production of the floxed
allele. A triplex PCR (Selfridge et al., 2001) distinguished
A
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Erccl+ and ErccF°* alleles from the Erccl' allele. Primers
033 M for exon 4 (5'-CCCGTGTTGAAGTTTGTGCG,
mouse Erccl cDNA sequence 429^48, GenBank Accession
no X07414) and 035 M for exon 5 (5'-CGAAGGGCGAAGTT
CTTCCC, mouse Erccl cDNA sequence 598-579) gave a
0.6 kb product for the wild-type and floxed alleles. The null
allele was detected as a 0.8 kb product from the exon 5 primer
and a primer for the neo cassette (5'-GGTTCGAAATGACCG
ACCAAGCG, 958-980 GenBank Accession no V00618). A
PCR reaction with primers 432E and 159M distinguished
between the wild-type (1.8 kb product) and floxed (1.4kb)
alleles (see Supplementary Information, Figure 1). 432E (5'-
TGCAGAGCCTGGGGAAGAACTTCGC; mouse Erccl
cDNA sequence exon 5; positions 568-592, GenBank Acces¬
sion no. X07414) and 159M (5'-TAGCCAGCTCCTTGAGA
GCC; mouse Erccl cDNA sequence exon 6, positions
657-638) with cycle conditions: 94°C 1 min, 66°C 1 min and
72°C 1.5min for 35 cycles.
Keratin 5 Cre Genotyping for the K5Cre transgene was
performed using primers G13586 (5'-ACCTGCCATGAAGA-
CAGCGTTTGCAC, B. taurus gene for keratin 5, promoter
region, positions 1115-1140, GenBank Accession no. Z32746)
and G13587 (5'-TGCACGTTCACCGGCATCAACG, Bac¬
teriophage PI Cre recombinase gene, coding region, positions
877-856, GenBank Accession no. X03453). A 1.4kb product
specific for the transgene was obtained with conditions: 94°C
1 min, 66°C 1 min and 72°C 1.5 min for 30 cycles.
Recombination of the Erccl floxed allele
Recombination of the Erccl floxed allele was detected with
primers F25731 (5'-TGTCTCCCTGGCTCTGGATCTGAC)
and F25732 (5'-TCAAAGTATGGTAGCCAAGGCAGC),
which lie immediately 5' of the first loxP site and 3' of the
second loxP site, respectively (see Figure 1 and Supplementary
Information, Figure 1). A 0.25 kb product specific for the
recombined allele was obtained with conditions: 94°C 1 min,
68°C 1 min and 72°C 1.5min for 25 cycles. Under these
conditions, the distance between the primers on the non-
recombined floxed allele is too great to give a PCR product.
Southern analysis
Separation of the epidermis from the dermis ofmouse tails has
been described previously (Remenyik et al., 2003). DNA was
extracted from mouse tissues and subjected to Southern
analysis as described (Thompson et al., 1989). The probe used
was a 600-bp PCR product spanning exons 1 and 2 (Figure 1).
This product was obtained with primers F29600 (5'-GAGTCT
AGCAGGAGTTGTGCTGGC, mouse Erccl cDNA se¬
quence 1-24, GenBank Accession no. X07414) and F29601
(5'-CTTCCTCCTGGTGGGTGGTCCTGAGG, mouse
Erccl cDNA sequence 161-136) with conditions: 94°C 1 min,
64°C 1 min and 72°C 1 min for 35 cycles.
Ultraviolet irradiation experiments
Animals were irradiated with a UVB light source (Phillips
TF20W/12RS tube, emitting 2.4Jm~2s"' and calibrated to
national standards). To study short-term responses, animals
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were killed at varying times after irradiation and ears were
removed and fixed in Methacarn (methanol:chloroform:acetic
acid, 3:2:1). Five micron transverse sections were cut and
stained with haematoxylin and eosin (H&E). Epidermal area
was measured along the length of the irradiated (upper)
surface, and the mean epidermal thickness was calculated by
dividing the area by the length. This was done to correct for
local variations in epidermal thickness along the length of the
ear. Immunohistochemistry for BrdU incorporation was
carried out by a modification (see Supplementary Information)
of a method described previously (Nunez et al., 2000).
For long-term irradiations, animals were monitored weekly
and changes in skin condition, tumour onset and tumour size
were recorded. An animal was killed when its largest tumour
exceeded 10mm in diameter. Tumours and apparently
unaffected areas of back skin were removed, fixed in buffered
formalin and processed for histology with H&E staining as
described above.
Gross and histologic classification of tumours
Ultraviolet irradiation-induced skin tumours were classified
based on their gross and histologic appearance using a
modification of the scheme proposed by Gallagher et al.
(1984) and Canfield et al. (1988). Briefly, skin lesions were
classified according to their gross appearance as papules
(raised epidermal mass less than 2mm in diameter), exophytic
masses (growth projecting from surface greater than 2mm in
diameter), and endophytic masses (inward growing mass
greater than 2 mm in diameter).
Histologic classification consisted of non-neoplastic appen¬
dage cysts, acanthosis (epidermal hyperplasia without dyspla¬
sia), and actinic keratosis (epidermal hyperplasia with
dysplasia of basal cell layer, or basal and spinous cell layer,
but retention of external granular cell layer). Epithelial
neoplasms consisted of carcinoma in situ (full-thickness
dysplasia, absent stratum granulosum, intact basement mem¬
brane) and SCC (penetration of basement membrane and
dermal invasion). Grade 1 SCC had prominent keratin pearls
with obvious granular cell layer; Grade 2 SCC had fewer
keratin pearls with few or absent granular cells often
associated with parakeratosis; Grade 3 SCC had no keratin
pearls, but keratinized groups of cells or individual cells.
Squamous cell carcinomas with GNS were those carcinomas
consisting of individual cells or small nests of cells which were
judged to have penetrated the basement membrane and
invaded the superficial dermis.
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